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Abstract 
More than 1.5 billion people, or 24% of the world’s population, are infected with helminths  
worldwide. Infections are highly epidemic in tropical and subtropical areas, with the greatest 
numbers occurring in sub-Saharan Africa, the Americas, China and East Asia. Helminths are 
strongly immunomodulatory, which has facilitated their ability to resist attack by their host’s 
immune system, which has made attempts to vaccinate against parasitic helminths an enormous 
challenge. In order to develop a vaccine, we need to understand more about the nature of the 
protective immune response against helminths, and how helminths have evolved to control the 
host immune system to enable their survival.  
Inflammasomes are important for immunity against invading microbial pathogens such as 
bacteria, viruses and protozoa by promoting the maturation and secretion of inflammatory 
cytokines such as IL-18 and IL-1β and resultant Type 1-mediated immunity. However, the roles 
for inflammasomes in Type 2 immunity to parasitic helminths are less well studied. Therefore, 
this dissertation has focused on studying the roles of distinct inflammasome activation 
pathways (NLR Family Pyrin Domain Containing (NLRP3 and NLRP1) in immunity and 
inflammation following infections with multiple species of gastrointestinal helminth. Firstly, 
we show that intestinal whipworm infection, Trichuris muris, and its excretory/secretory 
proteins can promote NLRP3-dependent IL-18 and IL-1β secretion in vivo and in vitro, in 
concert with signals from bacteria. Critically, we have identified a novel mechanism by which 
NLRP3-dependent IL-18 suppresses innate and adaptive immune responses to T. muris, 
resulting in immunopathology and more persistent infections. This suggest that worm-mediated 
NLRP3 inflammasome activation is one potential mechanism of how parasitic worms may 
enhance their survival in their host. We next assessed whether NLRP3 plays a similar or 
different role in regulation of immunity to a different species of parasite helminth, 
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Nippostrongylus brasiliensis, a model of hookworm that infects both the lung and intestine. 
Similar to results we observed with whipworm infections, N. brasiliensis infections promoted 
NLRP3-dependent increases in IL-18 and IL-1β levels in the lungs and gut and ablation of 
NLRP3 resulted in increased anti-parasitic immunity in the lung. NLRP3-deficient mice 
displayed marked increases in neutrophil recruitment to the lung, a cell type that is potently 
toxic to parasite larvae.  Thus we demonstrate that NLRP3 may restrain anti-parasitic neutrophil 
responses within the lung.  Lastly, we investigated for the first time the role for a distinct 
inflammasome regulator, NLRP1, in immunity to a parasitic helminth. We found that NLRP1 
does suppress immunity to both T. muris and N. brasiliensis infection in a similar way to 
NLRP3, however NLRP3 appears to play a greater role in regulating innate immunity to N. 
brasiliensis, in particular.  
Together these data provide novel insights into the activating and regulatory pathways of both 
the innate and adaptive immune systems following gastro-intestinal helminth infections. By 
understanding the precise mechanism of how inflammasomes regulate immunity and 
inflammation following helminth infection, it may help inform the development of novel vac 
vaccines against human infections.  
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1. CHAPTER 1: INTRODUCTION  
1.1 Parasitic helminth infections: Global health burden 
Parasitic helminth infections are among the most common and debilitating causes of chronic 
disease in humans. Helminths can be classified into two major groups; Nematodes 
(roundworms) that include the gastrointestinal worms (also known as soil-transmitted 
helminths) and filarial worms that cause lymphatic filariasis (LF) and onchocerciasis; and 
Platyhelminths (flatworms) that include the flukes such as schistosomes, and tapeworms such 
as the pork tapeworm that causes cysticercosis (Hotez et al., 2008). Among these parasites, soil-
transmitted helminths (STHs), such as Ancylostoma duodenale, Necator americanus, Ascaris 
spp. and Trichuris spp. are the most common parasitic helminth that infects humans, where 
approximately one-sixth of all humans are affected (Chanco and Vidad, 1978; Hotez et al., 
2009). Helminth infections are most common in developing countries, including those in sub-
Saharan Africa, South America and South-East Asia (Figure 1.1), where infections are 
especially problematic in children (Crompton, 1999). Furthermore, chronic intestinal helminth 
infections can also impact the pathology associated with other viral and bacterial diseases such 
as human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (Bentwich et al., 
1995; Chatterjee and Nutman, 2015). Prevalence, mortality and morbidity of intestinal helminth 
infections are influenced by genetics, public health measures and the environment. Children 
suffering from helminth infections exhibit signs of stunted growth, intellectual retardation, 
educational deficits and malnutrition (Bethony et al., 2006). Moreover, helminth infections 
negatively affect infant birth weight, survival as well as increased occurrence of maternal 
anemia during pregnancy (Bethony et al., 2006). Helminth infections are also an enormous 
problem in the livestock industry, leading to billions of dollars of production losses annually 
(Balic et al., 2000; Claerebout and Vercruysse, 2000). 
 3 
 
 
  
Figure 1.1 Global Distribution of Human Hookworm Infection (Hotez et al., 2005) 
 4 
1.2 Current control methods for worm infections 
The most effective control methods of helminth infections in humans are hygiene improvement 
throughout health education and appropriate sanitation procedures.  In addition, chemotherapy 
via the use of anthelminthic drugs can also reduce morbidity and prevalence of infection 
(Gazzinelli et al., 2012). Chemotherapy such as ivermectin, albendazole and praziquantel are 
widely used for helminth control and eradication when taken individually or as combinations 
(ivermectin and albendazole or albendazole and praziquantel), and are a safe tool against 
schistosomiasis and STH in endemic regions (Olds et al., 1999). However, the number of 
available anthelmintic drugs is limited and the costs of drug production and the necessity of 
repeated administrations are problematic. This is especially true for the livestock industry, 
where repeated drug treatments cost around one thousand millions pound sterling (£1000 
million) per annum in Britain alone (Newton and Munn, 1999). Currently, effective control 
depends on continuous use of anthelmintic drugs to protect humans and animals from 
infections. However, some important issues such as parasitic resistance against anthelmintic 
drugs have arisen in livestock, highlighting the importance for developing alternative control 
strategies (Balic et al., 2000; Hagel et al., 1999; Newton and Munn, 1999; Ruso et al., 2015). 
Therefore, more effective preventative treatments are required, such as- vaccine or vaccine/drug 
dual therapies.  
1.3 Current state of vaccine research 
There have been many examples of successful development of vaccines against viral and 
bacterial pathogens (Cowling et al., 2016; Mcaleer et al., 1984; Ruso et al., 2015), to date there 
are no vaccines that can limit the immense burden of human helminth infections. This may in 
part be due to the ability of worms to manipulate the immune system by suppressing immune 
responses, which is essential for the survival of the parasites. In many cases, the immune 
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responses that are mounted against parasitic helminths are ineffective, resulting in  an inability 
to clear the infection. This could be due to a number of factors, including  a failure to mount a 
protective memory T cell or antibody-mediated immune response that could protect against 
reinfection. The development of a vaccine would be critically important for assisting the 
existing chemotherapy methods for controlling infections in helminth-endemic areas.   
 
1.3.1 Vaccines in livestock and animals 
 
Vaccinations against helminths are an important element of disease prevention in an animal 
health program. Helminth-excreted proteases can protect sheep against Haemonchus contortus 
(Knox et al., 2003; Smith et al., 2003) and Ostertagia ostertagi (Geldhof et al., 2002).  
Similarly, substantial protection against livestock nematodes has been demonstrated with a 
purified recombinant protease vaccine (Knox et al., 1999). There are also successful metazoan 
parasite vaccines against the gastrointestinal nematode Haemonchus contortus (Knox, 2000) as 
well as cestodes, Taenia ovis (Johnson et al., 1989) and Echinococcus granulosus (Lightowlers 
et al., 1996). It has also been shown that canines can be vaccinated against hookworm 
Ancylostoma caninum via immunization with third-stage infective larvae (L3) that were 
attenuated by ionization radiation (Miller, 1965a, b). Irradiated schistosomes are also effective 
vaccines for animals (Eberl et al., 2001). Furthermore, antigens released by hookworm larvae 
are able to protect hamsters (Goud et al., 2004; Mendez et al., 2005) and dogs (Hotez et al., 
2003) from hookworm infections, where larval excretory/secretory (ES) proteins can promote 
a strong protective Th2 response (Allen and MacDonald, 1998). Further studies have identified 
purified recombinant proteins that are released by parasites that are effective vaccines for 
hookworm infections, including then cysteine hemoglobinase, Ac-CP-2 (Loukas et al., 2004), 
Ac-APR-1 and Ac-ASP-2 (Loukas et al., 2005). 
 
 6 
1.3.2 Human vaccines against helminths 
Development of a vaccine against human helminth infections remains elusive despite the 
tremendous progress made in vaccinology for other infectious diseases. It has been shown in 
some trials that Necator americanus ASP-2 adjuvanted with Alhydrogel are safe and 
immunogenic against hookworm infection (Goud et al., 2005), However, during phase 1 testing 
in a hookworm endemic area of Brazil, ASP-2 resulted in urticarial responses after a single 
vaccination (Diemert et al., 2012). Human Schistosoma mansoni TSP-2 is being developed as 
a recombinant protein to prevent heavy Schistosoma mansoni infection (Curti et al., 2013). 
Further, a human hookworm vaccine is being developed as a bivalent substance containing two 
recombinant proteins (GST-1 and APR-1 from N. americanus), to reduce moderate and heavy 
hookworm infections (Pearson et al., 2010).  These vaccines will target a pediatric population, 
as this age group is more susceptible to chronic infections (Bethony et al., 2006; Brooker et al., 
2004; Hotez et al., 2005; Hotez et al., 2008; Hotez and Brooker, 2004). The previous failures 
in vaccine development have been due to many reasons, including the ability of parasites to 
evade immune responses and our lack of understanding of how these parasites interact with 
their hosts to induce immunity. In order to develop vaccine, it is important to understand the 
immune response to infection in both human and animal models. 
 
1.4 Protective immune responses to helminth infections 
1.4.1 Lessons from humans in endemic areas  
Humans living in endemic areas are constantly exposed to parasites. However, there have been 
observations that some people are highly resistant to infection, while others develop chronic 
and recurring infections (Elliott et al., 2007). Some of this variation may be attributed to 
differences in nutrition, genetics and immune status. Susceptibility can be correlated to 
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variation of the genetic regulation of B cell activation as well as immunoglobulin secretion 
(Hagel et al., 1999). Serum antibody levels against hookworms are predominantly the Type-2-
immune associated immunoglobulins such as IgG1, IgG4 and IgE (Jarrett and Bazin, 1974). 
Furthermore, eosinophil and mast cell numbers are increased during hookworm human 
infection, in addition to increase of Type 2 cytokines (MacDonald et al., 2002). However, the 
study of immune responses against helminths in endemic areas is complicated due to 
coinfections with other infections such as bacteria and viruses, as well as infestations with 
multiple helminth species. Further, it is difficult to monitor patients over a long period of time 
without using chemotherapeutical intervention and it is impossible to know the frequency or 
timing of these infections. Only a few publications have described controlled infection of 
volunteers (Gaze et al., 2012; Maxwell et al., 1987; White et al., 1986), demonstrating that 
worm infections do indeed induce a biased Type 2 immune response. 
1.4.2 Lessons from experimental animal models  
Animal models have been critical for defining the immunological mechanisms of protection 
against helminths. For example, studies on the parasitic helminth infections such as Trichuris 
muris (a model of human whipworm Trichuris trichiura) and Nippostrongylus brasiliensis and 
Heligmosomoides polygyrus (mouse models of human hookworm) have greatly contributed to 
our knowledge of the components of immune responses that are responsible for resistance and 
susceptibility to infection (Camberis et al., 2003; Farah et al., 2001; Klementowicz et al., 2012). 
Helminths infections are often accompanied by polarized T helper Type 2 (Th2) immune 
response (Anthony et al., 2007; Maizels and Yazdanbakhsh, 2003; Mulcahy et al., 2004), 
characterized by increased production of interleukins (IL-4), IL-5, IL-9 and IL-13 by CD4+ T-
helper Type 2-cells. Experimental models revealed that the protection against nematode 
infection can be a CD4+ T cell-dependent process, with T cell-derived IL-4 being essential 
(Finkelman et al., 1997). Th2 cell-derived cytokines elicit activation of cells such as 
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macrophages, mast cells, eosinophils, basophils and neutrophils that coordinate immunity to 
the parasite. Th2 cell-derived cytokines also induce B-cells to produce helminth specific IgE 
and IgGs that, together with the persistence of memory Th2 cells, can provide long-lasting 
immunity to reinfection (Anthony et al., 2007; Erb, 2007; Finkelman et al., 1997; Maizels and 
Yazdanbakhsh, 2003; Mulcahy et al., 2004), However, the helminth- host immune system 
interaction is the result of co-evolution, thus helminths had to develop mechanisms to deal with 
the host’s immune system (Bentwich et al., 1995). There are different strategies for helminth 
immunomodulation leading to down-regulation of T cell immune responses, including 
stimulation of regulatory T-cell (Treg) immune responses, inhibition of effector cells as well as 
inhibition of immune cell proliferation (Allen and Maizels, 2011; Erb, 2007; Finkelman et al., 
1997; Mulcahy et al., 2004). Helminth infections in humans and animal models are associated 
with expansion of regulatory T-cell populations and it is believed that these cells may directly 
or indirectly suppress the anti-parasitic immune responses directed against the parasite 
(Ludwig-Portugall and Layland, 2012; Maizels and Smith, 2011; Metenou and Nutman, 2013). 
Regulatory T cells possess an array of mechanisms by which they may regulate immune 
responses, including the release of anti-inflammatory cytokines such as IL-10 and TGF-β  that 
can inhibit the development and function of pro-inflammatory Th1 and Th17 responses, but 
also restrain anti-parasitic Th2 responses (Flynn and Mulcahy, 2008; Maizels et al., 2004). This 
can enhance the ability of the worm to survive (Anthony et al., 2007), which is beneficial both 
for the parasite and the host, by the suppression of potentially pathogenic, tissue-destructive 
immune responses such as Type 1 immune responses or unrestrained Type 2 immune responses 
(Anthony et al., 2007). However, Type 2 immune responses are not associated with immunity 
to all helminths. In schistosomiasis, the host can develop protective  Th1 immune responses to 
parasites during early stages of infection, where Th2 immune responses occur later in response 
to eggs laid by the parasite (Stadecker et al., 2004). Together, the complete nature of the 
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immune response against helminth infection still remains unknown. The following section 
provides a more detailed about the mechanisms of worm expulsion as well as the role of 
immune cells and cytokines towards infection. 
 
1.4.3 Physiological mechanisms of worm expulsion 
 
While T cells play a crucial role in promoting the inflammatory response against infection, T 
cells do not kill the parasite directly. Rather, they orchestrate a downstream effector biological 
response that expels the worms. Epithelial turnover and mucin production are considered two 
of the key mechanisms of worm expulsion, which has been primarily demonstrated using the 
T. muris model of whipworm infection (Cliffe et al., 2005). Goblet cells within the crypts of 
colon and caecum produce mucins that form the major component of the mucus layer of the 
intestine and prevent close association of T. muris with the epithelial barrier (Klementowicz et 
al., 2012). Goblet cell hyperplasia occurs following exposure to T. muris infections in 
genetically-resistance mice such as C57BL/6 or BALB/c mice (Artis et al., 2004), and does not 
occur in susceptible mice such as AKR mice (Hasnain et al., 2011a; Hasnain et al., 2011b; 
Hasnain et al., 2010). Mucin production by goblet cells is regulated by Th2 cytokines such as 
IL-9 and IL-13 (Kondo et al., 2002; Taube et al., 2002; Whittaker et al., 2002). Furthermore, 
epithelial cells of intestine have a close relationship with gastrointestinal parasites such as T. 
muris (Tilney et al., 2005). The formation of an “Epithelial escalator” and increased epithelial 
turnover, where cells migrate from the bottom of the crypt “proliferation zone” to the shedding 
zone at the top of crypt, is an important mechanism that accelerates T. muris expulsion in 
resistant animals, and is delayed in susceptible mice (Cliffe et al., 2005). Moreover, Th2 
cytokines such as IL-4 and IL-13 promote increased intestinal smooth muscle contractility and 
also increased intestinal permeability and responsiveness to mediator including prostaglandin 
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that stimulates fluid secretion following H. polygyrus and N. brasiliensis infections  (Zhao et 
al., 2003). 
 
1.5 Adaptive immune responses to helminths 
 
1.5.1 T-helper cells and cytokines 
 
The immune system consists of 2 arms: The innate immune system and the adaptive immune 
system. Activation of adaptive immunity requires that foreign antigens must be recognized by 
innate immune cells, which process them into peptides that are presented to lymphocytes such 
as T cells and B cells through MHC molecules. For small foreign pathogens, such as bacteria, 
viruses, fungi and protozoan parasites, killing of the pathogen can be achieved following 
engulfment of the invading pathogen. However, helminths are large and impossible to be 
engulfed by immune cells. Thus, helminth proteins excreted during infection are processed and 
presented instead to adaptive immune cells (Gause et al., 1999). However, the precise cellular 
mechanisms of how helminth antigens are recognized by the immune system to promote 
adaptive immunity are incompletely understood.  
 
Within the adaptive immune system there are many distinct lymphocyte subsets that are 
important for immunity to different pathogens. CD8+ T cells have important roles in immunity 
to some infectious diseases via MHC-1 expression and induction of cell-mediated killing 
(Jordan and Hunter, 2010). However, the importance of CD8+ T cells during helminth 
infections is less clear, since helminths may be resistant to CD8-mediated attack due to their 
large size (Metwali et al., 2006). In contrast, CD4+ T helper cells are known to play a central 
and essential role in orchestrating immunity to large pathogens such as parasitic helminths. 
There are many different subsets of CD4+ T cells that play different roles depending on the 
nature of the infection, and the cytokines they release.  
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The development of a T-helper Type 1 (Th1) cell response is important for immunity to small, 
easily phagocytosed pathogens such as bacteria, viruses, fungi and protozoan parasites (Kidd, 
2003). However aberrant Th1 cell responses are associated with various autoimmune and 
inflammatory diseases (Liblau et al., 1995). Th1 cell development begins with the secretion of 
IL-12 and IL-18 by cells such as macrophages and DCs upon recognition of intracellular or 
extracellular pathogens (Farrar et al., 2002). IL-12 can induce the differentiation of naïve 
CD4+ T lymphocytes to become interferon-gamma (IFN-γ)-producing Th1 cells  (Trinchieri, 
1994), which can activate macrophages to become “classically activated macrophages” that can 
phagocytose and kill pathogens (Kidd, 2003). IL-12 also acts to up-regulate IL-18 receptor 
expression.  
 
Th17 cells represent a subset of CD4 effector T cells that are important for immunity to 
extracellular bacteria and fungi, but also associated with autoimmune diseases (Bettelli et al., 
2007; Weaver et al., 2006). Th17 cell development is dependent on RORγt transcription factor 
(Dong, 2006; Ivanov et al., 2006). IL-23 production by dendritic cells and macrophages is an 
important factor in production of a robust Th17 response; however, studies in vitro and in vivo, 
have shown that it is not responsible for the initial induction or commitment to differentiation 
of the Th17 phenotype (Mangan et al., 2006; Veldhoen et al., 2006). Other factors such as IL-
6 and TGFβ also play important roles in Th17 cell development (Kimura and Kishimoto, 2010). 
 
Th2 cells are important for immunity to large pathogens such as parasitic helminths, but are 
also associated with detrimental inflammation during allergies and asthma (Cooper, 2009). The 
differentiation of Th2 cells primarily involves the transcription factor GATA-3 and the action 
of IL-4 produced by a variety of cells such as natural killer T cells, eosinophils, mast cells, 
basophils and innate lymphoid cells (Kidd, 2003; Lafaille, 1998; Pelly et al., 2016; Wang et al., 
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2006). After Th2 cells become mature they  increase IL-4 production, which generates a 
paracrine loop and induces naive T cells to become Th2 cells (Kidd, 2003). Further, IL-6 also 
secreted during the early stages of a Th2 immune response, that induces the Th2 activation via 
the up-regulation of IL-4 and inhibition of STAT1 phosphorylation, through inhibition IFN-γ 
gene expression (Detournay et al., 2005; Dodge et al., 2003). 
 
1.5.2 B cells and antibody  
 
Production of IL-4 following helminth infection can promote generation of antigen-specific 
IgG1 and IgE secreting plasma cells (Gause et al., 1999). The relative importance of antibody 
in immunity to worms is still unclear, however antibody binding could directly neutralize the 
ability of the parasite to feed or migrate, or could activate downstream cellular immune 
responses (Liu et al., 2010; McCoy et al., 2008). Consistent with this, purified IgG and serum 
transfer from immune animals can confer protection against some species of helminth (Liu et 
al., 2010; McCoy et al., 2008). IgE is an important effector molecule that can activate immune 
effector cells during helminth infections, where mast cells and basophils are activated by IgE 
binding and subsequently release their granules and cytokines. However, it has been proposed 
that IgE is not essential for the protective immune response against parasites like H. polygyrus 
bakeri or N. brasiliensis (Liu et al., 2010; McCoy et al., 2008; Watanabe et al., 1988). 
Interestingly, depletion of B cells increases the severity of infections with helminths such as H. 
polygyrus bakeri (McCoy et al., 2008; Watanabe et al., 1988), suggesting that B cells have 
additional functions that may promote immune resistance, B cells also produce cytokines that 
have effect on the ongoing Th2 response and induce immune regulation (Wojciechowski et al., 
2009).  
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1.6 Innate immune responses to helminths 
 
The innate immune system plays important role as the first line of defense against parasitic 
infection. Cells and cytokines of this system can initiate and direct the adaptive immune 
response, in addition to controlling the early stages of infection. Dendritic cells, neutrophils, 
eosinophils, basophils, mast cells and macrophages are the main innate immune cells that 
immediately respond to invading pathogens. In addition to their role as the first effector cells, 
they can sense danger signals and pathogen-associated molecular patterns, producing cytokines 
that direct the immune response. 
1.6.1 Dendritic cells 
 
Dendritic cells (DCs) are important in stimulation and modulation of the host immune system 
following helminth infections, by acting as the primary cell that processes and presents antigens 
to the adaptive immune system (Pulendran et al., 2010). Helminth products can modulate DC 
activation and prevent their ability to promote Th1 and Th17 responses, but also induce Th2 or 
regulatory T cell responses (Aranzamendi et al., 2012; Donnelly et al., 2010; Goodridge et al., 
2003; Haçariz et al., 2009; Layland et al., 2007; Van der Kleij et al., 2002; Zaccone et al., 2011; 
Zaccone et al., 2003). DCs are crucial antigen presenting cells and are involved in T-cell 
activation and regulation (Mulcahy et al., 2004). Their activation results in increased surface 
expression of MHC class II and co-stimulation molecules including CD40, CD80 and CD86 
that modulate the developing adaptive immune response (Kumamoto et al., 2013). The DC-
signals responsible for inducing Th2 cell responses in-vivo are still unclear (Gao et al., 2013). 
Other studies have demonstrated that DC-mediated Th2 cell differentiation required the Notch 
ligand jagged (Krawczyk et al., 2008) and up-regulation of the molecules CD40 and OX40L 
(Ganley-Leal et al., 2006). But whether these pathways are required for DCs to induce CD4+ 
Th2 cell differentiation in vivo remains undefined. Further, the in vivo role of DCs in helminth 
infections is controversial. In some experimental systems, DCs alone are not sufficient to induce 
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a Th2 response (Paul and Zhu, 2010), suggesting that other cells also contribute. This may be 
due in part to active regulation of DC function by helminths, where the release of parasite 
enzymes can polarise DC responses and establish infections (Hewitson et al., 2009). 
 
1.6.2 Eosinophils  
 
Increases in eosinophil numbers in blood and tissues is a hallmark of parasitic helminth 
infections (Ganley-Leal et al., 2006; Huang and Appleton, 2016) Interlukin-5 (IL-5) is 
important for growth and differentiation of eosinophils (Dent et al., 1990; Lopez et al., 1986). 
Eosinophils provide immune protection against some helminth species by releasing their toxic 
granules that damage the parasite when they recruited to the site of infection (Makepeace et al., 
2012; Shamri et al., 2011; Voehringer et al., 2006).  For example, it has been highlighted that 
eosinophil-derived major basic protein (MBP) has toxicity against some species of 
helminth  (Stone et al., 2010). A recent report demonstrated that during a secondary immune 
response, eosinophils are activated by memory Th2 cells to express even higher levels of MBP, 
which makes them more toxic to N. brasiliensis larvae in the lung (Obata-Ninomiya et al., 
2018). In addition to toxic granule proteins, eosinophils can also express other proteins, such 
as cytokines, chemokines, growth factors and lipid mediators (Rothenberg and Hogan, 2006). 
For instance, eosinophils have been suggested to support Th2 immune response through 
releasing IL-4 (Voehringer et al., 2004). However it is clear that due to the chronic nature of 
some helminth infections, in the face of ongoing eosinophils, it suggests that worms may be 
able to evade eosinophil attack to prolong their survival (Maizels et al., 2012). For example, it 
has been proposed that eosinophils can be effective at killing infective larval stages but not the 
adult worms (Meeusen and Balic, 2000). Furthermore, studies using mice that over-express IL-
5, and hence display constitutive eosinophilia, have revealed that eosinophils may not be toxic 
to all species of helminth. For example, IL-5 transgenic mice display increased immunity to N. 
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brasiliensis but not other parasites such as Toxocara canis (Dent et al., 1999), which suggests 
that eosinophils can promote increased resistance to some helminth species but not others. 
1.6.3 Mast cells 
 
Mast cells are also considered to be a major hallmark of protective immunity to parasitic 
helminths (Weller et al., 2011). Mast cells can respond to circulating parasite-specific IgE via 
the expression of FcεRI receptors, which stimulates the release different mediators including 
histamine, cytokines or chemokines that induce Th2 immune responses (Melendez et al., 2007; 
Pearce, 2007). However the relative roles of mast cells in resistance to helminth infections 
varies greatly depending on the model (Anthony et al., 2007).  It has been suggested that mast 
cells have a key role in decreasing the fecundity of worm species (Anthony et al., 2007), whilst 
they are not essential for clearance of challenge infection by H. polygyrus bakeri (Hashimoto 
et al., 2010). Mast cells are mostly implicated in the clearance of gut helminths, however they 
do not appear to have important role in the clearance of other tissue dwelling helminths like S. 
mansoni (Gerken et al., 1990). However, in mice infected with N. brasiliensis, IL-3 and IL-4 
depletion lead to mucosal mast cell depletion but had no impact on worm expulsion (Madden 
et al., 1991). Furthermore, mast cells can orchestrate Type 2 immune reponses to helminths by 
regulation of tissue-derived cytokines (Hepworth et al., 2012) and inducing Type 2 cytokine 
producing-innate lymphoid cell responses (Shimokawa et al., 2017). 
 
 
1.6.4 Basophils 
 
Basophils have substantial role in context of Th2 immune responses, especially in allergic 
diseases and helminth infections (Ohnmacht and Voehringer, 2009; Voehringer, 2011). They 
can be activated by IgE, cytokines, TLR ligands and proteases, which leads to the production 
of mediators including histamine, chemokines, heparin or antimicrobial peptides and lipid 
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mediators like leukotriene C4 or prostaglandin D2 (Schroeder et al., 2001). Basophils also 
synthesize and produce cytokines, including IL-4, IL-5, IL-13 and TSLP and are thus 
considered as an early, innate regulator of Type 2 immunity (Min et al., 2004; Schroeder et al., 
2001). Several studies have also suggested that basophils can act as antigen-presenting cells via 
MHC-II expression (Perrigoue et al., 2009; Sokol et al., 2008; Yoshimoto et al., 2009) and 
recent studies showed that this may happen due to acquisition of MHC-II molecules from 
dendritic cells via cell contact-dependent trogocytosis (Miyake et al., 2017). Depletion of 
basophils in vivo results in impaired protective immunity to some helminth species during 
secondary infections (Ohnmacht et al., 2010; Ohnmacht and Voehringer, 2009)  and adoptive 
transfer of basophils increases CD4+ T cell proliferation against Schistosoma mansoni egg 
injection. However, other studies have shown that basophils are not necessary for the primary 
Th2 response to N. brasiliensis infection (Ohnmacht et al., 2010), suggesting that the relative 
role for basophils in immunity to helminths depends on the species of parasite and the frequency 
of exposure.  
 
1.6.5 Macrophages 
Macrophages play multiple roles in immunity to parasitic helminths. Macrophages are efficient 
at detecting danger signals in early infections with pathogens (Dunn et al., 1985). They express 
pattern recognition receptors (PRRs) that enable recognition of pathogen- associated molecular 
patterns (PAMPs) (Plüddemann et al., 2007). Macrophages have an important role as 
phagocytic cells and as antigen presenting cells (APC) and migrate to sites of infection and 
secrete mediators including cytokines and chemokines. Macrophages are important regulatory 
and suppressor cells during parasitic infections as well as in tumour-bearing hosts (Noel et al., 
2004; Sica and Bronte, 2007). Macrophages have two distinct types, M1 or classically activated 
macrophages and M2 or alternatively activated macrophages (AAMacs) that both have 
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important roles during Type 1 or Type 2 immune responses, respectively (Mills et al., 2000). 
IFN-γ plays crucial role in promoting M1 cell development in association with microbial 
products or tumor necrosis factor α (TNF-α), thus leads to secret pro-inflammatory cytokines 
such as (IL-12, IL-1β, TNF-α, IL-6 and IL-23) and chemokines (CXCL-9, 10, 11 and 16). M1 
are essential in polarized Th1 responses and induced resistance against intracellular 
microorganisms (Mantovani et al., 2005). M2 are less effective at killing microorganisms, but 
are important for inducing tissue remodelling and repair. For example migration of helminths 
through tissues can cause remarkable tissue damage, and macrophages might participate in 
wound healing by cleaning cell debris, releasing cytokines, growth factors which promote 
fibroplasia and angiogenesis (Martin and Leibovich, 2005). Further, it has been highlighted 
that the M2 phenotype of macrophages are important for immune killing of N. brasiliensis 
(Chen et al., 2014) and filarial parasites (Turner et al., 2018), and that macrophage-derived 
arginase is important for trapping N. brasiliensis larvae in the skin (Obata-Ninomiya et al., 
2013) and killing in the lung (Anthony et al., 2006).  Macrophages also play a critical role as 
providers of many of the molecules necessary for tissue repair, including arginase-1, 
transforming growth factor- (TGF-) β, and Resistin-like molecule (RELM)α (Forbes and 
Rosenthal, 2014). RELMα is a highly secreted protein in type-2 cytokine-induced inflammation 
including helminth infection and allergy (Batugedara et al., 2018). It has been suggested that 
RELMα acts as an immune brake that provides mutually beneficial effects for the host and 
parasite by limiting tissue damage and delaying parasite expulsion (Batugedara et al., 2018). 
 
 
 
 
 18 
1.6.6 Neutrophils  
 
 
Neutrophils have a central role in the type 1 immune responses, as they are often the first line 
of defense against pathogens such as bacteria, viruses and parasites. Neutrophils are phagocytic 
cells that release lytic enzymes, as well as produce reactive oxygen species with anti-microbial 
potential (Cassatella et al., 1997; Mollinedo et al., 1999). These substances can act in 
association with cells in the affected tissue, including macrophages and mast cells, thus 
exaggerate the initial inflammatory responses (Fialkow et al., 2007). However, some studies 
have been examined their role in case of metazoan parasites like helminths (Bonne-Anneé et 
al., 2011; Bonne-Année et al., 2013). Neutrophils are activated during sub-mucosal invasion of 
parasite larvae, and immediately recruited to the site of infection (Anthony et al., 2007). In 
Strongyloides stercoralis infections, neutrophils play important roles in destroying parasites 
(Galioto et al., 2006). Following N. brasiliensis infections neutrophils can infiltrate the lung at 
day 2 in primary inoculation, and depletion of these cells resulted in remarkably impaired 
parasite expulsion (Chen et al., 2014). Interestingly, it has recently been demonstrated that 
helminth infections can promote the development of a functionally-distinct “alternatively 
activated neutrophils” (‘N2’) population that distinct from classical (‘N1’) neutrophils, 
suggesting that neutrophils can have different functions depending on the nature of the 
infectious stimulus (Chen et al., 2014). Further, it has demonstrated that neutrophils and 
macrophages cooperate to drive N. brasiliensis killing in the lung (Sutherland et al., 2014). 
However, another study has not been able to demonstrate any role for neutrophils in 
mechanism of N. brasiliensis killing in the lung (Bouchery et al., 2015).  
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1.6.7 Innate lymphoid cells 
 
Innate lymphoid cells (ILCs) are cells of the innate immune system that represent a small 
portion of the immune cell population in lymphoid organs, at epithelial barrier surfaces, as well 
as in other tissues (Spits and Cupedo, 2012; Spits and Di Santo, 2011). ILCs express similar 
transcription factors and effector molecules expressed by T cell populations, but do not express 
specific antigen receptors, so they can be rapidly activated following infection before the 
development of the adaptive immune response (Spits and Cupedo, 2012; Spits and Di Santo, 
2011). There are at least 3 types of ILCs, including ILC 1 populations that express transcription 
factor T-bet and release IFN-γ (Spits and Cupedo, 2012; Spits and Di Santo, 2011). ILC2s 
express RORα and GATA3, release interleukin 5 (IL-5) and IL-13 (Spits and Cupedo, 2012a; 
Spits and Di Santo, 2011). ILC3 populations induce lymphoid organogenesis and analogous to 
Th17 cells which rely on the transcription factor RORγt, in addition to releasing IL-17A, IL-
17F as well as IL-22 (Spits and Cupedo, 2012; Spits and Di Santo, 2011). There has been 
considerable recent interest in ILC2s in their ability to promote immunity to parasitic helminths, 
since they may be critical early sources of IL-4, IL-5 and IL-13 (Moro et al., 2010; Neill et al., 
2010; Price et al., 2010). These cells are activated by epithelial cell-derived cytokines such as 
TSLP, IL-25 and IL-33. However, the precise roles of ILCs in helminth infections, including 
the factors that regulate their function, remain to be defined. It has been highlighted that 
Arginase-1 is a key regulator of ILC2 proliferative capacity and proinflammatory functions 
(Monticelli et al., 2016). Further, it has demonstrated the potential of both ILC2 and CD4+ T-
cell-mediated regulation of M2 macrophages-mediated N. brasiliensis killing through the 
expression of IL-4 and/or IL-13 (Bouchery et al., 2015). More recent work reveals that 
sensory neurons are a critical regulator of ILC2 responses during helminth infections 
(Cardoso et al., 2017), suggesting that in addition to tissue resident epithelial cells and their 
 20 
secreted cytokines, cells of the nervous system are important for sensing infection with 
helminths and directing downstream ILC2 responses and anti-parasitic immunity. 
 
1.6.8 Epithelial cells, TSLP, IL-25 and IL-33 
 
Intestinal epithelial cells (IECs) support a primary physical barrier against commensal and 
pathogenic microorganisms in the gastrointestinal tract, but also produce an array of cytokines 
and chemokines that can regulate inflammation (Nagler-Anderson, 2001). It has also been 
shown that epithelial microRNAs induce the mucosa–immune system crosstalk important for 
mounting protective T helper type 2 (TH2) responses (Biton et al., 2011). Furthermore, 
specialized epithelial cells can release anti-parasitic effector molecules at the mucosal barrier 
such as resistin-like molecule β (RELM β) that participate in protection against helminths 
(Herbert et al., 2009). For example, NF-κB signaling within intestinal epithelial cells (IECs) 
promotes CD4+ T-cell-dependent immunity to T. muris via the secretion of cytokines such as 
thymic stromal lymphopoietin (TSLP) (Zaph et al., 2007). TSLP in particular is a potent 
regulator of Type 2 immunity (Friend et al., 1994; Schramm et al., 2007; Sokol et al., 2008), 
by activating cells of the innate and adaptive immune system, including T cells, dendritic cells, 
basophils and mast cells (Ziegler et al., 2013). TSLP is critical for the detrimental airway 
inflammation associated with asthma, where TSLPR-deficient mice showed impaired type 2 
responses and reduced asthma symptoms (Zhou et al., 2005). In vivo studies have shown the 
importance of TSLP signaling in the clearance of T. muris (Massacand et al., 2009; Taylor et 
al., 2009). In contrast, in other helminth infections the role of TSLP in initiating type 2 immune 
responses is unclear, as TSLPR deficient mice mount normal type 2 immune responses and 
expel N. brasiliensis and H. polygyrus infections (Massacand et al., 2009).  
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Interleukin 25 or IL-17E is another epithelial-derived cytokine that plays a crucial role in the 
initiation of type 2 immune responses. Intraperitoneal injection of recombinant IL-25 leads to 
features associated with type 2 immune responses (Fort et al., 2001). Moreover, in allergic lung 
diseases, IL-25 is overexpressed in airway epithelial cells, leading to exaggerated type 2 
responses (Angkasekwinai et al., 2007). It has been shown that IL-25 is beneficial for host 
resistance in helminth infections. For instance, in N. brasiliensis or T. muris infections, animal 
deficient in IL-25 signalling exhibit delayed or absent expulsion of the these helminths (Fallon 
et al., 2006; Schmitz et al., 2005). Similarly, administration of IL-25 can induce worm 
expulsion in N. brasiliensis infections (Neill et al., 2010) via regulation of an intestinal ILC2- 
epithelial response against the parasite (von Moltke et al., 2016). Recent research has 
highlighted how specialised epithelial cells, called tuft cells, may be the key IL-25 producing 
cells, where tuft cells constitutively express IL-25 to sustain ILC2 homeostasis in the resting 
lamina propria in mice (von Moltke et al., 2016).  
 
Interleukin-33 is an alarmin that is released by epithelial cells following cell damage or stress. 
IL-33 has an important role in initiation of type 2 immune response, where injection of 
recombinant IL-33 results in eosinophilia, IgE class switching, releases of type 2 cytokines in 
addition to changes in mucus of the lung and gastrointestinal system (Schmitz et al., 2005). 
Furthermore, during T. muris infections, IL-33 administration promotes type 2 responses 
(Humphreys et al., 2008), and other studies have demonstrated that IL-33 promotes the 
production of type 2 cytokines such as IL-5 and IL-13 by ILC2s (Moro et al., 2010; Neill et al., 
2010). IL-33 may also activate human basophils to increase IL-4, IL-13 and histamine 
expression (Pecaric-Petkovic et al., 2009; Suzukawa et al., 2008). IL-33 also helps initiate type 
2 immune responses via activation of mast cells in humans and promotes differentiation of 
alternatively macrophages (Kurowska-Stolarska et al., 2009). Together, epithelial cells and the 
 22 
cytokines that they produce are central regulators of the innate and adaptive immune responses 
to helminth infections. 
 
1.7 Type 1 immune responses and helminth infections 
 
Th1 immune responses are induced by invading microorganisms such as viruses and bacteria, 
promoting IFN-γ expression by CD4+ T cells and cytotoxic CD8+ T cells, and activation of 
neutrophils and M1 macrophages. However, Type 1 immune responses also play substantial 
roles during helminth infections. The development of robust Type 1 immune responses 
following helminth infections can be harmful for host as well as to helminth, where subsequent 
activation of pro-inflammatory cells such as macrophages and neutrophils may be sufficient for 
killing the parasite, but could come at the expense of damage to host tissues where the parasite 
resides (Allen and Maizels, 2011). As such, infections with most species of helminth are 
associated with down-regulation of potentially damaging Type 1 immune responses (Anthony 
et al., 2007). 
Type 1 responses can also directly mediate parasite killing. For example, in schistosomiasis, a 
vaccine can promote macrophage and IFN-γ-dependent killing of schistosomula and limiting 
infection (Goud et al., 2004). Conversely, IFN-γ expression can promote parasite chronicity, 
where depletion of IFN-γ in T. muris-infected mice changed the immune response from a Th1 
response to a Th2 response, resulting in the reduced levels of the Th1 associated antibody 
IgG2a/c and higher levels of Th2 associated antibody IgG1 and enhanced parasite expulsion 
(Else et al., 1994). Hence, understanding the nature of how Th1 immune responses are regulated 
is important for understanding how infections can become chronic in some individuals, while 
other individuals can efficiently expel parasites. However, to date, most researchers have 
concentrated on either the early events that promote Type 2 immunity, or the effector 
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mechanisms that promote parasite expulsion. 
 
 
1.8 Interleukin -1 cytokines and regulation of immunity 
 
Interleukin-1 (IL-1) is a key mediator of innate immunity and inflammation, particularly 
promoting Type 1 cytokine responses. Within this family, there are IL-1-β, IL-1α, IL-18 and 
IL-33 that are similar by mechanism of origin, receptor structure, and signal transduction 
pathways utilized (Arend et al., 2008). Some studies have demonstrated the requirement for IL-
1 in the development of Th2 cells in vitro (Greenbaum et al., 1988; Lichtman et al., 1988). 
However, other studies have highlighted an involvement of IL-1 in inducing IFN-γ producing 
Th1 cells (Schmitz et al., 1993) and inhibiting effect of IL-1 on IL-4 producing by human T 
cells. Hence, individual members of the IL-1 cytokine family have varying functions. Excessive 
production of IL-1β can causes widespread tissue damage and is associated with acute and 
chronic inflammatory human diseases, such as auto-inflammatory or autoimmune pathologies 
(Dinarello, 2011; Masters et al., 2009).  
 
The IL-1 family of cytokines also plays a pivotal role in immunity to parasites, however their 
relative roles depends on the nature of the infection. It has been shown that IL-18 and IL-33 
can activate basophils resulting in the production of Type 2 cytokines such as IL-4 via a MyD88 
dependent pathway (Kroeger et al., 2009). Further, IL-18 can also act on CD4 T cells, for 
example, daily administration of IL-18 in particular with IL-2 induced a marked increase in 
serum IgE levels in a CD4+ T cell- and IL-4/IL-4R/STAT6-dependent manner  (Yoshimoto et 
al., 2000). In vivo studies have shown that IL-1R deficiency resulted in enhanced Th2 immune 
responses following Leishmania major infection (Satoskar et al., 1998), suggesting that IL-1β 
may suppress Type 2 responses. Consistent with this, in follow up studies IL-1β was shown to 
induce Th1 biased immune resistance to Leishmania major (Von Stebut et al., 2003). Consistent 
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with this, one study had reported that IL-1β suppresses Type 2 immunity to H. polygyrus by 
inhibiting IL-25 responses in the gut (Zaiss et al., 2013).  In direct contrast, studies in other 
models of parasitic helminth infection have revealed that IL-1β −/− mice showed defective Th2 
mediated induced resistance to T. muris (Helmby and Grencis, 2004; Humphreys and Grencis, 
2009), suggesting that IL-1β may in this context promote Type 2 responses.    This is supported 
by a recent study, that reported that IL-1β secretion is important positive regulator of group 2 
innate lymphoid cell function and plasticity (Ohne et al., 2016).  A recent report has 
demonstrated a novel immune modulatory strategy used by Fasciola hepatica involves 
secretion of the FhHDM-1, a cathelicidin-like protein, which impairs the activation of NLRP3 
by lysosomal cathepsin B protease, preventing the downstream production of IL-1β and Type-
1 immune responses (Alvarado et al., 2017). Together, it is evident that the role for IL-1β in 
immunity to parasites, including parasitic helminths remains unclear and depends on the nature 
of the infection and the tissues affected. 
 
IL-18 is another member of the IL-1 family of cytokines that has varying functions depending 
on the inflammatory context. IL-18 has direct antimicrobial and immunomodulatory effects that 
are IFN-γ and/or IL-12 independent and has a significant impact on the development of 
intestinal immunity against T. spiralis infection (Helmby et al., 2001; Neighbors et al., 2001). 
Interestingly, other studies have documented a role for IL-18 in inducing Th2 responses in vivo 
or in vitro by increasing levels of IgE, IL-4, and IL-13 (Hoshino et al., 2000; Yoshimoto et al., 
2000). Further, IL-18 can induce the production of TH2-type cytokines by both naive and 
TH1-polarized cells (Moller et al., 2001). IL-18 is a pleiotropic cytokine that can regulate both 
Type-1 and Type-2 responses, depending on the nature of the cytokine milieu, infectious stimuli 
and genetic background of the host (Nakanishi et al., 2001; Wei et al., 2004; Xu et al., 2000). 
IL-18 can promote Th1 immune responses and resistance to one species of the Leishmania 
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parasite (Li et al., 2004),  but induce non-protective Th2 responses to another species (Bryson 
et al., 2008). Further, one study highlights how IL-18 induces Type-2 responses when IFN-γ is 
absent (Liu et al., 2006), another study implicates IL-18 in suppressing Type-2 cytokine 
responses to T. muris (Helmby and Grencis, 2004). In conclusion, IL-1β and IL-18 can induce 
either a Th1 or Th2 response, depending on the cytokine milieu and genetic background of the 
host (Wei et al., 2004; Xu et al., 2000). Because of this, the IL-1 family of cytokines appear to 
have key and diverse roles in helminth infections. Understanding the mechanism of how these 
cytokine responses are initiated and regulated might help us understand why some infections 
are acutely resolved, and how some infections become chronic. 
 
1.9 Regulation of IL-1 cytokine production and secretion 
 
IL-1β and IL-18 production is a result of cell activation and promotes a multitude of metabolic, 
physiologic, inflammatory, hematologic and immunologic effects. The synthesis of IL-1 
cytokines is dependent on factors such as nuclear factor kappa B NF-kappa B activation 
pathway, following stimulation by pattern recognition receptors on the surface of immune cells, 
for example TLR (Croston et al., 1995). However, these cytokines are not functional and cannot 
be released from the cell until a second signal is activated. This second signal, and the 
subsequent maturation and release of IL-1β and IL-18 are dependent on the activation of 
inflammasome complexes (Cruz et al., 2007). 
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1.10 Inflammasomes  
 
The inflammasome is a part of the innate immune system, and consist of an intracellular sensor 
such as nod-like receptor (NLR) proteins that is coupled with caspase-1 and the adaptor 
apoptosis-associated speck-like protein containing a carboxy-terminal (ASC) and Caspase 
activation and recruitment domain (CARD) (Meylan et al., 2006; Yu and Finlay, 2008) 
(Figure1.2). Inflammasome expression is well characterised in immune cells of myeloid 
origin, but their components are also expressed by some non-professional immune cells 
(Schroder and Tschopp, 2010).Furthermore, different inflammasomes can have distinct 
tissue- or cell type-specific functions such as epithelial cells (Broz and Dixit, 2016; Kummer 
et al., 2007). Generally, expression of inflammasomes is constitutive, however cells can 
increase their expression of the various inflammasome protein components under some 
conditions (Latz et al., 2013). 
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Figure 1.2 Generic structure of inflammasome complexes, including Toll like receptor 
(NLR) that activates following interaction with pathogen molecule leading to activation 
of caspase1 via interaction with ASC (apoptosis-associated speck-like protein containing 
a carboxy-terminal CARD). From: www.invivogen.com 
 28 
Inflammasomes have two families, NLR and PYHIN (pyrin and hematopoietic interferon-
inducible nuclear antigens domain-containing protein) (Broz and Monack, 2011; Fernandes-
Alnemri et al., 2009). The NLR family is composed of a central nucleotide-binding and 
oligomerization (NACHT) domain, which is flanked by C-terminal leucine-rich repeats (LRRs) 
and CARD or pyrin  (PYD) domains (Schroder and Tschopp, 2010). It has been shown that 
LRRs are involved in ligand sensing and autoregulation, however CARD and PYD domains 
induce homotypic protein-protein association for downstream signalling (Schroder and 
Tschopp, 2010). The NACHT domain is the common domain to all NLR families, and promotes 
activation of the signalling complex in an ATP-dependent manner. There are 3 distinct 
subfamilies within the NLR family which are the NODs (NOD1-2, NOD3/NLRC3, 
NOD4/NLRC5, NOD5/NLRX1, CIITA), the NLRPs and the IPAF subfamily, consisting of 
IPAF (NLRC4) and NAIP (Schroder and Tschopp, 2010).  
 
ASC is an adaptor molecule that recognises the insoluble cytosolic fraction, known as speck, 
which is formed in cells that are undergoing apoptosis (Taniguchi and Sagara, 2007). It is 
characterized of an N-terminal PYD domain and a CARD, that acts directly with multiple 
PRRs, for instance NLRPs, NLR caspase recruitment domain-containing protein (NLRC), and 
AIM2, leads to caspase 1-activating platforms known as inflammasomes (Martinon et al., 2002; 
Masumoto et al., 1999). 
Activation of inflammasomes promotes a  programmed cell death process (Fink and Cookson, 
2005) whereas the dying cell induces potent cytokine production eventually leads to 
inflammation. Importantly, this activation  needs to a “second signal” that triggers maturation 
and secretion of IL-1β and IL-18 that dependent on the assembly of the inflammasome, 
activation of Caspase-1 enzyme which cleaves pro-inflammatory  IL-1 cytokines into their 
maturation and release them from the cell (McKee et al., 2009). 
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The hallmarks of inflammasome activation are the processing of caspase-1, the maturation and 
release of IL-18 and IL-1β and the intiation of pyroptosis, a lytic inflammatory cell death (Broz 
and Monack, 2013). These represent the primary ways in which researchers can detect and 
quantify the activation of inflammasomes. Moreover, it is possible to visualize endogenous 
ASC specks in infected cells and study the release of processed caspase-1, caspase-11 and 
mature cytokines into the cell supernatant by Western blotting (Broz and Monack, 2013), 
further intracellular staining of IL-18 expression by flow cytometry  (Gerdes et al., 2002). 
 
1.10.1 Types of inflammasomes  
It has been shown that the NLR family has more than 20 members identified in humans that 
such as nucleotide-binding domain (NBD) and leucine-rich repeat (LRR) proteins include 
NLRP1,  NLRP3, NLRC4, and AIM2 (Allen et al., 2013; Chen, 2014; Correa et al., 2012) 
(Figure 1.3) 
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Name Activator Adapter/ binder Function 
NLRC3 
 
? TRAF6 Negative TLR regulator? 
NLRC4 Flagellin, T3SS 
components 
ASC, Caspase-1 Inflammasome formation 
NLRC5 virus ? Transcription MHC class I 
related genes 
NLRX1 RNA? UQCRC2, MAVS, 
TUFM 
ROS production, autophagy, 
Negative TLR regulator and 
MAVS-dep. signalling 
NLRP1 
 
LF, MDP ASC, Caspase-1 Inflammasome formation 
NLRP2 
 
? ASC? Inflammasome formation? 
NLRP3 Pore-forming toxins, 
nucleic acids, ATP, uric 
acid, hyaluronan.. 
ASC, Caspase-1 Inflammasome formation 
NLRP4 ? Beclin-1 Negative regulator of NK-Kß 
activation and  autophagy 
NLRP6 ? ASC Inflammasome formation and 
Negative regulator of TLR 
NLRP7 Microbial acylated 
lipopeptide 
ASC Inflammasome formation 
NLRP10 ? ? Negative regulator of NK-Kß 
activation and  DC migration 
NLRP12 Lipopeptide (Yersinia 
pestis) 
ASC Negative regulator of TLR 
CIITA 
 
? ? MHCII regulator 
  
Figure 1.3: Summary of the main characteristics of the NLRs.(Chaput et al., 2013) 
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NLRP1, the first inflammasome to be characterized, has only been described to be activated in 
a physiologically relevant manner by a single signal, after exposure to the anthrax lethal toxin 
(LeTx). LeTx is consist of protective antigen and lethal factor. Lethal factor is a putative 
metalloprotease and a zinc metalloprotease-like consensus sequence that is essential for NLRP1 
activation (Fink et al., 2008). LeTx is important for the assembly of the NLRP1 inflammasome, 
which is crucial for immunity of mice to Bacillus anthracis spore infections. NLRP1 also 
contains a Function-to-Find domain (FIIND) and autoprocessing of NLRP1 within this FIIND 
is a prerequisite for the activation (Frew et al., 2012). 
 
NLRP3 is the most-studied inflammasome owing to its involvement in immunity to small 
pathogens such as bacteria, viruses and fungi and its important roles in sterile inflammation and 
metabolic diseases such as Type 2 Diabetes. The precise mechanism of how these stimuli 
activate NLRP3 is still unclear, however studies have demonstrated that NLRP3 can be 
activated via different pathways, for example canonical and non-canonical (Kayagaki et al., 
2013). The canonical NLRP3 pathway is activated by Gram-positive bacteria 
including Staphylococcus aureus and  viruses such as Influenza, pore-forming toxins including 
hemolysin and pneumolysin as well as endogenous ligands and crystalline substances such as 
ATP, silica and alum (Fitzgerald, 2010; Lamkanfi and Dixit, 2014; Rathinam et al., 2012). 
(Figure 1.4). 
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Figure 1.4: Describing that NLRP3 responds to a wide range of DAMPs and PAMPs, including 
infectious pathogens and exogenous materials. Activation of the NLRP3 inflammasome 
requires two signals and is controlled at transcriptional and post-translational levels. The first 
signal, also referred to as the priming signal, is the induction of the toll-like receptor 
(TLR)/nuclear factor (NF)-κB pathway to upregulate the expression of NLRP3 and pro-IL-1β. 
Signal 2 is transduced by various PAMPs and DAMPs to activate the functional NLRP3 
inflammasome by initiating assembly of a multi-protein complex consisting of NLRP3, the 
adaptor protein ASC, and pro-caspase-1, association of NLRP3 with ASC is required for 
recruitment of pro-caspase-1. From: www.invivogen.com 
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NLRC4 has a variance requirement for the adaptor protein, ASC; ASC is important for NLRC4-
induced caspase-1 and IL-1β maturation, however it is dispensable for NLRC4-promoted 
pyroptosis (Broz et al., 2010c; Van Opdenbosch et al., 2014). It is mostly activated by a 
different set of ligands including bacterial flagellin and components of the bacterial type III 
secretion system (Zhao et al., 2011). Further, NLRC4 activation needs another NLR protein, 
NAIP, which is important as a receptor for the NLRC4 stimulators (Freeman et al., 2017). NAIP 
has four different proteins in C57BL/6 mice and among them, NAIP1 binds to needle proteins 
of the type III secretion system, NAIP2 binds to the Salmonella SPI-1 basal rod component 
PrgJ, and NAIP5 and NAIP6 sense flagellin (Kofoed and Vance, 2011; Rayamajhi et al., 2013; 
Yang et al., 2013; Zhao et al., 2011).  
 
ALR inflammasomes are another type of inflammasome, which is responsible for inducing 
caspase-1 activation and IL-1β cytokine secretion. But, unlike NLR inflammasomes, ALR 
inflammasomes directly bind their ligand, dsDNA, via HIN-200 domains (Schattgen and 
Fitzgerald, 2011).  
 
AIM2 and IFI16 do not have CARD domains and hence need ASC recruitment via their PYD 
for inflammasome activation (Schattgen and Fitzgerald, 2011). AIM2 mostly senses double 
stranded DNA in the cytosol from DNA viruses for instance, mouse cytomegalovirus and 
vaccinia virus as well as cytosolic bacteria including Francisella tularensis and Listeria 
monocytogenes (Fernandes-Alnemri et al., 2010; Hornung et al., 2009; Rathinam et al., 2010). 
However, IFI16 typically senses DNA from Kapsosi’s sarcoma-associated herpes virus 
(KSHV) (Kerur et al., 2011). AIM2 has also been demonstrated to play a role in the 
adjuvanticity of DNA vaccines (Suschak et al., 2015) and is essential to autoimmune disorders 
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such as systemic lupus erythematosus through recognition of host DNA (Panchanathan et al., 
2011).  
 
 
  
Figure 1.5 Inflammasome activation. Pathogen-associated molecular patterns (PAMPs) interact 
with NLRs in the cytosol. Caspase1 is then activated which cleaves the immature pro-forms of 
IL-1β and IL-18, and allowing maturation and release from the cell. (Discov Med. July 26, 
2011). 
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Recent studies using animal models of disease where specific inflammasome components have  
been targeted for deletion (i.e. gene deficient mice, chemical inhibitors, CRISPR/Cas9) have 
been instrumental in defining the roles for the various inflammasomes in biology (Coll et al., 
2015; Fenini et al., 2018). While much has been learned recently about how important various 
inflammasome complexes are for promoting maturation of these pro-inflammatory cytokines, 
the mechanisms of how inflammasomes are activated, and their relative roles in various 
inflammatory and infectious diseases remain largely unexplored. 
 
1.11 Role of inflammasome in inflammatory diseases 
 
Inflammasomes have a key role in the pathobiology of a number of inflammatory disorders, 
where the most widely studied inflammasome thus far has been the NLRP3 inflammasome. For 
instance in diabetes, exogenous substances like the saturated fatty acids activate the NLRP3 
inflammasome and promote release of IL-1β (Vilaysane et al., 2010). NLRP3 inflammasome 
activation has also been shown in chronic kidney disease and diabetic nephropathy (Vilaysane 
et al., 2010). Atherosclerotic lesions have abundant cholesterol crystals have also been 
demonstrated to be a strong activator of NLRP3 (Duewell et al., 2010). Some studies have 
suggested that inflammasome activation and expression of IL-1β and IL-18 may be linked to 
susceptibility to inflammatory bowel diseases (IBDs) (Villani et al., 2009). It has been indicated 
that caspase-1, ASC, or NLRP3 deficiencies were associated with an increased severity of 
colitis in mice (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Hirota et al., 2011). However, 
other studies have examined the potential role of NLRP3 inflammasome in murine models of 
colitis, and have found different results (Bauer et al., 2010; Zaki et al., 2010). The NLRP3 
inflammasome also regulates graft-versus-host disease GvHD resulting in shaping of Th17 
responses in the intestines of the recipient (Fulton et al., 2012). The NLRC4 inflammasome is 
a direct negative regulator of colonic epithelial cell tumorigenesis that is not driven by the 
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microbiota (Hu et al., 2010). Hence targeting inflammasomes, particularly the NLRP3 
inflammasome, may be a rational approach for new therapies against autoimmune diseases. 
Consistent with this, a recent study used a potent, selective, small-molecule inhibitor of NLRP3 
(MCC950) that minimized IL-1β production and reduced the severity of experimental 
autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis, cryopyrin-
associated periodic syndrome (CAPS) and Muckle–Wells syndrome (Coll et al., 2015). 
 
1.12 Role of inflammasome in infectious diseases 
 
Inflammasomes, including the NLRP3 inflammasome, have a significant role in immune 
responses against small, easily phagocytosed infectious pathogens such as bacteria, viruses, 
fungi and protozoan parasitic infections. For example, activation of inflammasomes and 
secretion of IL-18 and IL-1β are important to eradicate bacterial infections (Broz et al., 2010; 
Maher et al., 2013; Muruve et al., 2008; Song-Zhao et al., 2014), viral infections (Allen et al., 
2009; Ermler et al., 2014; Kamada et al., 2014; Thomas et al., 2009) and fungal infections (Hise 
et al., 2009; Kistowska et al., 2014).In Candida infection, it has been demonstrated increase in 
mucosal expression of NLRP3 and NLRC4 inflammasomes, and up-regulation of these 
molecules is impaired in NLRP3 and NLRC4 knockout mice. These results documented that 
the NLRC4 plays a crucial role in limiting mucosal candidiasis (Tomalka et al., 2011). 
However, another study has showed, that dectin-1 can induced both IL-1β production and 
maturation via caspase-8-dependent inflammasome for protective immunity against fungi and 
mycobacteria (Gringhuis et al., 2012). 
 
There has been considerable research into the role for inflammasomes in immunity to parasites. 
Inflammasome activation promoted bias of adaptive immunity toward Th2-type responses 
against some parasitic infection such as is leishmaniasis (Gurung et al., 2015).  
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Two studies were documented the protective role of the NLRP3 inflammasome activation 
against Trypanosoma cruzi infection in the mouse model of Chagas’ diseases. They highlighted 
that the IL-1β production following T. cruzi infection was rely upon NLRP3, ASC, and caspase-
1 utilizing knockout mice and macrophages, which showed sever immunopathology and greater 
parasite burdens in ASC and caspase-1 deficient mice compared to wild type (Silva et al., 2013). 
In malaria infections, the NLRP3 inflammasome is activated by the crystalline malarial 
byproduct hemozoin (Hz), which results in cerebral malarial symptoms in mouse models 
(Griffith et al., 2009). Macrophages from wild type mice produced IL-1β and promoted 
caspase1 when incubated in hemozoin, however the impact was absent in macrophages from 
NLRP3 or ASC deficient mice (Griffith et al., 2009). In vivo, NLRP3 deficient mice had 
reduced Plasmodium berghei ANKA-promoted cerebral malaria without any change in parasite 
burden, highlighting the role of NLRP3 in immunopathology but not necessarily infection 
(Dostert et al., 2009). It has been reported that  dual engagement of the NLRP3 and AIM2 
inflammasomes by plasmodium-derived hemozoin and DNA occurs during malaria (Kalantari 
et al., 2014). A recent paper demonstrated that targeting the IL33-NLRP3 axis improves therapy 
for experimental cerebral malaria (Strangward et al., 2018). 
 
In Toxoplasma rodent models it has been shown that the NLRP1b inflammasome was activated 
during T. gondii infection of mice and rats, resulting in protective immunity against oral 
challenge infection (Ewald et al., 2014). NLRP1 has recently been shown to be important for 
immunity to protozoan parasite infections (Clipman et al., 2018; Ewald et al., 2014) . 
 
 
 
 38 
It has revealed that the NLRP3 inflammasome as well as the NLRP1 are important in murine 
resistance to T. gondii infection. In vivo, T. gondii activated the NLRP3 inflammasome in 
macrophages. NLRP3, ASC, and NLRP1 deficient mice all showed increased parasite burden 
and mortality. These studied highlighted that IL-18 may be a key cytokine in inflammasome-
mediated resistance to T. gondii infection (Gorfu et al., 2014)  . Moreover, P2X7 receptor 
mediates T. gondii control in macrophages through NLRP3 inflammasome activation and 
reactive oxygen species secretion (Moreira-Souza et al., 2017). Further,  NLRP3 and potassium 
efflux drive rapid IL-1β secretion from primary human monocytes against T. gondii Infection 
(Gov et al., 2017). 
 
1.13 Role of inflammasome in helminth infections and Type 2 immunity 
 
While the role for inflammasomes in Type 1-dependent immunity to small, easily phagocytosed 
infectious pathogens is becoming well established, the role of inflammasomes in Type 2 
immunity and inflammation remains unclear. Inflammasomes are suggested to play a role in 
the Type 2 inflammation in patients with asthma (Oliphant et al., 2011). Inhaled substances are 
linked to asthmatic inflammation but their role with the inflammasome is still unclear (Nadeem 
et al., 2008). It was demonstrated that extra- cellular ATP could be responsible for 
inflammasome activation in asthma. For instance, dust mites, a common asthmatic allergen, 
were shown to activate and release of ATP from macrophages, epithelial and dendritic cells 
(Suzuki et al., 2009). Furthermore, increases in ATP were observed in patients with asthma as 
a result of an allergen (Idzko et al., 2007).  IL-1β activity is also elevated in asthma models and 
can be related to the increased caspase-1 activity (Thomas and Chhabra, 2003). Moreover, 
patients with asthma have increased levels of IL-1β in their sputum compared with patients 
without asthma (Thomas and Chhabra, 2003). Interestingly, it has been highlighted that NLRP3 
expression in CD4+ T cells can act as a transcription factor, independent of its ability to activate 
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inflammasomes, and can stimulate a T helper type 2 response (Bruchard et al., 2015). Hence, 
there is some evidence that inflammasomes may promote Type-2 immune responses in asthma.  
While inflammasomes are generally associated with promotion of Type 2 immune responses in 
asthma, the role for inflammasomes in Type 2 inflammation during helminth infections is more 
controversial. For example, the NLRP3 inflammasome can mediate IL-1β production in 
schistosomasis, and genetic ablation of ASC and NLRP3 in mice lead to reduced liver 
pathology and down-regulated Th1, Th2, and Th17 adaptive immune responses (Ritter et al., 
2010). Hence in the context of Schistosoma infection, NLRP3 appears to promote 
inflammation. Moreover, NLRP3 inflammasomes can be activated in mouse hepatic stellate 
cells against S. japonicum infection (Meng et al., 2016). S. mansoni T2 ribonuclease omega-1 
can modulate inflammasome-dependent IL-1β secretion in macrophages (Ferguson et al., 
2015). However, a recent paper highlighted that the immune modulatory peptide FhHDM-1 
secreted by Fasciola hepatica inhibits NLRP3 inflammasome activation by suppressing 
endolysosomal acidification in macrophages (Alvarado et al., 2017). Another study using a 
different helminth model has demonstrated the opposite phenomenon, i.e. that infection by 
Heligmosomoides polygyrus bakeri and IL-1β production attenuates type 2 immunity and 
promotes parasite chronicity, however a role for specific inflammasome proteins was not 
defined (Zaiss et al., 2013). Further, it has been reported that cattle with deletion mutations in 
the NLRP3 gene display increased anti-parasitic resistance, highlighting the potentially critical 
role for NLRP3 in influencing immunity to helminths (Xu et al., 2014). 
 
Together, there has been very little research into roles of inflammasomes in immunity to 
helminths, and most of that has concerned the roles in schistosome infections, with very little 
research into the roles for inflammasomes in immunity to gastrointestinal helminths. Hence, 
there are still a lot of questions to address regarding whether inflammasomes play an important 
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role in regulating immunity and inflammation associated with parasitic helminth infection. This 
includes: (1) whether worm infections activate or inhibit inflammasomes in vitro and in vivo, 
(2) whether inflammasomes are important for in vivo immunity to helminths and (3) whether 
distinct inflammasome plays similar or different roles in immunity to helminths. Hence, future 
work should investigate the roles for specific inflammasome proteins, such as NLRP3, NLRP1 
in immunity to a variety of species of parasitic helminths and inflammation in multiple tissue 
sites. These two inflammasomes have been shown to play a dual role in immunity against 
protozoan infections (Gorfu et al., 2014), hence more research needs to be conducted to 
understand whether antigens derived from worms similarly  influence inflammasome activation 
and immunity.  
 
1.14 General Conclusion: 
 
Helminth parasites are incredibly successful pathogens, infecting a quarter of the world’s 
population, causing high morbidity. Protective immunity and expulsion of helminths is 
activated by Th2 cytokines and cells, in addition to macrophages, ILC2, basophils and 
eosinophils. Failure to mount these type 2 immune responses can lead to immunopathology 
mediated by Th1 cytokines such as IL-1β, IL-18 and IFN-γ. The mechanisms by which host 
immunity is initiated are still unknown. Clearly, understanding the early events that initiate and 
regulate immunity to helminths is critical, including the worm-derived antigens that are 
recognized by the immune system and how these signals are processed to evoke immune 
resistance, which would be informative for the rational development of vaccines against worm 
infections. In addition, it will help us understand how worms and worm-derived proteins may 
modulate host immunity, which may have implications for future developments of novel worm-
based therapies for inflammatory diseases in the first world. 
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For my PhD studies outlined in this thesis, my hypothesis was that inflammasome activation 
following helminth infection would be a critical influence on the nature of the innate or adaptive 
immune response to gastrointestinal helminths. 
 
 To address this hypothesis, my aims were to: 
 
1. Determine whether gastrointestinal helminths activate inflammasomes in vivo and in 
vitro and the mechanism by which this occurs. 
2. Investigate the role of NLRP3 inflammasomes in controlling immunity to the murine 
model of whipworm, T. muris. 
3. Define the molecular and cellular mechanism of NLRP3 inflammasome mediated 
immunity to T. muris. 
4. Assess the role for inflammasomes in regulation of innate immunity to a different 
species of helminth, the murine hookworm N. brasiliensis. 
5. Assess the role of the NLRP1 inflammasome in regulating immunity to distinct models 
of gastrointestinal helminth infection. 
By addressing these aims my studies will have for the first time addressed the roles for distinct 
inflammasome in immunity to multiple species, T. muris and N. brasiliensis, and the molecular 
and cellular immunological mechanisms by which inflammasome regulate the immunity 
against these infections. 
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1.15 Murine models of helminth infection used in these studies:	
 
1.15.1 T. muris	
T. muris utilizes a fecal/oral route of transmission and has a direct lifecycle whereby eggs are 
ingested by the host, hatch in the cecum and undergo three sequential moults before reaching 
sexual maturity, after which adult worms release eggs into the lumen of the gut to continue the 
cycle (Cliffe and Grencis, 2004). Mice are infected by oral gavage with 100-200 embryonated 
T. muris eggs, which typically results in an acute infection dependent on Type 2 immune 
responses that resolves within 3-5 weeks. If mice are administered lower doses of embryonated 
T. muris eggs (between 5 and 30), it causes a Type 1-dominated immune response and results 
in chronic infections that can last up to a year. Experimentally, analysis of worm burdens after 
sacrificing mice at day 21 or 35 post-infection allows for analysis of immune responses and 
how they may promote or suppress immunity to T. muris. 
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  Figure 1.6 T. muris life cycle. Infection occurs by the ingestion of infective eggs which 
hatch in the caecum 90 min post infection (p.i.) releasing the first larvae (L1). L1penetrate 
the caecum and proximal colon wall, dwell in the epithelial layer and undergo three more 
moults to L2 (9–11 days p.i.), L3 (17 days p.i.) and L4 stage (22 days p.i.). By day 32 p.i. 
female and male adult forms of T. muris can be observed in the caecum and proximal 
 colon of infected mice. Eggs, which leave the host organism with faeces, need 2 months to 
embryonate and become infective (Klementowicz et al., 2012) 
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1.15.2 N. brasiliensis.	
The N. brasiliensis life cycle begins when the elliptical eggs of the parasite are passed in the 
feces that hatch to first, second and third‐stage larvae (L3). Infection can be by oral ingestion, 
but skin penetration or sub-cutaneous injection is most efficient, with penetration within 5 min 
after placement on the skin. Parasitic larvae move deep into the epidermis, then migrate to the 
loose subcutaneous connective tissue where they find blood vessels that carry them to the lungs 
as early as 11 hr after invasion. Experimental inoculations are typically given by subcutaneous 
injection of between 250 and 600 infective L3. The third moult occurs in the lung between 19 
and 32 hr, and the emerging L4 remain in the lung up to 50 hr post‐infection before migrating 
via the trachea to the intestine. The final molt in the intestine begins at 90 to 108 hr post‐
inoculation and results in the L5, or mature adult. Adult worms are found loosely attached to 
the proximal half of the small intestine (Camberis et al., 2003). Mice are infected 
subcutaneously with 500 L3 which is result in an acute infection associated with a strong Type 
2 immune responses and the parasites can be recovered from the lungs within day 1-2  and gut 
within day 4-7 to determine levels of immunity to infections. 
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Figure 1.7 N. brasiliensis. Infection occurs by the skin penetration of L3 which migrates to 
lung at day 1 post infection (p.i.) to become L4, L4 that migrate to small intestine to become 
adults males and females at day 6 post infections (Camberis et al., 2003) 
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2.1 Abstract 
Inflammasomes promote immunity to microbial pathogens by regulating the function of IL-1-
family cytokines such as IL-18 and IL-1β. However, the roles for inflammasomes during 
parasitic helminth infections remain unclear. We demonstrate that mice and humans infected 
with gastrointestinal nematodes display increased IL-18 secretion, which in Trichuris-infected 
or worm antigen-treated mice and in macrophages co-cultured with Trichuris antigens or 
exosome-like vesicles, was dependent on the NLRP3 inflammasome. NLRP3-deficient mice 
displayed reduced pro-inflammatory Type 1 cytokine responses and augmented protective Type 
2 immunity, which was reversed by IL-18 administration. NLRP3-dependent suppression of 
immunity partially required CD4+ cells but was apparent even in Rag1-/- mice that lack adaptive 
immune cells, suggesting that NLRP3 influences both innate and adaptive immunity. These 
data highlight a role for NLRP3 in limiting protective immunity to helminths, suggesting that 
targeting the NLRP3 inflammasome may be an approach for limiting the disease burden 
associated with helminth infections. 
 
Keywords 
Inflammasome, NLRP3, IL-18, helminth, exosomes, immunopathology, goblet cells 
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2.2 Introduction 
The IL-1 family of cytokines, in particular IL-1α, IL-1β and IL-18, are important for the 
initiation and amplification of innate and adaptive immune responses and resistance against 
microbial infections. These cytokines are produced by innate immune cells such as 
macrophages, dendritic cells and monocytes, as well as non-hematopoietic cells such as 
epithelial or endothelial cells (Sims and Smith, 2010). Because of their potent and diverse 
functions, the biological activity of IL-1 family cytokines must be tightly controlled, since 
dysregulation of these responses is associated with the detrimental inflammation associated 
with autoimmune diseases (Dinarello, 2011). Regulation of the activity of many IL-1 cytokines 
is achieved by inflammasomes; multi-protein immune complexes that control the cleavage and 
subsequent activation of immature versions of these cytokines by the intracellular cysteine 
protease Caspase-1 (Netea et al., 2015). 
 
Inflammasomes play a critical role in immune defense against small, easily phagocytosed 
infectious pathogens by promoting Type 1 immune responses via secretion of IL-1β and IL-18 
(Arbore et al., 2016; McIntire et al., 2009; Strowig et al., 2012). The NLR family, Pyrin Domain 
Containing 3 (NLRP3) inflammasome is the most well-characterized inflammasome and is 
important for immunity to diverse pathogens such as bacteria (Broz et al., 2010; Muruve et al., 
2008), viruses (Allen et al., 2009; Kamada et al., 2014; Thomas et al., 2009), protozoan 
parasites (Gorfu et al., 2014; Silva et al., 2013) and fungal pathogens (Hise et al., 2009). Other 
inflammasomes, such as NLRP1, AIM2 and NLRC4, are similarly important for anti-microbial 
defense (Ewald et al., 2014; Rathinam et al., 2010; Tomalka et al., 2011). Inflammasomes are 
also implicated in the immunopathology of a number of inflammatory disorders, including 
diabetes (Lee et al., 2013), chronic kidney disease and diabetic nephropathy (Vilaysane et al., 
2010) and inflammatory bowel diseases (IBDs) (Villani et al., 2009).  
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There is emerging evidence that, in addition to promoting pro-inflammatory Type 1 or Type 17 
immune responses, inflammasomes can directly or indirectly influence Type 2 immune 
responses. For example, activation of the NLRP3 inflammasome promotes allergic Type 2 
inflammation in some murine models (Besnard et al., 2011; Ritter et al., 2014), and NLRP3 
promotes non-protective Type 2 immune responses to infections with the protozoan parasite 
Leishmania major (Gurung et al., 2015). These observations are consistent with a report that 
NLRP3 can directly promote T-helper Type 2 (Th2) cell differentiation by acting as a 
transcription factor (Bruchard et al., 2015). Other studies suggest that NLRP3 may suppress 
Type 2 immune responses, for example by inactivation of the alarmin IL-33 (Cayrol and Girard, 
2009; Moulin et al., 2007), or indirectly via promotion of Type 1 biased immune responses 
(Ritter et al., 2010). Hence, the role of inflammasomes in regulating Type 2 immune responses 
remains incompletely defined. 
 
Type 2 immune responses are associated with protective immunity to helminths, while Type 1 
responses promote chronic infections and immunopathology, although very little is known 
about whether inflammasomes control immunity to parasitic helminth infection. The blood 
fluke Schistosoma mansoni secretes proteins that directly activate the NLRP3 inflammasome 
and thereby promote IL-1β secretion (Ferguson et al., 2015; Ritter et al., 2010), and genetic 
deficiency of NLRP3 results in suppressed Th1, Th2, and Th17 immune responses and reduced 
liver pathology (Ritter et al., 2010). Similarly, secreted products from the intestinal nematode 
Heligmosomoides polygyrus activate the NLRP3 inflammasome in vitro and increase IL-1β 
secretion in vitro and in vivo (Zaiss et al., 2013); however, the in vivo role for inflammasomes 
in regulating anti-parasitic immunity was not determined. Hence, while the NLRP3 
inflammasome is a critical determinant of immunity and immunopathology associated to 
 51 
diverse pathogens, a role for any inflammasome complex in controlling Type 2 immunity 
during infections with large metazoan parasites like gastrointestinal helminths is unclear. 
 
In the present study, we describe a role for the NLRP3 inflammasome in suppressing protective 
innate and adaptive immune responses to infection with the gastrointestinal nematode Trichuris 
muris. Trichuris infection resulted in elevated IL-18 secretion in mice, and similar results were 
seen in human subjects experimentally infected with gastrointestinal nematodes. In vivo and in 
vitro murine studies revealed that proteins and exosome-like extracellular vesicles secreted by 
Trichuris enhance NLRP3-dependent IL-18 and IL-1β secretion, in combination with microbial 
signals such as LPS. Targeted ablation of NLRP3 caused reduced Type 1 cytokine responses, 
increased Type 2 responses, accelerated worm expulsion and lessened intestinal 
immunopathology, which was reversed by rIL-18 administration. While the presence of CD4+ 
cells was important for the ability of NLRP3 to influence anti-parasitic immunity, NLRP3 could 
suppress protective immunity to Trichuris even in the absence of a fully-functional adaptive 
immune system, highlighting a complex mechanism by which the NLRP3 inflammasome 
regulates inflammation and immunity to parasitic helminth infections. 
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2.3 Results 
2.3.1 Helminth infections promote Caspase1-dependent IL-18 expression that limits anti-
parasitic immunity.  
To investigate whether helminth infection was associated with inflammasome activation, wild 
type (WT) C57BL/6 mice were infected with T. muris and IL-18 and IL-1β levels were 
quantified in the serum at different time points post infection (p.i.). Caspase 1/Caspase 11 
double-deficient mice were included as a control due to their impaired ability to be activated 
by most inflammasome complexes (Schroder and Tschopp, 2010). Trichuris infection in WT 
mice caused significant elevations in serum IL-18 levels at day 21 p.i. (Figure 2.3.1 A), while 
IL-1β levels were not significantly increased at any time point (Figure 2.3.1 B). Caspase-1/11-
deficient mice had significantly reduced serum IL-18 and IL-1β levels compared with WT mice, 
suggesting that Trichuris elicits Caspase-1/11 dependent IL-18 expression (Figure 2.3.1 A-B). 
Following infection, Caspase-1/11-deficient mice had increased Trichuris antigen (Ag)-
specific serum IgG1 titers (Figure 2.3.1C) and significantly reduced worm burdens at day 21 
post-infection (p.i) compared with WT mice (Figure 2.3.1D), suggesting improved anti-
parasitic immunity. Consistent with an increased anti-parasitic response, Caspase-1/11-
deficient mice displayed significantly increased numbers of goblet cells in the colon compared 
with infected WT mice (Figure 2.3.1 E-F). Together, these data suggest that Caspase1/11-
dependent inflammasome activation suppresses immunity to Trichuris infection. 
 
We next aimed to determine whether gastrointestinal nematode infection of humans was also 
associated with inflammasome activation. Nineteen otherwise healthy subjects with celiac 
disease (on a gluten-free diet) from a non-helminth endemic area (Brisbane, Australia) were 
either infected with 15 Necator americanus (human hookworm) infective third stage larvae 
(L3, n=9) or were treated with a placebo (chili pepper solution, n=10) and serum was collected 
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at week 0 (day of treatment) and week 20 post-inoculation. Interestingly, helminth-infected 
humans, but not placebo-treated humans, displayed significant increases in serum IL-18 levels 
at week 20 p.i. (Figure 2.3.1 G). IL-1β levels were typically below the level of detection of the 
assay and not impacted by helminth or placebo treatment (Figure 2.3.1 H). These data suggest 
that gastrointestinal helminth infections in humans are also associated with inflammasome 
activation, specifically resulting in elevated IL-18 production.  
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(Cayrol and Girard, 2009; Moulin et al., 2007), or indirectly via
promotion of type 1 biased immune responses (Ritter et al.,
2010). Hence, the role of inflammasomes in regulating type 2 im-
mune responses remains incompletely defined.
Type 2 immune responses are associated with protective im-
munity to helminths, while type 1 responses promote chronic
infections and immunopathology, although very little is known
about whether inflammasomes control immunity to parasitic
helminth infection. The blood fluke Schistosoma mansoni se-
cretes proteins that directly activate the NLRP3 inflammasome
and thereby promote IL-1b secretion (Ritter et al., 2010; Fergu-
son et al., 2015), and genetic deficiency of NLRP3 results in
suppressed Th1, Th2, and Th17 immune responses and
reduced liver pathology (Ritter et al., 2010). Similarly, secreted
products from the intestinal nematode Heligmosomoides poly-
gyrus activate the NLRP3 inflammasome in vitro and increase
IL-1b secretion in vitro and in vivo (Zaiss et al., 2013); however,
the in vivo role for inflammasomes in regulating anti-parasitic
immunity was not determined. Hence, while the NLRP3 inflam-
masome is a critical determinant of immunity and immunopa-
thology associated with diverse pathogens, a role for any in-
flammasome complex in controlling type 2 immunity during
infections with large metazoan parasites like gastrointestinal
helminths is unclear.
In the present study, we describe a role for the NLRP3 inflam-
masome in suppressing protective innate and adaptive immune
responses to infection with the gastrointestinal nematode Tri-
churis muris. Trichuris infection resulted in elevated IL-18 secre-
tion in mice, and similar results were seen in human subjects
experimentally infected with gastrointestinal nematodes. In vivo
and in vitromurine studies revealed that proteins and exosome-
like extracellular vesicles secreted by Trichuris enhance NLRP3-
dependent IL-18 and IL-1b secretion, in combination with micro-
bial signals such as lipopolysaccharide (LPS). Targeted ablation
of NLRP3 caused reduced type 1 cytokine responses, increased
type 2 responses, accelerated worm expulsion, and lessened in-
testinal immunopathology, which was reversed by rIL-18 admin-
istration. While the presence of CD4+ cells was important for the
ability of NLRP3 to influence anti-parasitic immunity, NLRP3
could suppress protective immunity to Trichuris even in the
absence of a fully functional adaptive immune system, high-
lighting a complex mechanism by which the NLRP3 inflamma-
some regulates inflammation and immunity to parasitic helminth
infections.
RESULTS
Helminth Infections Promote Caspase-1-Dependent
IL-18 Expression that Limits Anti-parasitic Immunity
To investigate whether helminth infection was associated with
inflammasome activation, wild-type (WT) C57BL/6 mice were in-
fected with T. muris and IL-18 and IL-1b levels were quantified in
the serum at different time points post-infection (p.i.). Caspase-
1/caspase-11 double-deficient mice were included as a control
due to their impaired ability to be activated by most inflamma-
some complexes (Schroder and Tschopp, 2010). Trichuris infec-
tion in WT mice caused significant elevations in serum IL-18
levels at day 21 p.i. (Figure 1A), while IL-1b levels were not signif-
icantly increased at any time point (Figure 1B). Caspase-1/11-
deficient mice had significantly reduced serum IL-18 and IL-1b
Figure 1. Helminth Infections Promote Cas-
pase 1/11-Dependent IL-18 Expression that
Limits Anti-parasitic Immunity
(A and B) C57BL/6 wild-type (WT) and caspase-1/
11!/! mice were infected with Trichuris and
sacrificed at day 14 or day 21 post-infection (p.i.).
Serum IL-18 (A) and IL-1b (B) levels are shown.
(C) Trichuris antigen-specific IgG1 titers at day
21 p.i.
(D) Cecal worm burdens day 21 p.i., pooled from 2
experiments.
(E) Representative images of PAS/Alcian-blue-
stained cecum at day 21 p.i. Scale bar, 50 mm.
(F) Quantification of goblet cell numbers per cecal
crypt unit.
Data are expressed as mean with individual data
points or mean ± SEM and are representative of
4 experiments (n = 4–5/group).
(G and H) Human clinical trial volunteers with ce-
liac disease were infected with 15 Necator ameri-
canus larvae (n = 9) or a mock infection (placebo,
n = 10). Serum IL-18 (G) and IL-1b (H) levels in
individuals pre-infection (week 0) or 20 weeks p.i.
*p < 0.05 compared to WT. #p < 0.05 compared to
day 0 or week 0.
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Figure 2.3.1 Helminth infections promote Caspase 1/11-dependent IL-18 expression that limits anti-
parasitic immunity. C57BL/6 wild-type (WT) and Caspase1/11−/− mice were infected with Trichuris and 
sacrificed at d 14 or d 21 post-infection (p.i.). (A) Serum IL-18 and (B) IL-1β levels. (C) Trichuris antigen-
specific IgG1 titers at d 21 p.i. (D) Cecal worm burdens d 21 p.i, pooled from 2 experiments. (E) Representative 
images of PAS/Alcian Blue stained cecum at d 21 p.i. Scale bar = 50µm. (F) Quantification of goblet cell 
numbers per cecal crypt unit. Data are expressed as mean with individual data points or mean±SEM and are 
representative of 4 experi ents (n=4-5/group). Human clinical trial volunteers with celiac disease were infected 
with 15 Necator americanus larvae (n=9) or a mock infection (placebo, n=10). (G) Serum IL-18 an  (H) IL-
1β levels in individuals pre-infection (wk 0) or 20 w eks p.i. *p <0.05 compared to WT. #p<0.05 compar d to 
day 0 or week 0. 
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2.3.2 Trichuris and its secreted factors promote NLRP3-dependent in vivo and in vitro 
secretion of IL-18 and IL-1β. 
Inflammasomes are multi-protein complexes that contain members of the NLR family of 
proteins (i.e. NLRP3, NLRP1, NLRC4) or non-NLR proteins such as AIM2, which give the 
various inflammasomes their distinct properties and effector functions (Davis et al., 2011). 
Since the ligands for NLRP1, NLRC4 and AIM2 have been defined and are not likely to be 
contained within Trichuris (other than DNA), the well-characterized NLRP3 inflammasome 
was a likely mediator. Hence, we examined the potential role for the NLRP3 inflammasome in 
Trichuris-mediated stimulation of IL-18 and IL-1β secretion. WT and NLRP3-/- mice were 
infected with T. muris and serum IL-18 and IL-1β levels were measured at day 21 p.i. While 
WT mice exhibited significant increases in serum IL-18 and a trend towards increased IL-1β 
levels compared to naïve mice, NLRP3-/- mice displayed significantly reduced levels of these 
cytokines (Figure 2.3.2 A), suggesting that NLRP3 is important for in vivo IL-18 and IL-1β 
secretion. Previous studies have demonstrated that factors excreted and secreted by worms can 
activate inflammasomes in vitro (Ferguson et al., 2015; Ritter et al., 2010; Zaiss et al., 2013). 
To examine whether products released by Trichuris similarly activate inflammasomes, we 
purified excretory/secretory (ES) products from Trichuris adult worms and injected either WT 
mice or NLRP3-/- mice intra-peritoneally (i.p.) daily for 6 days and measured circulating IL-18 
and IL-1β levels at days 2 and 6. Injection of WT mice with ES products resulted in significantly 
increased levels of serum IL-18 and IL-1β at 2 days post-injection, with even higher levels at 
day 6 post-injection (Figure 2.3.2 B). In contrast, NLRP3-/- mice exhibited no increases in these 
cytokines following ES injection, suggesting that factors excreted or secreted by Trichuris may 
promote in vivo NLRP3 inflammasome-mediated IL-18 and IL-1β secretion.  
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We next adopted in vitro experiments to determine which cell type may be responsive to 
Trichuris ES, and whether ES products are sufficient for NLRP3-dependent IL-18 and IL-1β 
secretion. Macrophages are key cells responsible for inflammasome activation in response to 
pathogens (Sims and Smith, 2010), including helminths (Ferguson et al., 2015). Therefore, we 
generated bone marrow derived macrophages from WT mice and cultured them in the presence 
and absence of Trichuris ES products, known inflammasome activators (LPS and nigericin 
toxin) or culture media alone. Culturing macrophages from WT mice with ES, LPS or nigericin 
alone did not cause significant increases in IL-18 or IL-1β secretion compared to media control 
(Figure 2.3.2 C). As expected, LPS and nigericin stimulation did significantly increase IL-18 
or IL-1β secretion compared to media, however these levels were increased substantially if 
Trichuris ES was also included in the cultures (Figure 2.3.2 C). We next aimed to determine 
whether ES-mediated IL-18 or IL-1β secretion was dependent on NLRP3 and whether a specific 
fraction of Trichuris ES may exert these effects. Parasitic worm ES products are highly complex 
mixture of proteins, lipids, carbohydrates, microRNAs and small molecules, and recent studies 
have highlighted that these can be contained within extracellular vesicles such as exosomes, 
which facilitate host-pathogen interactions and immunomodulation (Eichenberger et al., 2018). 
Similar to results from Figure 2C, ES products or purified exosomes alone or in combination 
with LPS did not significantly increase secretion of IL-18 or IL-1β compared to treatment with 
media or LPS only (Figure 2.3.2 D). However, if WT macrophages were stimulated with ES 
or exosomes in the presence of known inflammasome activators (LPS and nigericin), the levels 
of both IL-18 and IL-1β rose significantly compared to stimulation with LPS + nigericin alone 
(Figure 2.3.2 D). Critically, this synergistic stimulation of IL-18 or IL-1β secretion by 
Trichuris ES products and exosomes was not apparent when cells from NLRP3-/- mice were 
used, indicating that molecules and extracellular vesicles secreted by Trichuris augment 
NLRP3-dependent secretion of IL-18 or IL-1β, in concert with microbial signals and toxins. 
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cellular immune responses at the site of infection (cecum) re-
vealed that Trichuris-infected NLRP3– /– mice displayed elevated
eosinophil frequencies in the cecum compared to WT mice (Fig-
ure S1A). Frequencies of other cell types typically associated
with type 2 immunity such as basophils (Figure S1B), mast cells
(Figure S1C), and macrophages (Figure S1D) were not elevated
in the ceca of infected NLRP3!/! mice. The degree of intestinal
immunopathology was significantly decreased in NLRP3!/!
mice compared to WT mice (Figures 3E and 3F), which corre-
sponded with significantly increased goblet cell responses (Fig-
ures 3G and 3H). One of the most well-studied mechanisms by
which the NLRP3 inflammasome is activated is by engagement
of the P2X7R by extracellular ATP (Riteau et al., 2010). However,
mice deficient in P2X7R do not display the same enhanced im-
munity phenotype as NLRP3!/! mice during Trichuris infection,
suggesting that a different pathway to NLRP3 inflammasome
activation may be more important (Figure S2). Together, these
data suggest that the NLRP3 inflammasome inhibits protective
type-2-associated immune responses and promotes immuno-
pathology following Trichuris infections, likely via a P2X7R-inde-
pendent mechanism.
Figure 2. Trichuris and Its Secreted Factors
Promote In Vivo and In Vitro NLRP3-Depen-
dent Secretion of IL-18 and IL-1b
(A) WT andNLRP3!/!mice were infected (INF) with
T. muris, and serum IL-18 and IL-1b levels were
determined at day 21 p.i. (n = 3–5 mice/group). N,
naive mice.
(B) WT and NLRP3!/! mice were injected intra-
peritoneally with 50 mg of Trichuris excretory/
secretory (ES) products and were bled immedi-
ately (day 0) or 2 or 6 days post-injection, and
serum levels of IL-18 and IL-1b levels were
determined (n = 3/group).
(C) Bone-marrow-derived macrophages from WT
mice were cultured with combinations of either
25 mg/mL of Trichuris ES, 1 mg/mL LPS, or 20 mM
nigericin. Plus (+) symbols denote inclusion of re-
agent; minus (–) symbol denotes media control.
(D) Bone-marrow-derived macrophages from WT
or NLRP3!/! mice were cultured with combina-
tions of 25 mg/mL of Trichuris ES, 25 mg/mL puri-
fied Trichuris adult worm exosomes, 1 mg/mL LPS,
or 20 mM nigericin (n = 4 wells/treatment). IL-18
and IL-1b were measured in supernatants or sera
by ELISA. All results are representative of 3 ex-
periments. *p < 0.05 compared to WT. #p < 0.05
compared to N, DAY 0, or media only control, ^^p <
0.05 compared to LPS + nigericin; ns, not signifi-
cantly different.
To investigate the immunological
mechanisms by which NLRP3 controls
immunity to Trichuris infections, we as-
sessed antigen-specific cytokine re-
sponses in the mLN of WT and NLRP3!/!
mice and cytokine responses in the co-
lon. NLRP3!/! mice displayed increased
IL-4 and IL-13 expression by Ag-stimu-
lated mLN cells compared to WT mice
(Figure 3I), consistent with an augmented type 2 immune
response in the intestinal draining lymph nodes. This was asso-
ciated with increased levels of IL-13 and thymic stromal lympho-
poietin (TSLP) in the colon tissue (Figure S3A). Levels of the type
2-associated cytokines IL-25 and IL-33 in the colon were not
significantly elevated in infected NLRP3!/!mice, nor were there
increases in innate lymphoid cell type 2 (ILC2) responses in either
the mLN or colonic lamina propria, since frequencies of CD3–
CD19– CD90+ GATA3+ cells in these tissues were not signifi-
cantly different to those in infected WT mice (Figure S3B).
Together, these data suggest that NLRP3 limits type 2 cytokine
responses to Trichuris infection. The augmented type-2-associ-
ated immune responses observed in NLRP3!/! mice was
accompanied by a significant reduction in type 1 cytokine re-
sponses, measured by interferon (IFN)-g expression (Figure 3I).
Given that IFN-g is associated with the development of chronic
infections and suppression of protective type 2 immune re-
sponses to helminths, including Trichuris (Else et al., 1994;
Coomes et al., 2015), we investigated the cellular sources of
IFN-g. While WT mice displayed significant increases in fre-
quencies (Figure 3J) and total numbers (Figure 3K) of CD4+
1088 Cell Reports 23, 1085–1098, April 24, 2018
Figure 2.3.2 Trichuris and its secreted factors promote NLRP3-dependent in vivo and in vitro secretion 
of IL-18 and IL-1β. (A) Wild-type (WT) and NLRP3-/- mice were infected (INF) with T. muris a d erum 
IL-18 and IL-1β levels were determined at d 21 post-infection (n=3-5 mice/group). N=naive mic . (B) WT 
and NLRP3-/- mice were injected intraperitoneally with 50 μg of Trichuris excretory/secretory (ES) products 
and were bled immediat ly (day 0) or 2 or 6 days post-injection and erum l vels of IL-18 and IL-1β l vels 
were determined (n=3/group). (C) Bone marrow-derived macrophages from WT mice were cultured with 
combinations of either 25 μg/ml of Trichuris ES, 1 μg/ml LPS or 20 μM nigericin. Plus (+) symbols denote 
inclusion of reagent, minus (-) symbol denotes media control. (D) Bone marrow-derived macrophages from 
WT or NLRP3-/- mice were cultured with combinations of either 25 μg/ml of Trichuris ES, 25 μg/ml purified 
Trichuris adult worm exosomes, 1 μg/ml LPS or 20 μM nigericin (n=4 wells/treatment). IL-18 and IL-1β 
were measured in supernatants or sera by ELISA. All results are representative of 3 experiments. *p <0.05 
compared to WT. # p<0.05 compared to N, DAY 0 or media only control, ^^ p<0.05 compared to 
LPS+nigericin, ns denotes not significantly different. 
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2.3.3 NLRP3 limits protective Type 2 immunity and promotes IFN-γ	 responses following 
Trichuris infection.  
Given the critical role for NLRP3 in Trichuris-mediated inflammasome activation and IL-18 
secretion, we assessed the in vivo role for NLRP3 in protective immunity to Trichuris infection. 
Similar to results seen in Caspase 1/11-/- mice (Figure 2.3.1), NLRP3- /- mice had significantly 
increased Trichuris Ag-specific serum IgG1 titers (Figure 2.3.3 A) and reduced worm burdens 
at day 14, 21 and 35 p.i compared to WT mice (Figure 2.3.3 B). NLRP3- /- mice also displayed 
significantly increased frequencies and total numbers of eosinophils in the mesenteric lymph 
node (mLN) compared to WT mice (Figure 2.3.3C-D), consistent with an elevated cellular 
Type 2 immune response. Further analysis of cellular immune responses at the site of infection 
(cecum) revealed that Trichuris-infected NLRP3- /- mice displayed elevated eosinophil 
frequencies in the cecum compared to WT mice (Supplementary figure 2.3.1 A). Frequencies 
of other cell types typically associated with Type 2 immunity such as basophils 
(Supplementary figure 2.3.1 B), mast cells (Supplementary figure 2.3.1 C) and macrophages 
(Supplementary figure 2.3.1 D) were not elevated in the ceca of infected NLRP3-/- mice. The 
degree of intestinal immunopathology was significantly decreased in NLRP3-/- mice compared 
to WT mice (Figure 2.3.3 E-F), which corresponded with significantly increased goblet cell 
responses (Figure 2.3.3 G-H). One of the most well studied mechanisms by which the NLRP3 
inflammasome is activated is by engagement of the P2X7R by extracellular ATP (Riteau et al., 
2010). However, mice deficient in P2X7R do not display the same enhanced immunity 
phenotype as NLRP3-/- mice during Trichuris infection, suggesting that a different pathway to 
NLRP3 inflammasome activation may be more important (Supplementary figure 2.3.2). 
Together, these data suggest that the NLRP3 inflammasome inhibits protective Type 2 
associated immune responses and promotes immunopathology following Trichuris infections, 
likely via a P2X7R-independent mechanism. To investigate the immunological mechanisms by 
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which NLRP3 controls immunity to Trichuris infections, we assessed antigen-specific cytokine 
responses in the mLN of WT and NLRP3-/- mice and cytokine responses in the colon. NLRP3-
/- mice displayed increased IL-4 and IL-13 expression by Ag-stimulated mLN cells compared 
to WT mice (Figure 2.3.3 I), consistent with an augmented Type 2 immune response in the 
intestinal draining lymph nodes. This was associated with increased levels of IL-13 and TSLP 
in the colon tissue (Supplementary figure 2.3.3 A). Levels of the Type 2-associated cytokines 
IL-25 and IL-33 in the colon were not significantly elevated in infected NLRP3-/- mice, nor 
were there increases in innate lymphoid cell Type 2 (ILC2) responses in either the mLN or 
colonic lamina propria, since frequencies of CD3- CD19- CD90+ GATA3+ cells in these tissues 
were not significantly different to those in infected WT mice (Supplementary figure 2.3.3 B). 
Together, these data suggest that NLRP3 limits Type 2 cytokine responses to Trichuris 
infection. The augmented Type 2-associated immune responses observed in NLRP3-/- mice was 
accompanied by a significant reduction in Type 1 cytokine responses, measured by IFN-γ 
expression (Figure 2.3.3 I). Given that IFN-γ is associated with the development of chronic 
infections and suppression of protective Type 2 immune responses to helminths, including 
Trichuris (Coomes et al., 2015; Else et al., 1994), we investigated the cellular sources of IFN-
γ. While WT mice displayed significant increases in frequencies (Figure 2.3.3 J) and total 
numbers (Figure 2.3.3 K) of CD4+ T cells that express IFN-γ, these responses were 
significantly diminished in NLRP3-/- mice. Similarly, IFN-γ responses by non-T cells (CD3- 
cells) were also significantly reduced in the absence of NLRP3 (2.3.3 L-M), together 
suggesting that NLRP3 promotes innate and adaptive IFN-γ responses following helminth 
infection, potentially representing a mechanism by which inflammasomes limit protective Type 
2 immunity to helminths. 
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 Figure 3. NLRP3 Limits Protective Type 2 Immunity and Promotes IFN-g Responses following Trichuris Infection
WT and NLRP3– /– mice were infected with T. muris and sacrificed at day 14, day 21, or day 35 p.i. N, naive mice.
(A) Trichuris antigen-specific IgG1 titers at day 21 p.i.
(B) Cecal worm burdens at day 14, day 21, and day 35 p.i. pooled from 2 experiments.
(C) Representative plots displaying Siglec F+ eosinophils frequencies in the mesenteric lymph nodes (mLN) at day 21 p.i.
(D) Total mLN eosinophils.
(E) Representative images of H&E-stained cecum at day 21 p.i. Scale bar, 50 mm.
(F) Blinded scores of cecal pathology, pooled from 4 experiments.
(G) Representative images of PAS/Alcian-blue-stained cecum tissue at day 21 p.i.
(H) Quantification of goblet cell numbers per cecal crypt unit.
(legend continued on next page)
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Figure 2.3.3 NLRP3 limits protective Type 2 immunity and promotes IFN-γ responses 
following Trichuris infection.Wild-type (WT) and NLRP3-
 /- mice were infected with T. muris and 
sacrificed at d 14, d 21 or d 35 post-infection (p.i.). N= naive mice. (A) Trichuris antigen-specific 
IgG1 titers at d 21 p.i. (B) Cecal worm burdens at  14, 21 and d 35 p.i. pooled from 2 experiments. 
(C) Representative plots displaying Siglec F+ eosinophils frequencies in the mesenteric lymph nodes 
(mLN) at d 21 p.i.  (D) Total mLN eosinophils. (E) Representative images of H&E stained cecum 
at d 21 p.i. Scale bar=50µm. (F) Blinded scores of cecal pathology, pool d from 4 experiments. (G) 
Representative images of PAS/Alcian Blue stained cecum tissue at d 21 p.i. (H) Quantification of 
goblet cell numbers per cecal crypt unit. (I) Trichuris antigen-specific IL-4, IL-13 and IFN-γ 
production by restimulated mLN cells. (J) Frequencies of CD3+ CD4+ IFN-γ+ cells in the mLN 
following ex vivo stimulation. (K) Total mLN CD4+ IFN-γ+ cells. (L) Frequencies of CD3- IFN-γ+ 
cells in the mLN. (M) Total mLN CD3 IFN-γ+ cells. Data are expressed as mean with individual 
data points, or mean±SEM, and are representative of 7 experiments where n=4-5/group. *p <0.05 
compared to WT, ns denotes not significantly different. 
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2.3.4 Therapeutic NLRP3 inhibition suppresses Type 1 immune responses and promotes 
resistance to Trichuris infection.  
To confirm the role for NLRP3 in regulating immunity to Trichuris infection, and to avoid 
potential impacts of developmental abnormalities in gene knockout mice, we next targeted the 
NLRP3 inflammasome therapeutically with a selective chemical inhibitor MCC950 (Coll et al., 
2015). C57BL/6 WT mice were i.p. treated daily with either PBS vehicle control or 20 
mg/kg/day of MCC950 starting on the initial day of Trichuris infection. Treatment with 
MCC950 lowered serum IL-18 and IL-1β levels in Trichuris-infected mice but these reductions 
were not statistically significant (Figure 2.3.4 A-B). MCC950 treatment significantly increased 
serum titers of Trichuris Ag-specific IgG1 (Figure 2.3.4 C), significantly lowered worm 
burdens at day 21 p.i. (Figure 2.3.4 D) and resulted in a non-significant trend towards increased 
mLN eosinophil numbers compared to the PBS control-treated mice (Figure 2.3.4 E), 
consistent with enhanced anti-parasitic responses. Trichuris-infected mice treated with 
MCC950 displayed evidence of decreased intestinal inflammation compared to PBS control 
mice, however blinded pathology scores were not significantly reduced (Figure 2.3.4 F-G). 
MCC950-treatment resulted in elevated Trichuris Ag-specific Type 2 cytokine responses in the 
mLN, and concurrent significant reductions in IFN-γ responses (Figure 2.3.4 H). Analysis of 
the cellular sources of IFN-γ revealed that IFN-γ responses by CD4+ CD3+ T cells and non-T 
cells (CD3- cells) were both significantly reduced by MCC950-treatment (Figure 2.3.4 I-J). 
Together, these data suggest that targeting the NLRP3 inflammasome therapeutically with a 
chemical inhibitor has a similar phenotypic effect to genetic NLRP3 deficiency. 
 62 
 
 
 
  
NLRP3 Can Regulate Immunity to Trichuris Independent
of the Adaptive Immune System
To further define the cellular mechanisms of NLRP3-dependent
regulation of immunity to infection, we aimed to assess whether
NLRP3 could influence innate immunity to Trichuris. C57BL/6
Rag1!/! mice (which do not possess a functional adaptive
immune system) were infected with Trichuris treated daily
with either PBS or 20 mg/kg/day i.p. of MCC950. C57BL/6
WT mice were included as a control for assessment of worm
burdens. Critically, MCC950 treatment was able to significantly
reduce worm burdens in Rag1!/! mice at day 21 p.i. compared
to PBS-treated mice (Figure 7A), which corresponded with
significantly increased eosinophil numbers in the mLN (Fig-
ure 7B). Analysis of cytokine responses in the mLN revealed
that while Rag1– /– mice treated with PBS displayed increased
IFN-g responses within cells that express CD90 following infec-
tion, mice that received the MCC950 had a reduced IFN-g
response in these cells (Figure 7C). Further analysis of this
Figure 4. Therapeutic NLRP3 Inhibition Suppresses Type 1 Immune Responses and Promotes Resistance to Trichuris Infection
(A–C) C57BL/6 WT mice were treated intraperitoneally (i.p.) daily with either PBS or 20 mg/kg/day of MCC950 following T. muris infection (INF) and sacrificed at
day 21 p.i. Serum IL-18 (A) and IL-1b (B) levels and Trichuris antigen-specific serum IgG1 titers (C) are shown. N, naive mice.
(D) Worm burdens, pooled from 2 experiments.
(E) Total mesenteric lymph node (mLN) eosinophils.
(F) Representative images of H&E-stained cecum tissue. Scale bar, 50 mm.
(G) Blinded scores of cecal pathology.
(H) Trichuris antigen-specific IL-4, IL-13, and IFN-g secretion by restimulated mLN cells.
(I) Total mLN CD4+ IFN-g+ cells.
(J) Total mLNCD3– IFN-g+ cells. Data are expressed asmean with individual data points or mean ± SEM and are representative of 4 experiments, n = 4–5 infected
or 1–2 naive mice/group. *p < 0.05 compared to PBS control; ns, not significantly different.
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Figure 2.3.4 Therapeutic NLRP3 inhibition suppresses Type 1 immune responses and promotes 
resistance to Trichuris infection.C57BL/6 WT mice were treated intraperitoneally (i.p) daily with 
either PBS or 20 mg/kg/day of MCC950 following T. uris infection (INF) and sacrificed at d 21 post-
infection (p.i.). N=naive mice. (A) Serum IL-18 and (B) IL-1β levels. (C) Trichuris antigen-specific 
serum IgG1 titers. (D) Worm burdens, pooled from 2 experiments. (E) Total mesenteric lymph node 
(mLN) eosinophils. (F) Representative images of H&E stained cecum tissue. Scale bar=50µm. (G) 
Blinded scores of cecal pathology. (H) Trichuris antigen-specific IL-4, IL-13 and IFN-γ secretion by 
restimulated mLN cells. (I) Total mLN CD4+ IFN-γ+ cells. (J) Total mLN D3- IFN-γ+ cell . Data are 
expressed as mean with individual data points or mean±SEM and are representative of 4 experiments, 
n=4-5 infected or 1-2 naive mice/group. *p <0.05 compared to PBS control, ns denotes not significantly 
different. 
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2.3.5 Exogenous delivery of rIL-18 reverses the enhanced anti-parasitic immunity of 
NLRP3-deficient mice.  
Activation of the NLRP3 inflammasome can have multiple downstream effects, including the 
release of mature IL-18, IL-1β and regulation of IL-33 secretion (Strowig et al., 2012). Data 
thus far has indicated that Trichuris infection increases IL-18 expression, and ablation of 
NLRP3 diminishes this response, suggesting that NLRP3 may control immunity or 
susceptibility to this parasite by regulating IL-18. To more precisely define the molecular 
mechanism of how NLRP3 controls immunity to Trichuris, we examined whether delivery of 
exogenous IL-18 to NLRP3-deficient mice could reverse the robust immunity of NLRP3-
deficient mice. NLRP3-/- mice were either treated every 3 days with PBS vehicle or recombinant 
murine IL-18 (200 ng/mouse i.p.) from days 7–19 post-Trichuris infection. C57BL/6 WT mice 
were included as a control and received PBS only. Results demonstrated that, as expected, the 
levels of IL-18 in the serum were increased in NLRP3-
 /- mice treated by rIL-18 (Figure 2.3.5 
A). Furthermore, while NLRP3- /- mice treated by PBS exhibited a trend towards increases in 
Trichuris Ag-specific serum IgG1 titers (Figure 2.3.5 B) and significantly increased eosinophil 
numbers in the mLN (Figure 2.3.5 C), rIL-18 treatment of NLRP3-/- mice normalized these 
responses to WT+PBS levels (Figure 2.3.5 B-C). Similarly, rIL-18 treatment of NLRP3-/- mice 
resulted in significantly higher worm burdens (Figure 2.3.5 D) and increased CD4+ IFN-γ 
responses (Figure 2.3.5 E) and a trend toward increased CD3- IFN-γ responses (Figure 2.3.5 
F) compared to NLRP3-/- mice treated with PBS. Lastly, treatment of NLRP3-/- mice with rIL-
18 led to increased inflammation in the cecum (Figure 2.3.5 G) and a significant increase in 
pathology score compared to PBS-treated mice (Figure 2.3.5 H). Together, these data suggest 
that NLRP3 may limit immunity to Trichuris by enhancing IL-18 production, which promotes 
Type 1 cytokine responses and resultant immunopathology associated with Trichuris 
infections. 
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cell population demonstrated that IFN-g-expressing CD90+
cells following Trichuris infection co-expressed the ILC markers
Sca-1 and CD127 as well as T-bet (Figure 7D), a phenotype
consistent with ILC type 1 cells (ILC1). Histological analyses
demonstrated that, while MCC950 treatment did not result in
significant reductions in immunopathology in the cecum (Fig-
ures 7E and 7G), there were significant increases in goblet
cell responses (Figures 7F and 7H). These data suggest that
the NLRP3 inflammasome can influence innate immunity to Tri-
churis infection, potentially acting via regulation of the function
of innate cells such as ILC1s, and, when taken into consider-
ation with results that CD4+ T cells are also important for
NLRP3-dependent immune regulation (Figure 6), imply that
the NLRP3 inflammasome can influence elements of both the
innate and adaptive immune system to limit protective immu-
nity to helminths.
Figure 5. Exogenous Delivery of rIL-18 Reverses the Enhanced Anti-parasitic Immunity of NLRP3-Deficient Mice
NLRP3– /– mice were either daily treated with PBS vehicle or recombinant murine IL-18 (200 ng/mouse i.p.) from days 7–19 post-Trichuris infection (INF) and were
sacrificed at day 21 p.i. WT control mice received PBS only.
(A) Serum IL-18 levels.
(B) Trichuris antigen-specific serum IgG1 titers.
(C) Total mLN eosinophils. N, naive mice.
(D) Worm burdens.
(E) Total CD3+ CD4+ IFN-g+ cells in the mesenteric lymph node (mLN).
(F) Total mLN CD3– IFN-g+ cells.
(G) Representative images of H&E-stained cecum tissue from infected mice. Scale bar, 50 mm.
(H) Blinded scores of cecal pathology. Data are expressed as mean with individual data points or mean ± SEM and are representative of 3 experiments, n = 4–6
mice/group. *p < 0.05; ns, not significantly different.
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Figure 2.3.5 Exogenous delivery of rIL-18 reverses the enhanced anti-parasitic immunity of 
NLRP3-deficient mice. NLRP3-
 /- mice were either daily treated with PBS vehicle or recombinant 
murine IL-18 (200 ng/mouse i.p.) from days 7–19 post-Trichuris infection (INF) and were sacrificed 
at day 21 post-infection (p.i.). WT control mice received PBS only. (A) Serum IL-18 levels. (B) 
Trichuris antigen-specific serum IgG1 titers. (C) Total mLN eosinophils. N=naive mice. (D) Worm 
burdens. (E) Total CD3+ CD4+ IFN-γ+ cells in the mesenteric lymph node (mLN). (F) Total mLN 
CD3- IFN-γ+ ce ls. (G) Repres ntative images of H&E stained cecum tissue from inf cted mic . Scale 
bar=50µm. (H) Blinded scores of cecal pathology. Data are expressed as mean with individual data 
points or mean±SEM and are representative of 3 experiments, n=4-6 mice/group. *p <0.05, ns denotes 
not significantly different. 
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2.3.6 NLRP3 partially requires CD4+ T cells to limit protective immunity to T. muris 
infection.  
Inflammasomes are critical mediators of innate immunity to infections (Pang and Iwasaki, 
2011), however they can also influence the development of adaptive immunity via regulation 
of T cell responses (Ciraci et al. 2012). Further, CD4+ T cells can also express NLRP3 
inflammasomes, which can promote Th1 cell differentiation (Arbore et al., 2016). Immunity to 
Trichuris is dependent on the generation of adaptive CD4+ T cell responses, hence to assess 
whether NLRP3-dependent regulation of immunity to Trichuris is dependent on CD4+ T cells, 
WT or NLRP3-/- mice were treated every 3 days with either 0.5 mg of a neutralizing anti-CD4 
mAb or a control rat IgG following Trichuris infection. As expected, treatment with anti-CD4 
mAb was able to effectively deplete CD3+ CD4+ cells in infected mice (Figure 2.3.6 A). While 
NLRP3-/- mice treated with control Ig exhibited characteristic significant increases in total mLN 
eosinophils compared to WT mice (Figure 2.3.6 B), these responses were significantly 
diminished when CD4+ cells were ablated. Anti-CD4 mAb treatment caused a significant 
increase in worm burdens in NLRP3-/- mice at d 21 p.i. compared to control IgG treated mice 
(Figure 2.3.6 C), which corresponded with significantly increased cecal pathology (Figure 
2.3.6 D-F) and significantly reduced presence of goblet cells (Figure 2.3.6 E-G). Together, 
these data suggest that CD4+ cells are partially required for the ability of NLRP3 to suppress 
immunity to Trichuris infection. 
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DISCUSSION
Parasitic helminth infections are among the most common and
debilitating causes of chronic disease in humans, infecting
over a billion people worldwide. However, there are no vaccines
that can protect humans against infection, owing in part to the
complexity of helminth life cycles, the immune-suppressive ca-
pacity of helminth antigens, and our relative lack of understand-
ing of how protective type 2 immune responses are initiated and
regulated. Inflammasomes are critical regulators of immunity to
pathogens, yet their roles in immunity to parasitic helminths
have been largely unexplored. The present study has identified
a role for the NLRP3 inflammasome in limiting both innate and
adaptive immunity of mice to a gastrointestinal helminth, via
regulation of IL-18 expression. We demonstrate that chronic hel-
minth infections of humans are similarly associated with elevated
IL-18 expression. Critically, targeting this pathway therapeuti-
cally with a chemical inhibitor was able to accelerate type 2 im-
mune-mediated clearance of the parasite, shedding light on how
innate immune receptors control immunity to helminths and
potentially identifying a strategy for limiting the disease burden
in helminth-infected animal or human populations.
NLRP3 has been implicated in promoting type 1 immune-
mediated protection against pathogens and detrimental inflam-
mation in some disease settings (Silva et al., 2013; Thomas
et al., 2009). In addition, recent studies have highlighted that
NLRP3 can have important roles in promoting type 2 immune re-
sponses (Bruchard et al., 2015; Gurung et al., 2015). Our findings
herein are consistent with a role for NLRP3 in promoting non-
protective type 1 immune responses to Trichuris, potentially by
eliciting IL-18 secretion, a cytokine also known as ‘‘IFN-g-
inducing factor’’ (Micallef et al., 1996). IL-18 is a pleiotropic cyto-
kine that can promote either a type 1 or type 2 response, de-
pending on the nature of the cytokine milieu, infectious stimuli,
and genetic background of the host (Xu et al., 2000). For
instance, IL-18 can induce type 1 immune responses and resis-
tance to one species of the Leishmania parasite (Li et al., 2004)
but induces non-protective type 2 responses to another species
Figure 6. NLRP3 Partially Requires CD4+ T Cells to Limit Protective Immunity to T. muris Infection
WT or NLRP3!/! mice were treated every 3 days with either 0.5 mg of a neutralizing anti-CD4 mAb or a control rat IgG following T. muris infection and were
sacrificed at day 21 p.i.
(A) Representative plots demonstrating successful depletion of CD3+ CD4+ cells in mesenteric lymph nodes (mLN) of infectedmice following anti-CD4 treatment.
(B) Total mLN eosinophils.
(C) Worm burdens.
(D) Representative images of H&E-stained cecum tissue.
(E) Representative images of PAS/Alcian-blue-stained cecum tissue.
(F) Blinded scores of cecal pathology.
(G) Blinded quantification of goblet cell numbers per cecal crypt unit. Scale bar, 50 mm. Data are expressed as mean with individual data points and are
representative of 2 experiments, n = 4–5 mice/group. *p < 0.05; ns, not significantly different.
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Figure 2.3.6 NLRP3 pa tially requires CD4+ T cells to limit protective immunity to T. muris infection. 
WT or NLRP3-/- mice were treated every 3 days with either 0.5mg of a neutralizing anti-CD4 mAb or a 
control rat IgG following T. muris infection and were sacrificed at day 21 post-infection (p.i.). (A) 
Representative plots demonstrating successful depletion of CD3+ CD4+ cells in mesenteric lymph nodes 
(mLN) of infected mice following anti-CD4 treatment. (B) Total mLN eosinophils. (C) Worm burdens. (D) 
Representative images of H&E stained cecum tissue. (E). Representative images of PAS/Alcian Blue stained 
cecum tissue. (F) Blinded scores of cecal pathology. (G) Blinded quantification of goblet cell numbers per 
cecal crypt unit. Scal  bar=50µm. Data are express d as mean with individual data points and are 
representative of 2 experi ents, n=4-5 mice/group. *p <0.05, ns denotes not significantly different. 
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2.3.7 NLRP3 can regulate immunity to Trichuris independent of the adaptive immune 
system.	
 
To further define the cellular mechanisms of NLRP3-dependent regulation of immunity to 
infection, we aimed to assess whether NLRP3 could influence innate immunity to Trichuris. 
C57BL/6 Rag1-/- mice (which do not possess a functional adaptive immune system) were 
infected with Trichuris treated daily with either PBS or 20 mg/kg/day i.p. of MCC950. 
C57BL/6 WT mice were included as a control for assessment of worm burdens. Critically, 
MCC950 treatment was able to significantly reduce worm burdens in Rag1-/- mice at day 21 
p.i. compared to PBS treated mice (Figure 2.3.7 A), which corresponded with significantly 
increased eosinophil numbers in the mLN (Figure 2.3.7 B). Analysis of cytokine responses in 
the mLN revealed that while Rag1-
 /- mice treated with PBS displayed increased IFN-γ 
responses within cells that express CD90 following infection, mice that received the MCC950 
had a reduced IFN-γ response in these cells (Figure 2.3.7 C). Further analysis of this cell 
population demonstrated that IFN-γ-expressing CD90+ cells following Trichuris infection co-
expressed the innate lymphoid cell (ILC) markers Sca-1 and CD127 as well as T-bet (Figure 
2.3.7 D), a phenotype consistent with ILC Type 1 cells (ILC1). Histological analyses 
demonstrated that while MCC950 treatment did not result in significant reductions in 
immunopathology in the cecum (Figure 2.3.7 E-G), there were significant increases in goblet 
cell responses (Figure 2.3.7 F-H). These data suggest that the NLRP3 inflammasome can 
influence innate immunity to Trichuris infection, potentially acting via regulation of the 
function of innate cells such as ILC1s and when taken into consideration with results that CD4+ 
T cells are also important for NLRP3-dependent immune regulation (Figure 2.3.6), implies that 
the NLRP3 inflammasome can influence elements of both the innate and adaptive immune 
system to limit protective immunity to helminths.  
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(Bryson et al., 2008). Previous studies have demonstrated that
IL-18 is a critical regulator of immunity to Trichuris, with differ-
ences in the relative role depending on the inflammatory context.
While one report highlights how IL-18 promotes type 2 re-
sponses when IFN-g is absent (Liu et al., 2006), another report
implicates IL-18 in suppressing type 2 cytokine responses to Tri-
churis (Helmby et al., 2001), which is more consistent with our
findings in NLRP3!/! mice. Hence it is likely that, in the context
of the present study, lowered IL-18 expression in the absence of
NLRP3 may contribute to the elevated type 2 responses and
diminished type 1 responses following Trichuris infection. How-
ever, it remains unclear whether elevations in type 2 immunity
were a consequence, or a cause, of reductions in Th1 cell or
ILC1 responses observed in NLRP3!/! mice (i.e., cross-regula-
tion of type 1 versus type 2 responses), or whether this was a
direct effect of IL-18 or other factors.
Our data are supportive for a central role for NLRP3-depen-
dent IL-18 in regulating immunity and inflammation following Tri-
churis infection, but we have also demonstrated that IL-1b levels
are similarly regulated by NLRP3, MCC950, and caspase-1/11,
raising the question as to the role for IL-1b in this system. While
IL-1b can have a role in suppressing protective immunity to other
helminth species (Zaiss et al., 2013), this contrasts with what is
observed during Trichuris infections, where IL-1/IL-1R interac-
tions promote type 2 immunity (Helmby andGrencis, 2004; Hum-
phreys and Grencis, 2009). IL-1b also has an emerging role in
stimulating ILC2 responses (Ohne et al., 2016) suggesting that,
at least in the context of Trichuris infection, defective IL-1b pro-
duction in NLRP3!/!micewould be unlikely to be responsible for
the increased type 2 immune responses we observed in the pre-
sent study.
The NLRP3 inflammasome can be activated by a wide variety
of stimuli, ranging from pathogen-associated molecular pat-
terns, danger signals (ATP, ADP, DNA), toxins, and crystals
(Schroder and Tschopp, 2010). We found that Trichuris adult
worms release factors that can support NLRP3-dependent
IL-18 and IL-1b secretion in vivo and in cultured macrophages.
Interestingly, worm secreted factors do not appear to induce
NLRP3-dependent IL-1b and IL-18 secretion alone, since signals
from known inflammasome activators (e.g., LPS and nigericin)
were also required. It is therefore unclear whether worm-derived
molecules are operating as a ‘‘first signal’’ to promote pro-IL-1b/
pro-IL-18 generation or as a ‘‘second signal’’ to activate the
NLRP3 inflammasome and promote cytokine maturation and
release, or both. We also cannot definitively say that Trichuris
and its secretions definitively elicit in vivo IL-18 secretion, since
it remains possible that IL-18 secretion is diminished in the
absence of NLRP3 due to an inability to respond to the micro-
biota. Regardless, our results are consistent with the premise
that worm-derived factors may be able to augment NLRP3 acti-
vation, provided that signals from commensal microbes are also
present.
While our study has not pinpointed the precise worm-derived
molecule(s) responsible for enhancing NLRP3-dependent IL-1b
and IL-18 secretion, as has been demonstrated for schisto-
somes (Ritter et al., 2010), we found that purified exosome-like
extracellular vesicles released from the worm can mediate
these effects. Helminth-derived exosomes have been recently
Figure 7. NLRP3 Can Regulate Immunity to T. muris Independent of
the Adaptive Immune System
C57BL/6 Rag1– /– mice were treated daily with either PBS or 20 mg/kg/day i.p.
of the NLRP3 inhibitor, MCC950 following Trichuris infection and were sacri-
ficed at day 21 p.i. C57BL/6WTmice received PBS only and were only used as
a control for worm burden.
(A) Worm burdens.
(B) Total mLN eosinophils.
(C) Frequencies of CD90+ IFN-g+ cells in the mLN.
(D) IFN-g-expressing CD90+ cells (shaded histograms) were gated and
analyzed for co-expression of ILC markers Sca-1, CD127, and T-bet. Clear
histograms represent gated CD90– cells from the same sample.
(E) Representative images of H&E-stained cecum tissue.
(F) Representative images of PAS/Alcian-blue-stained cecum tissue.
(G) Blinded scores of cecal pathology.
(H) Blinded quantification of goblet cell numbers per cecal crypt unit. Scale
bar, 50 mm. Data are expressed as mean with individual data points and are
representative of 3 experiments, n = 5–6 mice/group. *p < 0.05 compared to
NLRP3–/– + rat Ig. ns, not significantly different.
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Figure 2.3.7. NLRP3 can regulate immunity to T. muris independent of the adaptive immune 
system. C57BL/6 Rag1-
 /- mice were treated daily with either PBS or 20 mg/kg/day i.p. of the NLRP3 
inhibitor, MCC950 following Trichuris infection and were sacrificed at day 21 post-infection (p.i.).. 
C57BL/6 WT mice received PBS only and were only used as a control for worm burden. (A) Worm 
burdens. (B) Total mLN eosinophils. (C) Frequencies of CD90+ IFN-γ+ cells in the mLN. (D) IFN-γ-
expressing CD90+ cells (shaded histograms) were gated and analysed for co-expression of innate 
lymphoid cell markers Sca-1, CD127 and T-bet. Clear histograms represent gated CD90- cells from 
the same sample. (E) Repres ntative images of H&E stained cecum tissue. (F) Representative images 
of PAS/Alcian Blue stained cecum tissue. (G) Blinded score  of cec l pathology. (H) Blinded 
quantification of goblet cell numbers per cecal crypt unit. Scale bar=50µm. Data are expressed as 
mean with individual data points and are representative of 3 experiments, n=5-6 mice/group. *p<0.05 
compared to NLRP3-/-+rat Ig, ns denotes not significantly different. 
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Supplementary Figure 1. NLRP3-/- mice do not display elevated frequencies of basophils, mast 
cells or macrophages in the intestine following T. muris  infection. Related to Figure 3. C57BL/6 
WT and NLRP3-/- mice were infected with T. muris and sacrificed at d 21 p.i. Frequencies of  (A) 
Siglec F+ eosinophils,  (B) CD3- CD19- CD49b+ FcERI+ basophils,  (C) CD3- CD19- CD117+ FcERI+ 
mast cells and  (D) CD3-CD19- CD11b+ F4/80+ macrophages in cecal patch tissue. Data are 
expressed as mean cell frequency and are representative of 2 experiments, n=1 naive or pooled tissue 
samples from 5 infected mice/group 
Supplementary figure 2.3.1 NLRP3-/- mice do not display elevated frequencies of 
basophils, mast cells or macrophages in the intestine following T. muris infection. 
Related to Figure 2-3.3.3. C57BL/6 WT and NLRP3-/- mice were infected with T. muris 
and sacr ficed at d 21 p.i. Frequencies of (A) Siglec F+ eosinophils, (B) CD3- CD19- 
CD49b+ FcERI+ basophils, (C) CD3- CD19- CD117+ FcERI+ mast cells and (D) CD -
CD19- D11b+ F4/80+ macrophages in cecal patch tissue. Data are expressed as mean cell 
frequency and are representative of 2 experiments, n=1 naive or pooled tissue samples from 
5 infected mice/group  
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Supplemental Figure 2. P2X7R-deficent mice do not exhibit enhanced anti-parasitic immunity 
to T. muris. Related to Figure 3. C57BL/6 WT and P2X7R-/- mice were infected with T. muris and 
sacrificed at d 21 p.i. (A) Trichuris antigen-specific serum IgG1 titers. (B) Cecal worm burdens, 
pooled from 2 experiments. (C) Frequencies of mLN eosinophils. (D) Representative images of 
H&E stained cecum tissue, scale = 50µm. Data are expressed as mean and individual data points or 
mean±SEM and are representative of 4 experiments, n=4-5 mice/group. 
Supplement ry fig  .3.2 P2X7R- fici t ice do not exhibit enha ced anti-parasitic 
im unity to T. muris. Related to Figure 2-3.3. C57BL/6 WT and P2X7R-/- mice were infected 
with T. muris and sacrificed at d 21 p.i. (A) Trichuris antigen-specific serum IgG1 titers. (B) Cecal 
worm burdens, pooled from 2 experiments. (C) Frequencies of mLN eosinophils. (D) 
Representative images of H&E stained cecum tissue, scale = 50μm. Data are expressed as mean 
and individual data points or mean±SEM and are representative of 4 experiments, n=4-5 
mice/group.  
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Supplementary Figure 3. NLRP3-/- exhibit elevated intestinal TSLP expression but no increases 
in IL-33, IL-25 or ILC2 responses following Trichuris  infection. Related to Figure 3. C57BL/6 
WT and NLRP3-/- mice were infected with T. muris and sacrificed at d 21 p.i.  (A) Levels of IL-13, 
TSLP, IL-33 and IL-25 protein in colon tissue homogenates, measured by ELISA and normalized to 
weight of tissue in grams (g), expressed as mean and individual data points (n=5).  (B) Representative 
plots demonstrating frequencies of CD3- CD19- CD90+ GATA3+ cells in the mesenteric lymph node 
(mLN) or pooled colonic lamina propria (cLPL) of naïve or infected mice. Data are expressed as mean 
cell frequency and are representative of two experiments (n=1 naïve or pooled tissue samples from 5 
infected mice/group). 
Supplementary figure 2.3.3. NLRP3-/- exhibit elevated intestinal TSLP expression but no 
increases in IL-33, IL-25 or ILC2 responses following Trichuris infection. Related to 
Figure 2-3.3. C57BL/6 WT and NLRP3-/- mice were infected with T. muris and sacrificed at 
d 21 p.i. (A) Levels of IL-13, TSLP, IL-33 and IL-25 protein in colon tissue homogenates, 
measured by ELISA and normalized to weight of tissue in grams (g), expressed as mean and 
individual data points (n=5). (B) Representative plots demonstrating frequencies of CD3- 
CD19- CD90+ GATA3+ cells in the mesenteric lymph node (mLN) or pooled colonic lamina 
r pria ( LPL) of naive or infected mice. Data are expressed as m an cell frequency and are 
represe tativ  of two experiments (n=1 naive or pooled tissue samples from 5 infected 
mice/group).  
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2.4 Discussion 
 
Parasitic helminth infections are among the most common and debilitating causes of chronic 
disease in humans, infecting over a billion people worldwide. However, there are no vaccines 
that can protect humans against infection, owing in part to the complexity of helminth life 
cycles, the immune-suppressive capacity of helminth antigens and our relative lack of 
understanding of how protective Type 2 immune responses are initiated and regulated. 
Inflammasomes are critical regulators of immunity to pathogens, yet their roles in immunity to 
parasitic helminths have been largely unexplored. The present study has identified a role for 
the NLRP3 inflammasome in limiting both innate and adaptive immunity of mice to a 
gastrointestinal helminth, via regulation of IL-18 expression. We demonstrate that chronic 
helminth infections of humans are similarly associated with elevated IL-18 expression. 
Critically, targeting this pathway therapeutically with a chemical inhibitor was able to 
accelerate Type 2 immune-mediated clearance of the parasite, shedding light on how innate 
immune receptors control immunity to helminths and potentially identifying a strategy for 
limiting the disease burden in helminth-infected animal or human populations.   
NLRP3 has been implicated in promoting Type 1 immune-mediated protection against 
pathogens and detrimental inflammation in some disease settings (Silva et al., 2013; Thomas et 
al., 2009). In addition, recent studies have highlighted that NLRP3 can have important roles in 
promoting Type 2 immune responses (Bruchard et al., 2015; Gurung et al., 2015). Our findings 
herein are consistent with a role for NLRP3 in promoting non-protective Type 1 immune 
responses to Trichuris, potentially by eliciting IL-18 secretion, a cytokine also known as “IFN-
γ inducing factor” (Micallef et al., 1996). IL-18 is a pleiotropic cytokine that can promote either 
a Type 1 or Type 2 response, depending on the nature of the cytokine milieu, infectious stimuli 
and genetic background of the host (Xu et al., 2000). For instance, IL-18 can induce Type 1 
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immune responses and resistance to one species of the Leishmania parasite (Li et al., 2004), but 
induces non-protective Type 2 responses to another species (Bryson et al., 2008). Previous 
studies have demonstrated that IL-18 is a critical regulator of immunity to Trichuris, with 
differences in the relative role depending on the inflammatory context. While one report 
highlights how IL-18 promotes Type 2 responses when IFN-γ is absent (Liu et al., 2006), 
another report implicates IL-18 in suppressing Type 2 cytokine responses to Trichuris (Helmby 
et al., 2001), which is more consistent with our findings in NLRP3-/- mice. Hence it is likely 
that in the context of the present study, lowered IL-18 expression in the absence of NLRP3 may 
contribute to the elevated Type 2 responses and diminished Type 1 responses following 
Trichuris infection. However, it remains unclear whether elevations in Type 2 immunity were 
a consequence, or a cause, of reductions in Th1 cell or ILC1 responses observed in NLRP3-/- 
mice (i.e cross-regulation of Type 1 vs. Type 2 responses), or whether this was a direct effect 
of IL-18 or other factors. 
 
Our data are supportive for a central role for NLRP3-dependent IL-18 in regulating immunity 
and inflammation following Trichuris infection but we have also demonstrated that IL-1β levels 
are similarly regulated by NLRP3, MCC950 and Caspase-1/11, raising the question as to the 
role for IL-1β in this system. While IL-1β can have a role in suppressing protective immunity 
to other helminth species (Zaiss et al., 2013), this contrasts with what is observed during 
Trichuris infections, where IL-1/IL-1R interactions promote Type 2 immunity (Helmby and 
Grencis, 2004; Humphreys and Grencis, 2009). IL-1β also has an emerging role in stimulating 
ILC2 responses (Ohne et al., 2016) suggesting that, at least in the context of Trichuris infection, 
defective IL-1β production in NLRP3-/- mice would be unlikely to be responsible for the 
increased Type 2 immune responses we observed in the present study. 
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The NLRP3 inflammasome can be activated by a wide variety of stimuli, ranging from 
pathogen-associated molecular patterns, danger signals (ATP, ADP, DNA), toxins and crystals 
(Schroder and Tschopp, 2010). We found that Trichuris adult worms release factors that can 
support NLRP3-dependent IL-18 and IL-1β secretion in vivo and in cultured macrophages. 
Interestingly, worm secreted factors do not appear to induce NLRP3-dependent IL-1β and IL-
18 secretion alone, since signals from known inflammasome activators (e.g. LPS and nigericin) 
were also required. It is therefore unclear whether worm-derived molecules are operating as a 
“first signal” to promote pro-IL-1β/pro-IL-18 generation, or as a “second signal” to activate the 
NLRP3 inflammasome and promote cytokine maturation and release, or both. We also cannot 
definitively say that Trichuris and its secretions definitively elicit in vivo IL-18 secretion, since 
it remains possible that IL-18 secretion is diminished in the absence of NLRP3 due to an 
inability to respond to the microbiota. Regardless, our results are consistent with the premise 
that worm-derived factors may be able to augment NLRP3 activation, provided that signals 
from commensal microbes are also present. 
 
While our study has not pinpointed the precise worm-derived molecule(s) responsible for 
enhancing NLRP3-dependent IL-1β and IL-18 secretion, as has been demonstrated for 
schistosomes (Riteau et al., 2010), we found that purified exosome-like extracellular vesicles 
released from the worm can mediate these effects. Helminth-derived exosomes have been 
recently implicated in immune modulation (Buck et al., 2014) and pathogenesis (Chaiyadet et 
al., 2015) by parasitic helminths. T. muris exosomes contain hundreds of proteins, micro-RNAs 
and mRNAs that are postulated to mediate host-pathogen interactions (Eichenberger et al., 
2018), and the present study suggests that some of these factors may regulate activation of 
inflammasomes by host cells such as macrophages. Given that activation of this pathway is 
associated with greater parasite persistence in the intestine, it is possible that parasites such as 
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Trichuris may have evolved strategies to selectively target inflammasomes to regulate localized 
inflammation and enhance their survival within a host (Hewitson et al., 2009). In addition to 
worm-secreted factors and signals from commensal microbes, there are likely other 
mechanisms by which a worm infection could elicit inflammasome activation. For instance, 
helminth infections can induce substantial tissue damage during colonization and feeding that 
can release danger signals such as ATP, which is a well-described activator of the NLRP3 
inflammasome (Riteau et al., 2010). However, our finding that the ATP-P2X7R pathway does 
not appear to control Trichuris infections in the same way as NLRP3 suggests that other 
activation pathways are likely to play more substantial roles. Other danger signals such as ADP 
can also activate inflammasomes (Baron et al., 2015) and can promote immunity to helminths 
by interacting with A2B receptors (Patel et al., 2014).  
 
While inflammasomes are critical regulators of early innate responses to infection, by 
permitting rapid maturation and release of inflammatory cytokines, there is substantial evidence 
that inflammasomes are involved in shaping adaptive immunity (Ciraci et al., 2012). Our results 
are consistent with multiple roles for the NLRP3 inflammasome in controlling immunity to 
gastrointestinal helminths. NLRP3-/- mice display enhanced parasite antigen-specific humoral 
and Type 2 cytokine responses and the presence of CD4+ T cells is important for the optimal 
ability of NLRP3 to suppress protective immunity to Trichuris, demonstrating that NLRP3 
regulates adaptive immunity. Our results could not distinguish a potential role for CD4+ T cell-
intrinsic NLRP3 activation in regulating immunity to Trichuris, as has been shown in other 
models of infection and inflammation (Arbore et al., 2016), hence it remains possible that CD4 
cells could either be an upstream mediator (inflammasome activation) or downstream mediator 
(Th2-driven inflammation) of immunity. However, the fact that NLRP3 could suppress 
immunity to Trichuris in the absence of functional T cells and B cells (in Rag1-/- mice) 
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highlights the importance of NLRP3 in innate immunity. The precise mechanisms by which 
NLRP3 suppresses the innate response to Trichuris was not defined, but the selective elevation 
in eosinophil numbers in lymph nodes and intestinal tissues, increased goblet cell responses 
and the modulation of ILC1 function that arose following NLRP3 inhibition suggests that there 
may be multiple mechanisms involved. Previous reports have shown that NLRP3-dependent 
IL-1β negatively regulates immunity to different helminth species by suppressing IL-25 and 
IL-33 (Zaiss et al., 2013), factors that are known to promote ILC2 responses. However, none 
of these factors were elevated in NLRP3-/- mice in the present study, suggesting that other 
mechanisms may promote Type 2 immunity in the context of Trichuris infection. Interestingly, 
TSLP expression was elevated in infected NLRP3-/- mice, and TSLP is strongly associated with 
Type 2 immune responses and protective immunity to helminths, including Trichuris (Taylor 
et al., 2009), via associations with a range of accessory cells including dendritic cells, basophils, 
ILCs and mast cells. It is also possible that the absence of NLRP3-dependent cell death or 
pyroptosis in NLRP3-deficient mice may result in increased survival of innate immune cells 
(McIntire et al., 2009), which could provide increased immunity to parasitic helminth infection. 
Further, NLRP3 inhibition may influence the functions of non-hematopoietic cells in the 
intestine that promote worm expulsion, including epithelial cell turnover, goblet cell expansion 
and mucus production and smooth muscle hyper-contractility. 
 
Our observations that humans infected with a gastrointestinal nematode exhibit elevated serum 
IL-18 levels are consistent with activation of inflammasomes. Hence, it is conceivable that 
targeting the NLRP3 pathway in helminth-infected humans using MCC950 may be a rational 
approach for boosting Type 2 immunity to helminths, lowering worm burdens and limiting the 
health problems these infections cause in the developing world. However, people living in 
helminth endemic regions are often exposed to co-infections with bacterial, viral and parasitic 
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pathogens such as tuberculosis, HIV and malaria and previous studies have demonstrated a 
protective role for NLRP3 in these infection models (Dorhoi et al., 2012b; Shio et al., 2009). 
Hence, caution would be warranted to prevent such therapeutic strategies from having 
unwanted effects of reduced ability to fight other infections. Nevertheless, administering 
therapies that enhance a patient’s natural ability to mount protective Type 2 immune responses 
would have benefits over the use of anthelmintic drugs alone, for example NLRP3 inhibition 
could promote the development of more robust parasite-specific memory Th2 cells and IgG1 
responses that could protect an individual from reinfection. In conclusion, we have provided 
information on how the NLRP3 inflammasome regulates immunity and inflammation in 
helminth infections. Further work is necessary to define the role of this pathway in immunity 
to other helminth species and the roles for other inflammasomes (e.g. NLRP1, AIM2, NLRP6, 
NLRC4) in regulation of Type 2 immune responses.  
 
2.5 Materials and methods 
2.5.1 Mice and treatments 
Caspase-1/11 double-deficient, NLRP3-deficient, P2X7R-deficient and Rag-1-deficient mice, 
all on C57BL/6 genetic background, and C57BL/6 wild-type mice were bred and maintained at 
James Cook University (JCU) Cairns Campus. Male and female mice between 6 and 10 weeks 
of age were used. Experimental protocols were approved by the JCU Animal Ethics Committee 
(approval A2213). Mice were injected intraperitoneally (i.p) with 50 µg of Trichuris muris adult 
worm excretory/secretory (ES) antigens in PBS. Mice were i.p treated with 20 mg/kg/day of 
MCC950 (Coll et al., 2015) or PBS vehicle, daily starting on day 0 of Trichuris infection. Mice 
were treated with neutralizing antibodies against CD4 (GK1.5, Bioxcell, 0.5 mg/mouse) 
starting on day 0 and continuing every 3 days. Recombinant murine IL-18 (R&D systems) or 
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PBS vehicle were injected i.p. at a dose of 200 ng/mouse daily from day 7-19 post-Trichuris 
infection. 
 
2.5.2 Human ethics and experimental procedures  
The design and clinical results of the placebo-controlled clinical trial using N. americanus to 
treat celiac disease have been described elsewhere (Daveson et al., 2011). The trial was 
registered at ClinicalTrials.gov as NCT00671138. Briefly, otherwise healthy people with HLA-
DQ2+ celiac disease on a gluten-free diet were recruited, randomised into two groups and either 
infected percutaneously with 15 infective larvae of N. americanus or given placebo treatment 
with topical chili pepper solution. Blood was collected by venepuncture and serum was 
collected and stored at -80°C. 
 
2.5.3 Parasitological techniques 
T. muris was maintained in genetically susceptible mouse strains and T. muris ES antigens were 
obtained as described previously (Artis et al., 1999). Mice were infected by oral gavage with 
approximately 200 embryonated T. muris eggs. Trichuris-specific serum IgG1 titers were 
assayed by ELISA on plates with coated with T. muris antigen (5 µg/ml). Maintenance of the 
lifecycle of Necator americanus and experimental infections of human subjects were performed 
as described previously (Daveson et al., 2011). 
 
2.5.4 Bone marrow macrophage assays 
Bone marrow was isolated from hind legs of C57BL/6 or NLRP3-/- mice by flushing bones with 
DMEM and cells were cultured at 1×106 cells/ml in DMEM supplemented with 10% FBS, 5% 
horse serum (Invitrogen), 2 mM L-glutamine, 10 mM HEPES, 1mM sodium pyruvate and 10 
ng/ml M-CSF. On day 6, macrophages were harvested and plated overnight at a concentration 
 79 
of 2×105 cells/ml. The following day, cells were treated with media alone, or LPS (1 µg/ml) for 
4 h, 20 µM nigericin for 2 h, 25 µg/ml of Trichuris adult worm ES products or 25 µg/ml worm 
exosomes for 6 h, and cell-free supernatants were stored at -80°C. 
 
2.5.5 Mouse tissue collection, processing and pathology scoring 
Blood was collected by cardiac puncture for terminal procedures, or submandibular bleeding 
for non-terminal procedures, and serum was stored at -80°C. Single cell suspensions of mLN 
or cecal patch tissue were prepared by passing through 70 µm nylon mesh filters. Colonic 
lamina propria lymphocytes (LPL) were isolated as described previously (Zaph et al., 2007). 
For colon tissue homogenates, 1 cm of tissue was homogenized mechanically in 0.5 mL of PBS 
using a Tissue Lyzer (QIAGEN) and supernatants stored at -80°C. Cecal tissue was fixed in 
4% paraformaldehyde and embedded in paraffin, and 5 µM sections were stained with H&E or 
PAS/Alcian Blue stains. Scoring of pathology was performed from H&E-stained slides by an 
individual blinded to the experimental group. Tissue sections were scored on a scale of 0-5 for 
the following parameters; (1) epithelial pathology (crypt elongation, hyperplasia, erosion), (2) 
mural inflammation and (3) oedema for a maximal score of 15. Goblet cell responses were 
assessed by counting PAS-positive cell number per crypt unit, with a minimum of 20 crypt 
units assessed for each tissue sample. For determination of worm burdens, ceca were collected 
and worms were counted using a dissecting microscope. 
 
2.5.6 Statistical analyses 
Statistical analyses for murine in vitro and in vivo studies were performed using unpaired Mann-
Whitney U tests. Human cytokine data were compared using paired Mann-Whitney U tests. In 
vivo mouse experiments included n=1-3 naïve control mice and a minimum of n=4-6 infected 
mice and were repeated at least twice to demonstrate reproducibility. Results are expressed as 
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mean ± SEM or as individual data points and the differences were considered significant at a p 
value of <0.05. 
 
2.5.7 Supplementary Experimental Procedures 
 
2.5.7.1 Exosome-like extracellular vesicle purification 
 
Exosome-like vesicles were purified by differential centrifugation using a protocol based on 
ultracentrifugation coupled to membrane filtration to eliminate large contaminating 
extracellular vesicles (Mathivanan et al., 2010). Following culture of Trichuris adult worms, 
the culture media was collected and centrifuged at different speeds (500 g, 2,000 g and 4,000 g 
for 30 min each) to remove larger debris, and the resulting supernatant was centrifuged at 
15,000 g for 45 min at 4°C to remove larger microvesicles. Supernatants were filtered through 
a 0.2 µm ultrafiltration membrane and centrifuged at 120,000 g for 3 h at 4°C in an 
ultracentrifuge. The pellet was washed in PBS, ultracentrifuged again and the final pellet 
containing the exosome-like vesicles was resuspended in 250 µl of PBS and kept at -80°C until 
use.  
 
2.5.7.2 Cell culture and ELISA 
 
Single cell suspensions of mLN were plated at 5 × 106 cells/ml in complete medium (RPMI 
1640 supplemented with 10% heat-inactivated FBS, 100 U/mL penicillin, 100 µg/mL 
streptomycin, 2 mM L-glutamine and 50 µM 2-ME) and stimulated for 48 h with 50 µg/mL 
Trichuris Ag.  Supernatants or sera were assayed for IL-4, IL-13, IL-18, IL-1β, IL-25, IL-33, 
TSLP and IFN-g using standard sandwich ELISA protocols (eBioscience or ELISAkit.com.au). 
For colon tissue homogenate analyses, cytokine levels were normalised to weight of colon 
tissue. 
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2.5.7.3 Flow cytometry  
 
Cell preparations were surface-stained with anti-mouse fluorochrome-conjugated mAbs against 
CD3(145-2C11), CD4 (RM4-5), CD11b (M1/70), CD90.2 (53-2.1), CD117 (2B8), CD127 
(SB/199), FcεRI (MAR-1), F4/80 (T45-2342), Sca-1 (D7) and Siglec F (E50-2440). For 
staining with intracellular molecules, cells were stimulated for 4 h with 50 ng/mL PMA and 
500 ng/mL ionomycin in the presence of 10 µg/mL brefeldin A (Sigma Aldrich). Cells were 
first stained with antibodies to cell surface antigens and then with fluorochrome-labeled anti-
IFN-g, anti-GATA3 and anti-T-bet Abs following fixation and permeabilization using a 
commercial kit (eBioscience). Cells were analysed by flow cytometry using a FACS Canto II 
or Aria III cytometer (BD Biosciences) and further analysis was performed using FlowJo 
software (Tree Star, Inc). 
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Linker to chapter 3 
In the previous chapters 2 we aimed to determine how a gastrointestinal helminth (T. muris) 
activates the NLRP3 inflammasome and the role of NLRP3 in regulating immunity and 
inflammation to infection. We showed that T. muris and its excretory antigens promote NLRP3-
dependent IL-18 secretion in vitro and in vivo and IL-18 is a critical factor in suppressing innate 
and adaptive immunity to the parasite (See summary model figure below).  
 
However, there are still significant unknowns about how NLRP3 controls immunity to helminth 
parasites. First, it is unclear whether the same IL-18-dependent mechanisms operate during 
infections with other species of gastrointestinal helminth, or whether NLRP3 can control 
immunity via distinct mechanisms. A second key question is whether NLRP3 has a role in 
rapid, innate immunity to infections. 
 
Summary and model
Alhallaf et.al 2018
Cell Reports
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To address these key research questions, the aim of the next Chapter is to investigate the role 
of the NLRP3 inflammasome in regulating early immune responses to a different species of 
gastrointestinal helminth, the murine model of hookworm, N. brasiliensis. Immunity to this 
parasite is critically dependent on the innate immune response that occurs in the first few days 
of infection, in a variety of different tissues (skin, lung and small intestine). Hence it is a good 
opportunity to examine the role of NLRP3 in regulating innate immunity at a variety of tissue 
sites.  
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3.1 Abstract 
Inflammasomes have a key role in promoting Type 1-mediated immunity to infections with 
viruses, bacteria, fungi and protozoan parasites, by regulating the function of pro-inflammatory 
IL-1-family cytokines such as IL-18 and IL-1β. However, recent studies have also highlighted 
an important role for inflammasomes in promoting or inhibiting Type 2 immune responses, 
such as those seen in allergic disease or helminth infections.  We recently identified an 
important role for the NLRP3 inflammasome in suppressing protective Type 2 immunity of 
mice to gastrointestinal whipworm infection via regulation of IL-18 secretion. However, the 
role of NLRP3 in other models of helminth infection and the mechanisms by which NLRP3 
control anti-parasitic immunity remain incompletely defined. In the present study we 
demonstrate that infection with a rodent model of hookworm, Nippostrongylus brasiliensis, 
results in NLRP3-dependent increases in IL-18 and IL-1β secretion in the lung and intestine, 
consistent with inflammasome activation in these tissues. NLRP3 deficient mice displayed 
elevated protective Type 2 immune responses compared to wild type mice, including elevated 
IL-4, Retnla and Arg1 expression in the lung that was associated with reduced lung larval 
burdens as early as 2 day post-infection. Examination of lung cellular infiltrates revealed a 
significant increase in neutrophil recruitment to the lung in NLRP3-/- mice and co-culture of 
sort-purified neutrophils with N. brasiliensis larvae resulted in killing of the parasite, potentially 
representing a mechanism of how neutrophils may provide enhanced innate protection against 
primary infection. Our findings suggest that NLRP3 may control the early innate immune 
response to helminth infection, suggesting that targeting NLRP3 to promote anti-parasitic 
neutrophil responses may provide enhanced protection against infections with these pathogens. 
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3.2 Introduction 
The innate immune system defends against internal and external pathogens and often involves 
detection of the invader by pattern-recognition receptors on innate immune cells such as 
monocytes, macrophages, neutrophils, and dendritic cells (DCs) (Fullard and O'Reilly, 2015; 
Schroder and Tschopp, 2010). These cells can either kill the pathogen directly, or play a crucial 
role in directing an adaptive immune response that provides long-lasting protection (Iwasaki 
and Medzhitov, 2015). Many of these innate immune responses are stimulated by the secretion 
of members of the IL-1 family of cytokines such as interleukin-1β (IL-1β) and interleukin-18 
(IL-18) (Netea et al., 2015). Secretion of these cytokines is tightly controlled by 
inflammasomes, which are multi-protein immune complexes that control the cleavage and 
subsequent activation of immature versions of these cytokines by the intracellular cysteine 
protease Caspase-1 (Netea et al., 2015). Numerous inflammasomes have been studied, such as 
nucleotide-binding and oligomerization domain-like receptor pyrin domain containing protein-
1 (NLRP1), NLRP6, NLRP3 and double-stranded DNA (dsDNA) sensors absent in melanoma 
2 (AIM2) and NLRC4 (Ozaki et al., 2015). The most well-characterised inflammasome is the 
NLRP3 inflammasome, which is expressed by multiple cell lineages (Eigenbrod and Dalpke, 
2015; Guarda et al., 2011; Shao et al., 2015; Zhong et al., 2013), and is critical for defense 
against small, easily phagocytosed infectious pathogens such as bacteria, viruses, protozoa and 
fungi by enhancing Type-1 immune responses via secretion of IL-1β and IL-18 (Allen et al., 
2009; Broz et al., 2010a; Dostert et al., 2009; Ermler et al., 2014; Gorfu et al., 2014; Kamada 
et al., 2014; Maher et al., 2013; McIntire et al., 2009; Muruve et al., 2008; Song-Zhao et al., 
2014; Strowig et al., 2012; Thomas et al., 2009). 
In addition to influencing Type-1-mediated immunity to pathogens, NLRP3 plays an important 
role in regulating Type-2 immune responses to infections with large metazoan pathogens such 
as parasitic helminths. For instance, it has been demonstrated that cattle with deletion mutations 
 88 
in the NLRP3 gene display increased anti-parasitic resistance, highlighting the potentially 
critical role for NLRP3 in influencing immunity to helminths (Xu et al., 2014). Consistent with 
this, murine studies have shown that NLRP3 suppresses Type 2 immune responses to infection 
with schistosomes (Ritter et al., 2010) and may also suppress protective immunity to 
gastrointestinal helminths by promoting IL-1β responses (Zaiss et al., 2013). Despite this 
supporting evidence, the precise roles of NLRP3 inflammasomes in immunity to diverse 
species parasitic helminths, and the immunological mechanisms of how they influence innate 
and/or adaptive immunity remain incompletely defined. We recently showed that decreased IL-
18 expression in the absence of NLRP3 may contribute to the amplified Type-2 responses and 
diminished Type-1 responses following T.muris infection (Alhallaf et al., 2018). While CD4+ 
cells were partially required for the ability of NLRP3 to inhibit immunity to T. muris infection, 
NLRP3 could also inhibit immunity to T. muris in the absence of adaptive immune cells, 
highlighting the potential importance of NLRP3 in regulating anti-parasitic innate immunity 
(Alhallaf et al., 2018). However, the role of NLRP3 in regulating innate immune responses 
against helminths remains incompletely defined and may depend on the type of helminth, tissue 
site of infection and the time point of assessment. 
 
In the present study, we used a murine model of hookworm infection (Nippostrongylus. 
brasiliensis) to assess the role for NLRP3 in regulating the early innate immune responses to 
infection. N. brasiliensis is a tissue-invasive helminth that enters the body through the skin and 
then migrates to the lung via the bloodstream over the course of 1-2 days. The parasite then 
traverses the trachea and oesophagus to reach the small intestine where it becomes fully mature 
over the course of 6-7 days. We found that N. brasiliensis infection resulted in NLRP3-
dependent elevations in levels of IL-1β and IL-18 in the lung and small intestine, consistent 
with inflammasome activation in both tissue sites. NLRP3-deficient mice exhibited increased 
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Type 2 immune responses and reduced parasite burdens in the lung as early as day 2 post-
infection, which correlated with increased neutrophil recruitment to the lung, highlighting a 
potential anti-parasitic role for neutrophils in the absence of NLRP3. Co-culture of sort-purified 
neutrophils with N. brasiliensis larvae resulted in potent killing of the parasite in vitro. Our 
findings suggest that NLRP3 may suppress early neutrophil responses in the lung following N. 
brasiliensis infection, thus targeting NLRP3 may be a novel approach for enhancing innate 
immunity to hookworm-like parasites. 
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3.3 Results 
3.3.1 NLRP3 is critical for in vivo inflammasome activation following N. brasiliensis 
infection.  
Multiple species of helminth and the molecules they excrete or secrete can activate the NLRP3 
inflammasomes in vivo and in vitro (Alhallaf et al., 2018; Ritter et al., 2010; Zaiss et al., 2013). 
Hence we first aimed to assess whether N. brasiliensis infection can similarly mediate NLRP3-
dependent inflammasome activation. C57BL/6 WT or NLRP3-/-mice were infected with 500 N. 
brasiliensis L3 and IL-1β and IL-18 levels were measured in the small intestine at day 6. While 
N. brasiliensis infection in WT mice caused significant increases in IL-1β and IL-18 levels in 
the gut, consistent with inflammasome activation, NLRP3-/- mice displayed no significant 
infection-induced response (Figure 3.3.1 A-B). These data suggest that N. brasiliensis infection 
is associated with NLRP3 activation in the intestine, which consistent with other models of 
gastrointestinal helminth infection (Alhallaf et al., 2018).  
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Figure 3.3.1 NLRP3 is critical for in vivo inflammasome activation following N. brasiliensis 
infection. C57BL/6 WT and NLRP3-/- mice were infected with N. brasiliensis and sacrificed at 
d 6 post-infection (p.i.). (A) IL-1β and (B) IL-18 were measured in small intestinal tissue 
homogenate supernatants by ELISA. Data are expressed as mean with individual data points 
and are representative of 3 experiments, n=5 mice/group. # p<0.05 compared to naïve (N).  * 
p<0.05 significant compared to WT. ns denoted not significantly different 
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3.3.2 NLRP3 inflammasome inhibits type 2 gut-stage immunity to N. brasiliensis. 
Given the critical role for NLRP3 in N. brasiliensis-mediated inflammasome activation in the 
gut, we next wanted to assess the in vivo role for NLRP3 in protective immunity to N. 
brasiliensis infection. WT or NLRP3-/- mice were infected with 500 N. brasiliensis L3 and the 
small intestine was removed at day 6 post infection. Analysis of worm burdens at day 6 post-
infection revealed that NLRP3- /- mice had significantly reduced worm burdens (Figure 3.3.2 
A) and presence of parasite eggs in faeces (Figure 3.3.2 B) at day 6 p.i compared to WT mice, 
consistent with increased anti-parasitic immunity. This was associated with significantly 
increased frequencies and total numbers of eosinophils in the mesenteric lymph node (mLN) 
(Figure 3.3.2 C-D) and significantly increased goblet cell responses compared to WT mice 
(Figure 3.3.2 E-F). Together, these data suggest that NLRP3 may suppress protective Type-2 
immune responses during intestinal N. brasiliensis infection. 
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Figure 3.3.2 NLRP3 inflammasome inhibits type 2 gut-stage immunity to N. brasiliensis. 
WT or NLRP3-/-mice were infected with 500 N. brasiliensis L3 and small intestine were 
removed at day 6 post infection. (A) small intestine worm burdens. (B) Fecal eggs numbers per 
pellet. (C) Representative plots displaying Siglec F+ eosinophils frequencies in the mesenteric 
lymph nodes (mLN) at d 6 p.i. (D) Total mLN eosinophils (E) Representative images of 
PAS/Alcian Blue stained small intestine (F) Blinded quantification of goblet cell numbers. 
Data are expressed as mean with individual data points and are representative of 5 experiments, 
n=5 mice/group. *p <0.05 compared to WT.  
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3.3.3 NLRP3 inflammasome limits lung-stage innate immune responses to N. brasiliensis 
infection 
We next assessed whether NLRP3 inflammasome activation and increased Type-2 mediated 
immunity to N. brasiliensis was evident prior to the intestinal stage, i.e. in the lung. C57BL/6 
WT and NLRP3- /- mice were infected with N. brasiliensis and lungs were removed at day 2 
post infection. Analysis of IL-1β and IL-18 levels in lung homogenates revealed that while 
infected WT mice exhibited significant increases in levels of these cytokines compared to naïve 
WT mice (Figure 3.3.3 A-B), NLRP3-/- mice did not display any infection-induced elevations 
in IL-1β or IL-18 (Figure 3.3.3 A-B), hence lung-stage infection with N. brasiliensis induces 
NLRP3 inflammasome dependent IL-1β and IL-18 secretion. NLRP3-/- mice displayed a 
significant reduction in lung larval burdens (Figure 3.3.3 C) and increased mRNA levels of IL-
4, Retnla and Arg1 compared to WT mice (Figure 3.3.3 D-F), suggesting that NLRP3 may 
suppress innate Type 2 immune responses against N. brasiliensis in the lung. Retnla and Arg1  
are important M2-derived factors that resolve inflammation and repair damaged tissue 
(Mantovani et al., 2013; Murray et al., 2014). 
Our previous study demonstrated that NLRP3-mediated suppression of immunity to T .muris 
was partially dependent on CD4+ cells and adaptive immunity (Alhallaf et al., 2018). To assess 
whether NLRP3-dependent regulation of immunity to N. brasiliensis is also dependent on CD4+ 
T cells, WT C57BL/6 mice or NLRP3-/- mice were treated one day before N. brasiliensis 
infection and every 2 days thereafter with either 0.5mg of a neutralizing anti-CD4 mAb or a 
control rat IgG following N. brasiliensis infection. Interestingly, depletion of CD4+ cells did 
not significantly affect the lung larval burdens in NLRP3-/- mice at day 2 post-infection (Fig 
3.3.3 G), suggesting that CD4+ cells were not required for the increased lung-stage anti-
parasitic immunity of NLRP3-/- mice. In contrast, depletion of CD4+ cells in NLRP3-/- mice did 
significantly ablate the normally robust protective immunity to N. brasiliensis at the level of 
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the gut at 6 p.i. (Figure 3.3.3 H). Together, these data suggest that NLRP3 suppression of 
protective immunity to N. brasiliensis in the lung may be independent of adaptive CD4+ cells, 
however NLRP3 may influence downstream CD4+-dependent protective immunity at the level 
of the gut. 
One of the mechanisms by which the NLRP3 inflammasome is activated is by engagement of 
the P2X7R (Purinergic Receptor P2X 7) by extracellular ATP (Riteau et al., 2010), which may 
be released from damaged cells. To determine if the P2X7R was similarly associated with 
suppressed immunity to N. brasiliensis, WT C57BL/6 mice or P2X7R -/- mice were infected with 
500 N. brasiliensis L3 and the small intestine was removed at day 6 post infection. Consistent 
with results seen in NLRP3-/- mice, P2X7R-deficient mice display a significant decreased in 
worm burdens during N. brasiliensis infection, suggesting that P2X7R may be involved in 
NLRP3-mediated suppression of protective immunity to N. brasiliensis (Supplementary 
Figure 3.3.1 A) .  
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Fig	3
NLRP3	inflammasome limits	lung-stage	neutrophil-dependent
innate	immune	responses	to	N.	brasiliensis infection.
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Figure 3.3.3 NLRP3 inflammasome limits lung-stage innate immune responses to N. brasiliensis 
infection. WT and NLRP3-/- mice were infected (INF) with N. brasiliensis and lungs were harvested at d 
2 p.i. (A) Lung IL-1β levels and (B) lung IL-18 levels in tissue homogenates measured by ELISA (C) 
Lung larval burdens. (D) IL-4 protein, (E) Retnla and (F) Arg1 mRNA levels in lung homogenates 
measured by ELISA or qPCR. Data are expressed as mean with individual data points and are 
representative of 4 experiments, n=5 mice/group. *p <0.05 compared to WT. WT C57BL/6 mice or 
NLRP3-/- mice were treated one day before infection and every 2 days thereafter with either 0.5 mg of a 
neutralizing anti-CD4 mAb or a control rat IgG following N. brasiliensis (G) lung larval burdens day 2 
(H) gut worm burdens day 6. Data are expressed as mean with individual data points and are representative 
of 2 experiments, n=5 mice/group. # p<0.05 compared to naive (N). *p <0.05 compared to rat Ig control. 
ns denotes not significantly different.  
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3.3.4 NLRP3-/- mice display elevated neutrophil recruitment to the lung following N. 
brasiliensis infection		
We next aimed to profile the nature of the cellular infiltrate within the lung of WT and NLRP3 
mice to determine what innate immune cells may be associated with the increased immunity to 
N. brasiliensis. Analysis of cellular immune responses in lung tissue enzymatic digests using 
flow cytometry revealed that while WT mice exhibited elevations in frequencies (Figure 3.3.4 
A) and significant increases in total numbers (Figure 3.3.4 B) of Siglec F+ CD11b+ eosinophils 
and Siglec F- CD11b+ neutrophils following infection, these responses were exaggerated in 
NLRP3- /- mice (Figure 3.3.4 A-B). Frequencies and total numbers of Siglec F+ CD11bint 
alveolar macrophages were not elevated in NLRP3-/- mice (Figure 3.3.4 A-B). Further 
confirmation of the cellular phenotypes using additional markers demonstrated that neutrophils 
co-expressed Ly6G, macrophages co-expressed CD11c and eosinophils were SSC-high 
(Supplementary Figure 3.3.2 A). 
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Figure 3.3.4 NLRP3-/- mice display elevated neutrophil recruitment to the lung following N. 
brasiliensis infection. C57BL/6 WT and NLRP3-/-  mice were infected with 500 N. brasiliensis L3 and 
sacrificed at d 2 post-infection (A) Representative plots displaying of Siglec F+ CD11b+ eosinophils, 
Siglec F- CD11b+ neutrophils and Siglec F+ CD11bint macrophages frequencies in lung tissue at d 2 p.i. 
(B) Total lung neutrophils, eosinophils and macrophages. Data are expressed as mean with individual 
data points and are representative of 3 experiments, n=5 mice/group. *p <0.05 compared to WT. ns 
denotes not significant 
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3.3.5 NLRP3-/- mice display elevated neutrophil chemokines in the lung 
Given that neutrophils were the most abundant infection-induced immune cell in the lung of 
NLRP3-/- mice, we next assessed the levels of key neutrophil chemoattractants in lung tissue 
homogenates. C57BL/6 WT and NLRP3- /- mice were infected with N. brasiliensis and Ccl3, 
Cxcl1 and Cxcl2 mRNA levels were measured at day 2 post infection using qPCR. While 
infected NLRP3- /- mice displayed approximately 2-fold increased levels in Cxcl1 compared to 
WT but no apparent increase in Ccl3 (Figure 3.3.5 A-B), expression of Cxcl2 was elevated 
nearly 20-fold compared to WT (Figure 3.3.5 C). These data suggest that elevated neutrophil 
recruitment to the lung of NLRP3-/- mice may be as a result of increased expression of 
chemokines, especially CXCL2. 
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Figure 3.3.5. NLRP3-/- mice display elevated neutrophil chemokines in the lung. C57BL/6 WT mice 
were infected with 500 N. brasiliensis L3 and sacrificed at d 2 post-infection and Ccl3, Cxcl1 and Cxcl2 
mRNA levels were measured at day 2 post infection using qPCR (A) Lung Ccl3 (B) Lung Cxcl1 (C) Lung 
Cxcl2. Data are expressed as mean with individual data points and are representative of 2 experiments, n=4 
mice/group. *p <0.05 compared to WT. ns denotes not significant. 
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3.3.6 Neutrophils promote rapid immunity to Nippostrongylus brasiliensis lung-stage 
infection		
Given the critical role for neutrophils in immunity to N. brasiliensis (Chen et al., 2014), and 
also the role of NLRP3 in regulating the lung neutrophil response to infection, we next wanted 
to assess whether elevated neutrophilia in NLRP3- /-  mice promoted enhanced protection 
against primary N. brasiliensis infection. WT and NLRP3- /-  mice were treated with either anti-
Gr1 mAb (to deplete neutrophils), or a control Ab (rat Ig), infected with 500 L3 and sacrificed 
at day 1 p.i. As expected, treatment with anti-Gr1 was able to effectively deplete neutrophils in 
infected mice (Figure 3.3.6 A). Also as expected, administration of anti-Gr1 resulted in death 
of WT and NLRP3-/- mice between 18-48 hours post-infection (Supplemental Figure 3.3.3 A), 
consistent with previous reports that highlight a critical role for neutrophils in preventing N. 
brasiliensis larvae-associated bacterial dissemination (Pesce et al., 2008). Interestingly 
however, this Gr-1 cell depletion in both WT and NLRP3-/-  mice was associated with increased 
lung larval burdens (Figure 3.3.6 B), suggesting impaired anti-parasitic immunity in 
neutrophil-depleted mice. This was associated with lowered eosinophil responses in the lung 
(Figure 3.3.6 C) and lowered IL-4 expression in anti-Gr-1 treated NLRP3-/- mice (Figure 3.3.6 
D). Together these data suggest that elevated neutrophil responses in NLRP3-/- mice may be at 
least partially responsible for elevated Type 2 immune responses and anti-parasitic immunity 
following N. brasiliensis infection. 
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Figure 3.3.6. Neutrophils promote rapid immunity to N. brasiliensis lung-stage infection 
C57BL/6 WT and NLRP3-/- mice were either daily treated with control rat Ig or anti-Gr1 
antibody 1d before N. brasiliensis infection and were sacrificed at day 1. (A) Representative 
plots displaying successful depletion of CD11b+ Ly6G+ neutrophils frequencies in the WT 
mouse lung at d2 following anti-Gr1 antibody. (B) Lung larval burdens. (C) Total lung 
eosinophils (D) Lung IL-4. Data are expressed as mean with individual data points and are 
representative of 3 experiments, n=5 mice/group. # p<0.05 compared to WT. *p <0.05 
compared to rat Ig control. ns denotes not significant. 
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3.3.7 Neutrophils are potently anti-parasitic to N. brasiliensis larvae in vitro 
To assess whether neutrophils in this model may be directly killing N. brasiliensis larvae, as 
neutrophils and macrophages have been shown to collaborate in killing various helminth 
species (Bonne-Annee et al., 2013; Bonne-Annee et al., 2014; Jong et al., 1984), we conducted 
in vitro co-culture experiments with N. brasiliensis L3 and sort-purified cell populations. 
Neutrophils were sorted from bone marrow of WT mice and macrophages were enriched from 
bone marrow cultures. N. brasiliensis L3 were cultured for 24 h with either neutrophils, no cells 
(control) or bone-marrow-derived macrophages for 24h in the presence of normal mouse serum. 
As expected, L3 cultured with no cells remained highly motile and curved with near 100% 
viability (Figure 3.3.7 A). However, inclusion of macrophages into the cultures resulted in an 
average motility of 65%, suggesting macrophages were partially toxic to L3. Most strikingly, 
the presence of the neutrophils resulted in an almost complete reduction in parasite viability 
(Figure. 3.3.7 A), which was supported by the presence of straight motionless larvae with 
evidence of cells adhering to parasites as well as fibrous extracellular material, consistent with 
neutrophil extracellular traps (Behrendt et al., 2010; Gabriel et al., 2010). (Figure 3.3.7 B-C). 
These data support the notion that neutrophils may be directly cytotoxic to infective parasitic 
larvae, hence elevated neutrophil responses in NLRP3 deficient mice and direct parasite killing 
may be one mechanism by which NLRP3 mice are more resistant to infection. 
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Neutrophils are potently anti-parasitic to N. brasiliensis larvae in vitro
Fig	7
NeutrophilsNo cells Macrophages
A B
C
150
50
0
Worms motility
*
*
100
100µm 100µm 100µm
100µm 100µm 100µm
Figure 3.3.7. Neutrophils are potently anti-parasitic to N. brasiliensis larvae in vitro 
Neutrophils were sorted from bone marrow of WT mice and macrophages were enriched from 
bone marrow cultures. N. brasiliensis L3 were cultured for 24 h with either neutrophils, no cells 
control or bone-marrow-derived macrophages for 24h in the presence of normal mouse serum. 
(A). Worm motility. (B-C) Representative pictures displaying no cells, macrophage and 
neutrophils. Data are expressed as mean with individual data points and are representative of 2 
experiments, n=2 cell culture replicates/treatment. *p <0.05 compared to WT. 
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Supplementary figure 3.3.1 P2X7R-deficient mice display enhanced immunity to N. 
brasiliensis infection. C57BL/6 WT and P2X7R-
 /- mice were infected with N. brasiliensis  and 
sacrificed at d 6 p.i. (A) Worm burdens. Data are expressed as mean with individual data points 
and are representative of 2 experiments, n=5 mice/group. *p <0.05 compared to WT. 
.   
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Supplementary figure 3.3.2. Phenotyping of lung innate immune cells. Further confirmation of the 
cellular phenotypes described in Fig. 4.3.4. Using additional markers demonstrated that gated 
neutrophils (red gate) co-expressed Ly6G, macrophages (blue gate) expressed CD11c and eosinophils 
(green gate) were SSC-high. 
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Supplementary figure 3.3.3. Neutrophils is important against N. brasiliensis infection. WT 
and NLRP3-
 /-  mice were treated with either anti-Gr1 mAb (to deplete neutrophils), or a control 
Ab (rat Ig), infected with 500 L3. (A) Survival rate in infected mice. Data are expressed as mean 
with individual data points and are representative of 2 experiments, n=5 mice/group. 
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3.4 Discussion 
Understanding the nature of the immune response to parasitic helminths is critical for the 
rational design of preventative therapies against infection, such as vaccines. Helminths have 
evolved to manipulate and limit elements of the host immune response to enhance their ability 
to survive, which may explain why effective vaccination against helminths has proven to be an 
enormous challenge. While inflammasomes are a crucial element of the protective immune 
response against a variety of pathogens, recent literature suggests that inflammasomes may in 
fact suppress the protective immune response against parasitic helminths.  Consistent with this, 
in the present study we identified an additional mechanism of how the NLRP3 inflammasome 
may limit innate immunity of mice to a hookworm-like parasite, potentially via limiting the 
recruitment of anti-parasitic neutrophils into the lung.  
 
NLRP3 is important in inducing Type 1 immune responses against microbial pathogens (Silva 
et al., 2013; Song-Zhao et al., 2014), however other studies have demonstrated that NLRP3 is 
promoting Type 2 immune responses (Bruchard et al., 2015; Gurung et al., 2015). In the present 
study, infection-induced NLRP3 activation is associated with reduced Type 2 immune 
responses including IL-4 and eosinophils in the lung and gut, intestinal goblet cell responses 
and markers of alternatively activated macrophages (AAMac) in the lung (Retnla and Arg1) 
that have been associated with direct killing of helminths and tissue repair (Gobert et al., 2000; 
Jang and Nair, 2013). Our previous results have demonstrated that NLRP3 may suppress Type-
2 immune responses via regulation of IL-18 secretion and promotion of Th1 and ILC1 
responses (Alhallaf et al., 2018). In the present study we have reported infection-induced 
elevations in lung and gut IL-18 but did not observe increased Th1 cytokines in either tissue 
(data not shown), suggesting that there may be different mechanisms by which NLRP3 can 
regulate the immune responses. Consistent with this, compared to results seen in Trichuris 
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infections (Alhallaf et al., 2018), CD4 cells do not appear to be an essential downstream 
modulator of NLRP3-dependent suppression of immunity to N. brasiliensis, particularly lung-
stage immunity. This suggests that NLRP3 may be regulating an early innate component of the 
immune response to N. brasiliensis and not adaptive immune cells or antibodies that would take 
much longer than 1-2 days to develop. We did observe increased eosinophil responses in 
NLRP3- /- mice and these cells are important for immunity against  N. brasiliensis infections 
(Al-Dahwi et al., 2006; Knott et al., 2007; Shin et al., 1997), however we did not demonstrate 
a causal role for these cells in direct killing of parasites, such studies could involve depletion 
of eosinophils using anti-CCR3 antibodies or by crossing NLRP3- /- mice with eosinophil 
deficient mouse strains (Knott et al., 2007). Similarly, macrophages are important for N. 
brasiliensis killing (Bouchery et al., 2015; Chen et al., 2013). While we did not observe 
increased numbers of macrophages in the lung (Fig 4), we did observe increased AAMac 
markers Arg1 and Retnla that have been associated with protective immunity to N. brasiliensis 
(Jang and Nair, 2013), in concert with ILC2 cells. This suggests that NLRP3 may influence the 
phenotypes of macrophage responses within the lung, which may regulate anti-parasitic 
responses. However further studies are required to delineate the precise role for NLRP3-
dependent regulation of macrophage function in the context of N. brasiliensis infection. 
While we were not able to demonstrate a causal role for eosinophils or macrophages in NLRP3-
dependent suppression of immunity to N. brasiliensis, we did observe correlations between 
rapid neutrophil recruitment to the lung and enhanced anti-parasitic immunity. Neutrophils are 
well studied during microbial infections in the context of type 1 immune responses (Mantovani 
et al., 2011), and they are also important against helminth infection (Chen et al., 2012; Chen et 
al., 2014; Morimoto et al., 2004). It has demonstrated that neutrophils are recruited to site of 
infection and arrive following the production of CXCL1, CXCL8 and CXCL2 (Miotla et al., 
2001; Ribeiro et al., 1990). We found that CXCL2 levels were the most strongly upregulated 
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in NLRP3-deficient mice, implicating this chemokine as likely to mediate elevated neutrophil 
chemotaxis to the lung. How NLRP3 regulates expression of CXCL2 was not determined.  
CXCl2 expression in dependent on NF-kappa B, TNF, platelet-activating factor (PAF) and IKK 
kinase alpha (IKKα) (Burke et al., 2014; da Silva et al., 2012; De Plaen et al., 2006; Goktuna 
et al., 2014), however it is unclear how NLRP3 may influence expression of CXCL2 in response 
to these factors. CXCL2 is expressed primarily by epithelial cells, mast cells and macrophages 
(De Filippo et al., 2013; Ohtsuka et al., 2001). It is possible that following N. brasiliensis 
infection in the lung, CXCL2 is expressed by intestinal epithelial cells (IECs) and this mediates 
recruitment of neutrophils to the lung tissue, however further work examining cell-specific 
expression of CXCL2 is required to demonstrate which cell type is responsible for recruiting 
neutrophils. 
 
Our in vitro culture data suggest that neutrophils are highly toxic to N. brasiliensis larvae, 
rendering the larvae straight and immotile. Neutrophils possess an array of mechanisms by 
which they could damage helminths, including complement-mediated cytotoxicity, production 
of oxygen free radicals or the release of extracellular traps (Bonne-Annee et al., 2013; Galioto 
et al., 2006). Neutrophils are similarly associated with killing other species of helminth, 
including larval stages of Strongyloides stercoralis, where neutrophils alone could kill the 
parasite, however eosinophils and macrophages were also required for optimal killing (Bonne-
Annee et al., 2013; Chen et al., 2014; Galioto et al., 2006). In contrast, neutrophils seem to have 
a limited role during infection with S. mansoni, as their depletion did not influence the severity 
of disease (Herbert et al., 2004). While neutrophils have been shown to be important in vitro, 
there is relatively little evidence that they are important in vivo (Pesce et al., 2008). The present 
study showed that neutrophil depletion by anti-Gr-1 mAb injection had a partial reduction in 
anti-parasitic immunity. Hence while neutrophils appear to be at least partially responsible for 
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increased parasite killing in absence of NLRP3, other factors may also be involved. 
Additionally, anti-Gr-1 treatment is known to deplete other immune cells subsets such as 
monocytes, macrophages and some T cells subsets (Daley et al., 2008), hence we cannot be 
completely certain that the observed effects were due to neutrophil depletion alone. Further 
studies involving more specific depletion of neutrophils (for example using anti-Ly6G 
antibodies) as well as other cell subsets mentioned earlier (eosinophils, macrophages) but also 
ILC2s and basophils that are also associated with immunity to N. brasiliensis may reveal more 
information about the range of immune factors that promote innate resistance to the parasite. 
 
The role for inflammasome activation during helminth infections is becoming increasingly 
appreciated, however it remains unclear how helminths activate inflammasomes. Further, there 
is evidence that some helminth-derived factors may also inhibit inflammasome activation 
(Ritter et al., 2010). Previous in vitro studies have highlighted that factors excreted and secreted 
by other parasites can directly activate inflammasomes (Ferguson et al., 2015; Ritter et al., 
2010; Zaiss et al., 2013). Further, our recent work have highlighted that factors excreted or 
secreted by Trichuris may activate the NLRP3 inflammasome in vivo and in vitro and some of 
these factors may be contained within extracellular vesicles or exosomes (Alhallaf et al., 2018). 
In the current study we demonstrate that N. brasiliensis infection is similarly associated with 
NLRP3-dependent inflammasome in lung and gut, but we did not establish whether this was 
mediated by worm-secreted molecules, or other factors such as parasite-induced tissue damage. 
For example, damage to the lung tissue may result in ATP release, which is a well-known 
activator of NLRP3 via interaction with the P2X7R. Furthermore, helminths such as Trichinella 
spiralis also can directly modify host-derived ATP (Gounaris et al., 2004), which may activate 
the P2X7R. Interestingly, we found that P2X7R deficient mice had similar phenotypes to 
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NLRP3-deficient mice (e.g increased anti-parasitic immunity) suggesting that the P2X7R may 
be associated with NLRP3 activation in this model. 
 
In conclusion, we have provided novel information on how the NLRP3 inflammasome 
regulates innate immune cells like neutrophils during helminth infections. We have identified 
that activation of NLRP3 inflammasome is important for controlling early immune responses 
potentially by suppressing the recruitment and function of innate immune cells such as 
neutrophils. By identifying the precise worm-secreted molecules that activate or inhibit 
inflammasome activations and which cellular and molecular pathways are important, we may 
be able to create a novel treatment for boosting immunity to helminth infections. 
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3.5 Materials and Methods 
 
3.5.1 Parasitological techniques 
N. brasiliensis was maintained in Sprague–Dawley rats (Animal Resources Centre, Perth, WA, 
Australia) and infective L3 were prepared from rat fecal cultures. Mice were infected by 500 
L3 subcutaneously.   
 
3.5.2 Mice and treatments 
NLRP3 and P2X7R -deficient mice all on C57BL/6 genetic background, and parental C57BL/6 
wild-type (WT) control mice were bred and maintained at James Cook University (JCU), Cairns 
Campus. Male and female mice between 6 and 8 weeks of age were used. All experimental 
protocols were approved by the JCU Animal Ethics Committee. Mice were treated with 
neutralizing antibodies against CD4 (GK1.5, Bioxcell, 0.5 mg/mouse) starting on day -1 and 
continuing every 2 days until necropsy. For neutrophil depletion, Anti-Gr1 antibody (BioXcell) 
or isotype control rat Ig was administered to mice both intraperitoneally (i.p.) (0.5 mg in 0.2 
ml)  
 
3.5.3 Mouse tissue collection and processing 
At necropsy, lung tissue was minced and incubated with stirring at 37 °C for 30 min in HBSS 
with 1.3 mM EDTA (GIBCO), followed by treatment at 37 °C for 1 h with collagenase (1 
mg/ml; Sigma) in RPMI 1640 (Mediatech) with 5% FCS (Biowest) and with 100 µg/ml of 
DNase (Sigma) for 10 min. Cells were lysed with ACK Lysing Buffer (Lonza) to remove 
erythrocytes, blocked with Fc Block (BD Biosciences). Single cell suspensions of mesenteric 
lymph node (mLN) were prepared by passing through 70um nylon mesh filters. For lung and 
colon tissue homogenates, 1 cm of colon tissue or one lobe of lung tissue was homogenized 
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mechanically in 0.5 mL of PBS using a Tissue Lyzer (QIAGEN) and supernatants stored at -
80°C. Gut or lung homogenates were assayed for IL-4, IL-1β and IL-18 using standard 
sandwich ELISA protocols (eBioscience or ELISAkit.com.au). 
 
 Gut was fixed in 4% formaldehyde and embedded in paraffin, and 5 μM sections were stained 
with PAS/Alcian Blue stains using the standard protocol of an institutional histology service 
provider (QIMR Berghofer Medical Research Institute). For determination of worm burdens, 
small intestines were collected and worms were counted using a dissecting microscope. Lung 
larval burdens were assessed by mincing the mouse lungs with scissors in PBS and counting 
emigrated larvae under a dissecting microscope. 
 
3.5.4 In vitro larval killing assay.  
In vitro killing assays were performed by plating of 100 larvae into 48-well plates. Normal 
mouse serum collected from naive C57BL/6J mice via exsanguination or cardiac puncture was 
immediately filter sterilized prior to freezing. Serum was added to plates, as a source of 
complement, at a concentration of 25% of the total well volume. Macrophages Bone marrow 
was isolated from hind legs of C57BL/6 or NLRP3-/- mice by flushing bones with DMEM and 
cells were cultured at 1×106 cells/ml in DMEM supplemented with 10% FBS, 5% horse serum 
(Invitrogen), 2 mM L-glutamine, 10 mM HEPES, 1mM sodium pyruvate and 10 ng/ml M-CSF. 
On day 6, macrophages were harvested and plated overnight at a concentration of 2×105 
cells/ml. The following day, cells were treated with media alone, or LPS (1 µg/ml) for 4 h, 20 
µM nigericin for 2 h, 25 µg/ml of N. brasiliensis L3 ES products and cell-free supernatants 
were stored at -80°C. 
 CD11b+ and Ly6G+ neutrophils were sorted from bone marrow of WT mice and (1 × 106) cells 
were added to select wells in a final volume of 250 µl with RPMI 1640 (Mediatech) 
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supplemented with 10% heat-inactivated FBS and 100 U/ml penicillin plus 100 µg/ml 
streptomycin and incubated for 24 h. The contents of the wells were then assessed for larval 
viability of every larva in the culture wells where larvae were considered viable if they were 
visibly motile or curved. If larvae were straight and not motile then they were classified as non-
viable. 
 
3.5.5 Flow cytometry  
Cell preparations were surface-stained with anti-mouse fluorochrome-conjugated mAbs against 
CD11b (M1/70), CD11c (HL3), Gr-1 (RB6-8C5), Ly6G (1A8), and Siglec F (E50-2440) Cells 
were first stained with cell surface and analysed by flow cytometry using a FACS Canto II or 
Aria III cytometer (BD Biosciences) where dead and doublet cells were excluded by the use of 
a live gate and doublet discrimination. Further analysis was performed using FlowJo software 
(Tree Star, Inc).  
 
3.5.6 Real-Time PCR and relative quantification analysis 
Total RNA was extracted from excised lungs, at the sites where the worms were located. Total 
RNA from each tissue obtained mice was isolated using Trizol Reagent (Sigma-Aldrich), 
according to the manufacturer instructions, according to the manufacturer instructions. The 
cDNA was synthesised using SuperScript III First-Strand Synthesis System (Invitrogen).  
For quantitative PCR, 40 ng total RNA reverse transcribed to cDNA was added to 10 𝜇L of 
TaqMan® Universal PCR Master Mix, No AmpErase® UNG (2x ), 1 𝜇L of the specified 
TaqMan® Gene Expression Assay, and water to final reaction volume of 20 𝜇L. Reac- tions 
were performed on the Abi Prism 7000 (Applied Biosystems), with the following thermal cycler 
conditions: initial setup of 2 min UNG activation at 50 °C, followed by 10 min at 95 °C, and 
40 cycles of 15 s denaturation at 95 °C and 1 min of anneal/extend at 60 °C each. Samples were 
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amplified in a 96-well plate. On each plate endogenous control, samples and negative control 
were analyzed in triplicate. Cycle threshold (Ct) value was calculated for each sample, house- 
keeping and uninfected control. To normalize for differences in efficiency of sample extraction 
or complementary DNA synthesis we used β-actin as housekeeping gene. To estimate influence 
of infection in the expression levels of cytokines we use a comparative (2−ΔΔCT – method) 
(Livak and Schmittgen, 2001). The fold change in the target gene was normalized to β-actin 
and standardized to the expression of naïve mice to generate a relative quantification of the 
expression levels. 
 
3.5.7 Statistical analyses 
 
Statistical analyses for murine studies were performed using unpaired Mann-Whitney U tests. 
Human cytokine data were compared using paired Mann-Whitney U tests. Results represent 
the mean ± SEM and the differences were considered significant at a p value of <0.05. 
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Linker to chapter 4 
 
In the previous chapter 3 we aimed to address how a rodent model of hookworm, N. brasiliensis, 
activates the NLRP3 inflammasome, and the role of NLRP3 in regulate early immune responses 
against hookworm infections. We showed that NLRP3 may suppress the early innate immune 
response to helminth infection, and NLRP3 can potentially inhibit anti-parasitic neutrophil 
responses, thereby preventing the development of optimal immune protection against N. 
brasiliensis infections. Together with the results from Chapter 2, thus far we have demonstrated 
a critically important role for NLRP3 in suppressing immunity to two distinct species of 
helminths, via two distinct immunological mechanisms. However, NLRP3 is just one member 
of an increasingly large family of inflammasome complexes, which also includes members such 
as NLRP1, NLRP6, AIM2 and more, which have shown to play different biological roles 
depending on the inflammatory context. Hence in my last Chapter, I aim to determine if the 
NLRP1 inflammasome plays an important role in immunity to gastrointestinal helminths, and 
to begin to establish whether distinct inflammasomes play similar or different roles in 
controlling and innate and adaptive immune response to parasitic helminths. 
 
. 
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4.1 Abstract 
Type 2 immune responses are critical for protective immunity to gastrointestinal helminths, 
however helminths are proficient at suppressing host immune responses to enhance their 
survival. One mechanism by which helminths may modulate the host immune system is via 
activation of inflammasomes in innate immune cells, which can initiate non-protective Type 1 
immune responses. We recently demonstrated roles for worm-induced activation of the NLRP3 
inflammasome in suppressing innate and adaptive immunity to models of hookworm and 
whipworm infection in mice, however the roles for other types of inflammasomes during 
helminth infections are completely unknown. In this study, we examined the role of the NLRP1 
inflammasome in immunity to the gastrointestinal helminths Nippostrongylus brasiliensis and 
Trichuris muris. Following N. brasiliensis infection, NLRP1 deficient mice displayed elevated 
protective Type 2 immune responses compared to wild type (WT) mice and reduced gut worm 
burdens, similar to what has been previously observed in NLRP3-deficient mice. However, 
unlike what is observed in NLRP3-/- mice, absence of NLRP1 did not result in enhanced early 
immunity to lung stages of N. brasiliensis infection suggesting that NLRP1 may be more 
involved in regulating gut-stage immunity to N. brasiliensis infection. Consistent with these 
results, NLRP1-/- mice also display increased gut-stage Type 2 immunity to infection with the 
gastrointestinal helminth T. muris. Together, these findings reveal that NLRP1 may be an 
important negative regulator of immunity to diverse gastrointestinal helminths.  
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4.2 Introduction 
Type-2 immune responses are associated with the development of CD4+ T helper Type 2 (Th2) 
cells, expression of the cytokines interleukin-4 (IL-4), IL-5, IL-9 and IL-13, IgE production and 
expansion of innate immune cells like eosinophils, mast cells and basophils, which coordinate 
a protective immune response against helminth infection (Anthony et al., 2007). Conversely, 
interferon-γ (IFN-γ)-dominant Type-1 immune responses to helminth infections can result in 
chronic infections and immunopathology(Anthony et al., 2007; Stadecker et al., 2004). The 
molecular and cellular mechanisms by which helminth infection results in acute resolving 
infections (and Type 2 immune responses), or chronic infections (and Type 1 responses) are 
highly complex and incompletely understood. Further, it is clear that helminths have evolved 
sophisticated mechanisms by which they manipulate the host immune response to enhance their 
survival (Maizels and Yazdanbakhsh, 2003). The cellular basis of this immunoregulation 
involves the modulation of both the innate and adaptive immune responses and the promotion 
of regulatory cell responses (Maizels and Yazdanbakhsh, 2003).  
 
Recent research has highlighted one of the mechanisms by which helminths influence the host 
immune system to promote chronic infections is to activate innate immune receptors known as 
inflammasomes (Zaiss et al., 2013). Inflammasomes are multiprotein complexes expressed by 
a variety of immune cells, where their activation results in release of the proinflammatory 
cytokines IL-1β and IL-18, which are critical for inducing protective immunity to microbial 
pathogens (Dinarello and Fantuzzi, 2003; Sahoo et al., 2011; Sims and Smith, 2010). In 
contrast, multiple recent reports suggest that activation of these pathways by helminths is 
associated with suppression of protective Type 2 immune responses (Alhallaf et al., 2018; Zaiss 
et al., 2013). For example, we have recently showed that NLRP3 can suppress both innate and 
adaptive immunity against T. muris infection (Alhallaf et al., 2018), which is consistent with 
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reports from other models of helminth infection (Ritter et al., 2010; Zaiss et al., 2013). We also 
have highlighted the importance of the NLRP3 in limiting the early neutrophil-mediated 
immune responses against N. brasiliensis (unpublished). However, the innate immune system 
is comprised of many different types of inflammasomes that all respond to varying stimuli and 
exert diverse effector functions (Martinon et al., 2002). For example, the AIM2, NLRP1 and 
NLRC4 inflammasomes are important for anti-microbial defense (Ewald et al., 2014; Rathinam 
et al., 2010; Tomalka et al., 2011), but to date the only inflammasome that has been studied in 
the context of helminth infections is NLRP3. Hence whether distinct inflammasomes play 
different roles during helminth infections has never been examined.  
 
Roles for NLRP1 in immunity and cell biology are being increasingly appreciated, where 
NLRP1 is a central regulator of programmed cell death (pyroptosis) in response to microbial 
stimuli (Masters et al., 2012; Moayeri et al., 2003; Terra et al., 2010). In addition, NLRP1 has 
recently been shown to be important for immunity to protozoan parasite infections (Clipman et 
al., 2018; Ewald et al., 2014). Comparison of the relative roles for NLRP1 with NLRP3 revealed 
that both inflammasome proteins play important roles in immunity of mice to Toxoplasma 
gondii (Gorfu et al., 2014), suggesting that along with NLRP3, NLRP1 may be an important 
sensor or regulator to infections with protozoan parasites, where there may be overlapping 
functions of distinct inflammasomes in our immune system. Whether NLRP1 plays a role in 
immunity to parasitic helminths has yet to be determined. 
 
In the present study we have examined the role for the NLRP1 inflammasome in immunity to 
a model of hookworm N. brasiliensis and whipworm T. muris. Infections with N. brasiliensis 
resulted in NLRP1-dependent elevations in IL-18 and IL-1β secretion in the intestine, however 
in vitro activation of inflammasomes by worm-secreted antigens was primarily NLRP3-
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dependent. Similar to results seen in NLRP3-/- mice, NLRP1-/- mice exhibited enhanced 
intestinal Type 2 immune responses and accelerated worm expulsion compared to wildtype 
mice. Interestingly however, NLRP1 does not play a substantial role in controlling the early 
innate immune response to N. brasiliensis infection in the lung, suggesting that there may be 
distinct mechanisms by which NLRP1 and NLRP3 control immunity to helminths in different 
tissues. Together these results highlighting the importance of the NLRP1 inflammasome 
regulates intestinal inflammation and immunity to diverse parasitic helminth infections. 
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4.3 Results 
4.3.1	 N. brasiliensis infection elicits NLRP1-dependent elevations in IL-18 and IL-1β 
secretion in the intestine. 
Activation of the NLRP1 inflammasome has been demonstrated by anthrax lethal toxin 
(Moayeri et al., 2003) and T. gondii infection (Gorfu et al., 2014), however it is unclear if 
parasitic helminths also activate NLRP1 to promote secretion of IL-1β and IL-18. Hence we 
first assessed whether NLRP1 was important for N. brasiliensis-mediated inflammasome 
activation. C57BL/6 WT and NLRP1-
 /- mice were infected with N. brasiliensis and small 
intestinal IL-18 and IL-1β levels were measured at day 6 p.i. While WT mice exhibited 
significant increases in both gut IL-18 and IL-1β levels compared to naive control mice, 
NLRP1-
 /- mice displayed significantly reduced levels of these cytokines (Figure 4.3.1 A-B), 
suggesting that there is still evidence of NLRP1-independent activation which is likely due to 
NLRP3.  
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Figure 4.3.1. N. brasiliensis infection elicits NLRP1-dependent elevations in IL-18 and IL-1β 
secretion in the intestine. C57BL/6 WT and NLRP1-/- mice were infected with N. brasiliensis and 
sacrificed at d 6 post-infection (p.i.). (A) gut IL-1β and (B) IL-18 levels in small intestinal tissue 
homogenates were measured by ELISA. Data are expressed as mean with individual data points and 
are representative of 3 experiments, n=5 mice/group. # p<0.05 compared to naive (N). *p <0.05 
compared to WT.  
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4.3.2 N. brasiliensis	antigens do not significantly activate NLRP1 inflammasomes in vitro. 
Our previous report demonstrated that one of the ways in which worms may activate 
inflammasomes is via the release of excretory/secretory (ES) proteins (Alhallaf et al., 2018). 
Hence we next addressed whether N. brasiliensis was able to activate inflammasomes in vitro 
in cultured macrophages, and whether this was dependent on NLRP1 or NLRP3. Bone marrow 
derived macrophages from WT, NLRP1-/- and NLRP3-/- mice were cultured for 6 hours in the 
presence and absence of native N. brasiliensis ES larvae, known inflammasome activators (LPS 
and nigericin), or culture media alone. Similar to what have been seen in T. muris (Alhallaf et 
al., 2018), culturing macrophages from WT mice with N. brasiliensis ES alone did not 
substantially increase secretion of IL-1β compared to treatment with culture media only. 
However, if known inflammasome activators (LPS and nigericin toxin) were included the levels 
of IL-1β rose significantly (Figure 4.3.2 A). Critically, this synergistic stimulation of IL-1β 
secretion by N. brasiliensis ES was significantly dependent on NLRP3.  Absence of NLRP1 
only caused a modest reduction in IL-1β secretion, suggesting that in vitro inflammasome 
activation by worm antigens appears to be more dependent on NLRP3 than NLRP1 (Figure 
4.3.2 A).  
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Fig:2 Nippostrongylus-mediated NLRP1 inflammasome activation 
in vitro.
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Figure 4.3.2. N. brasiliensis-mediated modest NLRP1 inflammasome activation in vitro. Bone marrow-
derived macrophages were obtained from WT C57BL/6 mice, NLRP1-/-  and NLRP3-/- mice and were cultured 
for 6 hours with combination of either 25 μg/ml of N. brasiliensis larvae, LPS (1 µg/ml)+nigericin (20 µM), or 
media only. IL-1β were measured in supernatants by ELISA. *p <0.05 compared to WT. ns denotes not 
significantly different. 
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4.3.3 NLRP1-deficient mice displayed reduced intestinal worm burdens following N. 
brasiliensis	infections. 
We next investigated whether NLRP1 plays a role in vivo in immunity to N. brasiliensis. 
C57BL/6 WT and NLRP1-/- mice were infected with N. brasiliensis and sacrificed at day 6 post 
infection, NLRP3- /-  mice were included as a comparison. NLRP3-/- and NLRP1-/- mice had 
significantly reduced gut worm burdens (Figure 4.3.3 A), and had significantly reduced faecal 
egg numbers, compare to WT mice (Figure 4.3.3 B), and had visible increases in the presence 
of goblet cells compared to WT mice (Figure 4.3.3 C).  Together, these data suggest that both 
NLRP1 and NLRP3 play significant roles in suppressing immunity to N. brasiliensis infections 
at the level of the intestine. To determine whether NLRP1 can similarly suppress immunity to 
other gastrointestinal helminths, C57BL/6 WT and NLRP1-
 /- mice were infected with T. muris 
and we assessed the in vivo role for NLRP1 in protective immunity to T. muris infection. Similar 
to results seen in N. brasiliensis infections, NLRP1-/- mice had significantly reduced T. muris 
worm burdens (Supplementary Figure 4.3.1 A), and displayed significantly increased 
frequencies and total numbers of eosinophils in the mesenteric lymph node (mLN) compared 
to WT mice (Supplementary Figure 4.3.1 B-C), suggestive of an increased Type 2 cellular 
immune response. This was consistent with increased IL-5 and IL-13 expression by Ag-
restimulated mLN cells in NLRP1-/- mice compared to WT mice (Supplementary Figure 4.3.1 
D-E), had a trend toward reduced IFN-γ expression by Ag-restimulated mLN cells compare to 
WT (Supplementary Figure 4.3.1 F), and had displayed evidence of decreased intestinal 
inflammation compared to WT mice, and significantly reduced caecal pathology scores.  
Together these data suggest that NLRP1 limits Type 2 immune responses following T. muris 
infections (Supplementary Figure 4.3.1 G-H). 
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Figure 4.3.3. NLRP1 deficient mice displayed reduced intestinal worm burdens following N. 
brasiliensis infections. C57BL/6 WT and NLRP1-/- mice were infected with N. brasiliensis and sacrificed 
at d 6 post-infection (p.i.). (A) small intestine worm burdens and. (B) Fecal eggs numbers per pellet. (C) 
Representative images of PAS/Alcian Blue stained small intestine. Data are expressed as mean with 
individual data points and are representative of 4 experiments, n=5 mice/group. *p <0.05 compared to 
WT. 
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4.3.4 NLRP1 deficient mice display a trend toward to increase type 2 immune responses 
following N. brasiliensis infections. 
 
Previous reports have shown that NLRP3 can suppress Type 2 immunity to both T. muris and 
N. brasiliensis infections, however it is unclear if NLRP1 plays a similar or different role in 
immune regulation.  To investigate the immunological mechanisms by which NLRP1 controls 
immunity to N. brasiliensis infections. C57BL/6 WT and NLRP1-/- mice were infected with N. 
brasiliensis and we assessed the immune responses in WT and NLRP1-/- mice. NLRP1-/- mice 
displayed a trend toward increased frequencies and total numbers of eosinophils in the 
mesenteric lymph node (mLN) compared to WT mice (Figure 4.3.4 A-B), consistent with an 
elevated cellular immune response. NLRP1-/- mice displayed increased IL-5 and IL-13 
expression in the small intestine compared to WT mice (Figure 4.3.4 C-D) and had a trend 
toward reduced IFN-γ levels in the small intestine (Figure 4.3.4 E). Together, these data 
suggest that NLRP1 may play a limited role in inhibiting protective Type-2 immunity following 
N. brasiliensis infections. 
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Figure 4.3.4. NLRP1 deficient mice display a trend toward to increase type 2 immune 
responses. C57BL/6 WT and NLRP1-
 /- mice were infected with N. brasiliensis and sacrificed at d 
6 post-infection (p.i.). (A) Representative plots displaying Siglec F+ eosinophils frequencies in the 
mesenteric lymph nodes (mLN) at d 6 p.i. (B) Total mLN eosinophils (C) Small intestine 
homogenate IL-5 (D) Small intestine homogenate IL-13 and (E) Small intestine homogenate IFN-
γ. Data are expressed as mean with individual data points and are representative of 3 experiments, 
n=5 mice/group. *p <0.05 compared to WT. ns denotes not significantly different. 
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4.3.5 NLRP3 is more important than NLRP1 for early immune responses in the lung 
following N. brasiliensis infection. 
We have previously highlighted that NLRP3 suppresses very early innate immunity to N. 
brasiliensis in the lung, potentially by limiting neutrophil recruitment to the lung. Hence, we 
next aimed to address whether NLRP1 plays a similar role at the lung stage of N. brasiliensis 
infection. WT, NLRP1-/- and NLRP3-/- mice were infected with N. brasiliensis and lung larval 
burdens and cellular infiltrates were assessed at day 2 post-infection. As expected NLRP3-/- 
mice had significantly reduced worm burdens, however NLRP1-/- mice had modest, non-
significant reductions in worm burdens compared to WT mice (Figure 4.3.5 A), suggesting a 
limited role for NLRP1 in suppressing lung-stage immunity to N. brasiliensis. Comparison of 
lung neutrophil, macrophage and eosinophil numbers showed that as expected NLRP3-/- mice 
had significantly increased frequencies and total number of neutrophils compared to WT mice 
(Figure 4.3.5 B-C). However, NLRP1-/- mice did not display elevated neutrophil responses in 
the lung (Figure 4.3.5 B-C), suggesting that there are distinct mechanisms by which the 
different inflammasome proteins NLRP1 and NLRP3 control tissue-specific immunity to 
worms. 
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Fig5: NLRP1 limits cellular immunity and promotes worm 
burdens following Nippostrongylus Infection
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Figure 4.3.5. NLRP3 is more important than NLRP1 for early immune responses in the 
lung following N. brasiliensis infection. WT, NLRP1-/-  and NLRP3- /- mice were infected (INF) 
with N. brasiliensis, worm burdens and lung cellular immune responses were determined at d 2 
p.i. (n=5 mice/group). (A) Lung worm burdens. (B) Representative plots displaying of Siglec F+ 
CD11b+ eosinophils, Siglec F- CD11b+ neutrophils and Siglec F+ CD11bint macrophages 
frequencies in lung tissue at d 2 p.i. (C) Total lung eosinophils, macrophages and neutrophils. 
Data are expressed as mean with individual data points and are representative of 2 experiments, 
n=5 mice/group. *p <0.05 compared to WT. ns denotes not significantly different. 
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Supplementary figure 4.3.1. NLRP1 inflammasome inhibits Th2 immunity and induce 
worm burdens. WT and NLRP1−/− mice were infected with 200 T muris eggs and sacrificed at 
d 21 post-infection (p.i.). (A) Cecal worm burdens at d 21 p.i. (B) Representative plots 
displaying Siglec F+ eosinophils frequencies in the mesenteric lymph nodes (mLN) at d 21 p.i.  
(C) Total mLN eosinophils at d 21 p.i. (D, E and F) T . muris antigen-specific IL-5, IL-13 and 
IFN-γ production by restimulated mLN cells. (G) Representative images of H&E stained cecum 
at d 21 p.i. Scale bar=50µm. (H) Blinded scores of cecal pathology, pooled from 2 experiments. 
Data are expressed as mean with individual data points and are representative of 2 experiments, 
n=5 mice/group. *p <0.05 compared to WT. ns denotes not significantly different.  
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4.4 Discussion   
Type 2 immune responses are important for immunity to parasitic helminths, however it is 
clear that helminths are able to evade this immune response to enable their survival within 
their host (Maizels and McSorley, 2016). Previous research shown that inflammasomes, 
particularly NLRP3 may be important for suppressing protective immune responses to helminth 
infection, resulting in immunopathology and chronic infections. In present paper we showed 
that a different inflammasome pathway, involving NLRP1, is also important for controlling 
intestinal immune responses following infection with a mouse model of hookworm, N. 
brasiliensis and a model of whipworm infection, T. muris. However, data from this report and 
previous studies support the notion that NLRP3 appears to play a more substantial role in 
immunity to helminths, in particular lung-stage immunity to N. brasiliensis and activation of 
inflammasomes in vitro. Together it is evident that there are multiple distinct inflammasomes 
that may play important roles in immunity to invading pathogens such as parasitic helminths, 
and these inflammasomes may play different functions depending on the nature of the pathogen 
and the tissue that is infected. 
Our results suggest that N. brasiliensis infection induce NLRP1 and NLRP3 inflammasomes 
activation in vitro and in vivo, therefore this study represents the first report of activation of 
multiple inflammasomes by a helminth pathogen. These results are consistent with those seen 
during other infectious diseases, such as Salmonella infection (Qu et al., 2016), and in 
Toxoplasma infection. In these studies it was observed Toxoplasma infection of murine bone 
marrow-derived macrophages primarily activates the NLRP3 and NLRP1 inflammasomes, 
leads to rapid secretion of IL-1β (Gorfu et al., 2014). Similar activation of NLRP1 was observed 
in rat macrophages (Cirelli et al., 2014). Together, these studies using diverse pathogens have 
shown that exposure to infectious stimuli can activate multiple pathways to inflammasome 
activation, which may lead to distinct downstream mechanisms of immunity to the pathogen. 
 136 
Data from the present study suggest that NLRP1 may be important for controlling the intestinal 
phases of both N. brasiliensis and T. muris infections, where NLRP1 deficient mice displayed 
increased cellular immune responses, measured by mLN eosinophils, IL-5, IL-13 and 
accelerated worm expulsion. However, taking into consideration data from previous studies and 
the present study, it appears as if NLRP3 may be more important for innate immunity within 
the lung. For example, NLRP3 is more essential for the rapid neutrophil and eosinophil 
response in the lung. We were not able to define the precise mechanism of how NLRP1 controls 
innate or adaptive immunity to gastrointestinal helminths within the intestine. NLRP1 may 
influence the balance of Type 1 and Type 2 cytokine responses, where in the absence of NLRP1 
there is a more biased Type 2 immune response and enhanced protective immunity. There is 
also a possibility that NLRP1 and NLRP3 may be expressed on different cells that may explain 
their different roles in regulating immunity. For example, the reason why NLRP3 is more 
important for innate immunity to N. brasiliensis is that it may be expressed on innate immune 
cells, while NLRP1 is more restricted to adaptive immune cells. Further studies should examine 
the nature of the intestinal cellular immune responses and immune gene expression in NLRP1 
deficient mice that would help define a specific molecular or cellular pathway that is up-
regulated in NLRP1-deficient mice that may contribute to enhanced Type 2 immunity. 
Our results from chapter 2 highlighted the importance of T. muris in activate the NLRP3 
inflammasome in vitro and in vivo, however, in present chapter we found that in macrophages, 
activation of inflammasomes by N. brasiliensis antigens was more dependent on NLRP3 than 
NLRP1 (see Fig 4.3.2). However, our in vivo studies revealed that NLRP1 may control 
infection-induced IL-18 and IL-1β levels in the gut, similarly to NLRP3 (see chapter 3 Fig 
3.3.1), hence there must be some NLRP1-dependent activation of inflammasomes that is 
occurring in vivo. There may potentially be other gut-resident cells that are activating 
inflammasomes in vivo, for example epithelial cells, dendritic cells and neutrophils. 
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Alternatively, intestinal macrophages may differ from bone marrow macrophages in their 
responsiveness to N. brasiliensis and its secreted antigens. Overall, there are very few known 
factors that stimulate NLRP1 inflammasome activation, hence further studies to investigate the 
potential worm-derived factors, or host-derived factors (such as damage-associated molecules 
or commensal bacteria) would be important for fully elucidating the mechanism of how NLRP1 
controls anti-parasitic immune responses. 
 
In summary, we establish that both NLRP1 and NLRP3 are important in vivo regulators of gut 
stage following N. brasiliensis infection. Our findings also indicate that in vivo and in vitro 
innate resistance to lung stage following N. brasiliensis infection is more NLRP3 dependent 
than NLRP1, indicate that there are distinct mechanisms by which different inflammasomes 
control immunity N. brasiliensis infection. Further investigations are needed to identify the 
mechanisms of the NLRP1 pathway in regulation of Type 2 immune responses and whether 
other inflammasomes (such as AIM2, NLRP6, NLRP12 and NLRC4) also play roles in 
immunity to parasitic helminths. 
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4.5 Materials and Methods 
4.5.1 Parasitological techniques 
4.5.1.1. Nippostrongylus brasiliensis  
N. brasiliensis was maintained in Sprague–Dawley rats (Animal Resources Centre, Perth, WA, 
Australia) and infective L3 were prepared from rat fecal cultures. Mice were infected by 500 
L3 subcutaneously.   
 
4.5.1.2 Trichuris muris  
T. muris was maintained in genetically susceptible or immunocompromised mouse strains and 
T. muris excretory/secretory (ES) antigens were obtained as described previously (Artis et al., 
1999). Mice were infected by oral gavage with approximately 200 embryonated T. muris eggs. 
Trichuris-Ag specific cytokine responses in mLN cells were assayed by ELISA.  
 
4.5.2 Mice and treatments 
NLRP1-deficient, NLRP3-deficient mice on C57BL/6 genetic background, and parental 
C57BL/6 wild-type control mice were bred and maintained at James Cook University (JCU), 
Cairns Campus. Male and female mice between 6 and 8 weeks of age were used. All 
experimental protocols were approved by the JCU Animal Ethics Committee 
 
4.5.3 Mouse tissue collection and processing  
At necropsy, Lung tissue was minced and incubated with stirring at 37 °C for 30 min in HBSS 
with 1.3 mM EDTA (GIBCO), followed by treatment at 37 °C for 1 h with collagenase (1 
mg/ml; Sigma) in RPMI 1640 (Mediatech) with 5% FCS (Biowest) and with 100 µg/ml of 
DNase (Sigma) for 10 min. Cells were lysed with ACK Lysing Buffer (Lonza) to remove 
erythrocytes, blocked with Fc Block (BD Biosciences).  
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Single cell suspensions of mLN tissue were prepared by passing through 70 µm nylon mesh 
filters. For small intestine or colon tissue homogenates, 1 cm of tissue was mechanically 
homogenized in 0.5 mL of PBS using a Tissue Lyzer (QIAGEN) and supernatants were assayed 
for IL-5, IL-13, IL-1β and IL-18 using standard sandwich ELISA protocols (eBioscience or 
ELISAkit.com.au). Small intestine or colon tissue was fixed in 4% formaldehyde and 
embedded in paraffin, and 5 μM sections were stained with H&E or PAS/Blue stains using the 
standard protocol of an institutional histology service provider (QIMR Berghofer Medical 
Research Institute). For determination of worm burdens, small intestines or colons were 
collected and worms were counted using a dissecting microscope. Lung larval burdens were 
assessed by mincing the mouse lungs with scissors in PBS and counting emigrated larvae under 
a dissecting microscope. 
 
4.5.4 In vitro bone marrow macrophage assays 
Bone marrow was isolated from hind legs of C57BL/6, NLRP1 and NLRP3-/- mice by flushing 
bones with DMEM and cells were cultured at 1×106 cells/ml in DMEM supplemented with 10% 
FBS, 5% horse serum (Invitrogen), 2mM L-glutamine, 10mM HEPES, 1mM sodium pyruvate 
and 10 ng/ml M-CSF. On day 6, macrophages were harvested and plated at a concentration of 
2×105 cells/ml.  The following day, cells were treated with 25 µg/ml of Nippostrongylus, LPS 
(1µg/ml)+nigericin (20 µM) Sigma-Aldrich, or media only for 6 hours, and cell-free 
supernatants were stored at -80°C. 
 
 
4.5.5 Flow cytometry  
Cell preparations were surface-stained with anti-mouse fluorochrome-conjugated mAbs against 
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CD11b (M1/70), CD11c (HL3), Gr-1 (RB6-8C5), Ly6G (1A8), and Siglec F (E50-2440) Cells 
were stained with cell surface Ags and then with fixation and permeabilisation using a 
commercial kit (BD Biosciences). Cells were analysed by flow cytometry using a FACS Canto 
II or Aria III cytometer (BD Biosciences) where dead and doublet cells were excluded by the 
use of a live gate and doublet discrimination. Further analysis was performed using FlowJo 
software (Tree Star, Inc).  
 
4.5.6 Statistical analyses 
 
Statistical analyses for murine studies were performed using unpaired Mann-Whitney U tests. 
Mice cytokine data were compared using paired Mann-Whitney U tests. Results represent the 
mean ± SEM and the differences were considered significant at a p value of <0.05. 
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5. General Discussion 
 
5.1 Overview 
Helminth parasites infect almost one-third of the human population, rendering them among the 
most predominant infectious diseases in the world (Hotez et al., 2008). Additionally, helminths 
are a prevalent problem in the livestock industry where they are considered a major economic 
burden. These infections can also be responsible for promoting long-term chronic infections 
with other pathogens due to downregulation of immune responses (Elliott et al., 2007; Hoerauf 
et al., 2005; Maizels and Yazdanbakhsh, 2003). The eradication of helminthic infections 
remains difficult because of a lack of effective vaccines, inadequate anthelminthic drug 
treatment efficacy, emerging drug resistance, and rapid reinfection. Since helminth parasites 
are masters of evading the immune system, it is imperative that more research goes into the 
immunological basis of why some helminth infections become chronic and some are efficiently 
expelled, so that the power of the immune system can be unleashed to fight these pathogens.  
 
Data presented in this dissertation provide evidence that inflammasomes, which had previously 
been known for being important for immunity to small microbial pathogens, play an important 
role in whether infections with helminths are acutely expelled, or become chronic with 
increased worm burdens. Specifically, I have shown that the NLRP3 and NLRP1 
inflammasomes regulate cellular and molecular immune responses to multiple species of 
gastrointestinal helminths, the whipworm T. muris and hookworm N. brasiliensis, by a range 
of potential biological mechanisms including actions on the innate and adaptive immune 
system. I have identified that targeting the NLRP3 inflammasome therapeutically results in a 
boost in protective Type-2 immune responses, reduced worm burdens and decreased 
immunopathology associated with infection. Furthermore, we have identified that 
inflammasomes may also regulate the innate neutrophil-mediated immune responses to the 
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hookworm N. brasiliensis. Together, my research project has shed new light on a previously 
under-researched topic, that is how innate immune receptors such as inflammasomes are 
activated or inhibited and most importantly identified some molecular and cellular mechanisms 
by which these inflammasomes regulate immunity to infections.  
 
5.2 Activation of inflammasomes by helminths. 
 
Inflammasomes are important mediators of immunity to pathogens, however their roles in 
immunity to parasitic helminths has been under-studied. Inflammasome formation is triggered 
by a range of substances that emerge during infections, tissue damage or metabolic imbalances 
(Pelegrin and Surprenant, 2007; Vilaysane et al., 2010). ASC is composed of an N-terminal 
PYD domain and a CARD, which interacts directly with multiple PRRs, such as NLRPs, NLR 
caspase recruitment domain-containing protein (NLRC), and AIM2, to form caspase 1-
activating platforms termed inflammasomes (Martinon et al., 2002; Masumoto et al., 1999). 
Once the protein complexes have formed, the inflammasomes activate caspase 1, which 
proteolytically activates the pro-inflammatory cytokines IL-18 and IL-1β (Martinon et al., 
2002; Masumoto et al., 1999). However, the mechanisms underlying both the activation and 
regulation of this inflammatory pathway during helminth infections has been unclear. Here we 
have provided evidence that helminths such as T. muris and N. brasiliensis, and their 
excretory/secretory products and bacteria serve as an integral activating signal for the NLRP3 
and to a lesser extent, NLRP1 inflammasomes.  
The NLRP3 inflammasome can be activated in response to a range of stimuli including those 
of microbial, endogenous and exogenous origins. However, the precise pathway at which these 
stimuli converge to activate NLRP3 still unknown. For instance, exogenous pathogens can 
activate the NLRP3 pathway such as Sendai virus (Kanneganti et al., 2006), influenza virus 
(Ichinohe et al., 2009; Kanneganti et al., 2006), adenovirus (Muruve et al., 2008), 
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Staphylococcus aureus (Mariathasan et al., 2006), Listeria monocytogenes (Mariathasan et al., 
2006; Warren et al., 2008) and Shigella flexneri (Willingham et al., 2007) . Further, bacterial 
pore forming toxins can also activate this pathway; nigericin (Streptomyces hygroscopicus), 
maitotoxin (Gambierdiscus toxicus), aerolysin (Aeromonas hydrophila) and listeriolysin O (L. 
monocytogenes) are also responsible for activating caspase-1 in a NLRP3 dependent manner 
(Gurcel et al., 2006; Mariathasan et al., 2006). In contrast, less is known about how the NLRP1 
inflammasome can be activated, where the B. anthracis lethal toxin (LeTx) (Boyden and 
Dietrich, 2006), and peptidoglycan (PGN) or its degradation product muramyl dipeptide (MDP) 
(Faustin et al., 2009), have been shown to be responsible. In our studies, we reported that adult 
worms from T. muris and N. brasiliensis release factors that can promote NLRP3-dependent 
IL-18 and IL-1β secretion in vivo and in vitro. A role for NLRP1 in in vitro inflammasome 
activation by helminth antigens was not clearly defined. Interestingly, we found that worm 
secreted factors do not induce NLRP3-dependent IL-1β and IL-18 secretion alone, since signals 
from known inflammasome activators (e.g. LPS and nigericin) were also needed. These data 
suggest that worm molecules may have a role as a “second signal” in this system that boosts 
NLRP3 activation in the presence of signals from other microbes. This may be important in the 
context of an intestinal bacterial infection where the parasite is feeding and disrupting the 
epithelial barrier, potentially exposing the host to increased stimuli from resident commensal 
or pathogenic bacteria. It would be interesting to conduct in vivo studies to determine whether 
bacteria are also necessary for in vivo inflammasome activation by helminths (i.e. using germ-
free mice or antibiotic treatments), however these studies would have some practical limitations 
in that helminths such as T. muris can’t establish efficient infections in the absence of 
commensal flora (Hayes et al., 2010). 
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Our research has not addressed the precise worm-derived molecule(s) responsible for 
inflammasome activation, or the receptor for the worm-derived molecules which has been 
highlighted in schistosomes (Ritter et al., 2010). However we did make some progress in 
identifying that purified extracellular vesicles (exosomes) produced by the T. muris worm can 
promote NLRP3 activation as efficiently as native ES proteins. Helminth-derived exosomes are 
becoming increasingly appreciated for their roles in immune modulation by parasitic helminths 
(Buck et al., 2014), where they contain hundreds of proteins, micro-RNAs and mRNAs that can 
mediate host-pathogen interactions (Eichenberger et al., 2018). Our study was the first evidence 
that helminth-derived exosomes can activate inflammasomes and future studies could explore 
the potential factors within exosomes that mediated these effects. Understanding which 
molecules activate /inhibit the inflammasomes may lead to significant outcome for the 
development of new strategies cure gastro-intestinal helminth infections. For instance, a novel 
immune modulatory strategy used by F. hepatica involves secretion of the FhHDM-1, a 
cathelicidin-like protein, which impairs the activation of NLRP3 by lysosomal cathepsin B 
protease, preventing the downstream production of IL-1β and Type-1 immune responses 
(Alvarado et al., 2017). It is conceivable that other worms may secrete an array of factors that 
may inhibit inflammasome activation, which could be identified, purified and used in human 
autoimmune diseases such as IBD, rheumatoid arthritis or Type 1 diabetes to dampen damaging 
Type-1 cytokine responses. Alternatively, if we can identify a specific worm-derived molecule 
that activates inflammasomes, which may act to enhance its ability to survive in its host, there 
may be an opportunity to design a vaccine or chemical inhibitor that will block worm-induced 
inflammasome activation and maybe accelerate immunity to the worm. This would have 
advantages over current methods of inhibiting NLRP3 using chemical inhibitors such as 
MCC950 which would block all inflammasome activity and hence may have side effects such 
as increased susceptibility to infectious pathogens. Together, there is much work to do beyond 
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my research project to define how a range of species of worms, and their secreted products, 
influence activation of the various inflammasome pathways and progress in this area could lead 
to significant outcomes for both parasitic diseases, and inflammatory diseases.  
In addition to worm-secreted factors and signals from commensal microbes, there are likely 
other mechanisms by which a worm infection could promote or inhibit inflammasome 
activation. It has revealed that pannexin hemichannel can activate the NLRP3 inflammasome 
mostly in response to ATP, through the P2X7 receptor, nigericin and maitotoxin (Pelegrin and 
Surprenant, 2006, 2007). We found that the ATP-P2X7R pathway does appear to control N. 
brasiliensis infections in the same way as NLRP3, suggesting that during N. brasiliensis 
infections, the presence of larvae within the lungs and the damage they cause when they traverse 
from the lung vasculature into the airways (potentially generating damage-associated factors 
like ATP) may be an important factor in inflammasome activation within the lung. This was in 
contrast to what we observed in T. muris infections in the gut, where P2X7R-deficient mice did 
not have the same phenotype as NLRP3-deficient mice, suggesting that there are clear 
differences in the mechanisms by which worms activate inflammasomes, depending on the type 
of worm and tissue infected.  
Our data demonstrated that N. brasiliensis and T. muris molecules activate NLRP3 and promote 
IL-18 and IL-1β secretion by macrophages in vitro. However, were we unable to determine if 
macrophages were responsible for in vivo infllammasome activation. Further studies such as 
looking at intestinal macrophages in naive and helminth infected mice to assess inflammasome 
activation by cleavage of Caspase-1, ASC speck formation and IL-18/IL-1β production would 
more convincingly show that macrophages respond to helminth infection to activate 
inflammasomes, or whether other cells may be also important for the inflammasome activation 
in vivo. For example, it has been reported that antigen-specific CD8+ T cell feedback activates 
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NLRP3 inflammasome in antigen-presenting through perforin (Yao et al., 2017). Moreover, it 
has been revealed that dendritic cells activate NLRP3 inflammasome against 
Chlamydia infection (Omosun et al., 2015), and against Histoplasma capsulatum (Chang et al., 
2017). Further, It has demonstrated that human neutrophils express NLRP3 and secreted IL-1β 
against H. Pylori infections (Perez-Figueroa et al., 2016). Further, Natural killer cells can also 
activate NLRP3 in response to colorectal cancer (Dagenais and Saleh, 2016). Hence, it would 
be interesting to conduct in vitro studies to determine whether other cells such as T cells, 
dendritic cells, NK cells and neutrophils are also important for the NLRP3 inflammasome 
activation in responsible to helminths.  
	
5.3 Mechanism(s) by which NLRP3 and NLRP1 regulate immune responses following 
helminth infections 
In the present studies we identified a novel role for the NLRP3 inflammasome in manipulating 
both innate and adaptive immunity of mice to a whipworm T. muris infection, where regulation 
of IL-18 expression may be the primary mechanism. Targeting this pathway therapeutically 
with a chemical inhibitor MCC950 was able to exaggerate Type-2 immune-mediated clearance 
of the parasite, demonstrated the importance of NLRP3 in suppressing immunity to T. muris. 
Studies outlined in Chapter 4 demonstrated that NLRP1 appears to play a similar role in 
suppressing immunity to T. muris, where NLRP1-deficient mice displayed elevated protective 
Type 2 immune responses associated with reduced gut worm burdens at day 21 post-infection.  
However, there is less evidence that this mechanism is mediated by IL-18 and IFN-γ-dominated 
Type-1 immune responses, which is what was observed for NLRP3 (see results from Chapter 
2). In contrast, NLRP1 may act via some other mechanism, for example by directly inhibiting 
the Type 2 immune response. This may be a role for NLRP1-mediated IL-1β, which would be 
consistent with a previous study where IL1β suppresses Type 2 immunity by inhibiting IL-25 
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responses in the gut (Zaiss et al., 2013). Similarly, another study has reported that IL-1β 
secretion is a critical regulator of group 2 innate lymphoid cell function and plasticity (Ohne et 
al., 2016).  Unfortunately, I was unable to confirm whether IL-1β secretion was directly 
associated with boosting Type-2 immune responses, or if there was a different NLRP1-
mediated mechanism of how immunity to T. muris was suppressed. In any case, ours is the first 
study to report the roles for multiple distinct inflammasomes in immunity to helminths and they 
support findings from studies with protozoan parasite infections where both NLRP1 and 
NLRP3 both play significant roles(Gorfu et al., 2014) . These finding suggest that significant 
redundancy exists within the immune system where multiple proteins/factors play similar or 
overlapping roles. This has the benefit of enabling protection of the host from infectious 
challenge if a particular inflammasome is non-functional due to genetic polymorphism, i.e. 
another inflammasome may be sufficient to help fight the infection and ensure survival of the 
affected host.   
 
My studies have shown that IL-18 may be a critical downstream regulator of NLRP3-
dependent immune responses but questions still remain as to how IL-18 functions to regulate 
immunity to helminths. IL-18, which was originally termed IFN-γ-inducing factor, was 
fundamentally considered a TH1-inducing cytokine, and IL-18R is expressed by NK cells, 
Th1 cells, macrophages and dendritic cells in response to IL-12 stimulation (Yoshimoto et 
al., 1998). Hence in our T.muris studies is remains possible that IL-18 may be engaging with 
one of these target cells to exert its biological effect. For example, NK cells or ILCs promptly 
produce effector cytokines such as IFN-γ in response to stimulation with IL-18 and data from 
Chapter 2 support a potential role for ILC1s in helminth-induced immune regulation via NLRP3 
(Cella et al., 2014; Diefenbach et al., 2014; McKenzie et al., 2014). In addition, IL-18 is 
critically important in controlling intestinal immune function where intestinal epithelial cells 
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can produce, and respond to IL-18 via expression of the IL-18R  (Nowarski et al., 2015; 
Siegmund, 2010). As part of our studies we were not able to ascertain if IL-18 is acting on 
immune cells (ILCs, Th1 cells) or non-haematopoietic cells such as epithelial cells but this 
could be investigated further by studies using bone-marrow chimeric mice, or mice with cell 
specific deletions in IL-18R. 
 
The role for IL-18 in the immune system is very complex, since IL-18, is unessential for the 
initial polarization of TH1 cells, but delivers an accelerating and amplifying signal for their 
proliferation and IFN-γ secretion. Further IL-18 can induce the production of TH2-type 
cytokines by both naive and TH1-polarized cells (Moller et al., 2001). IL-18 is a pleiotropic 
cytokine that can regulates both Type-1 and Type-2 responses, relying on the nature of the 
cytokine milieu, infectious stimuli and genetic background of the host (Nakanishi et al., 2001; 
Wei et al., 2004; Xu et al., 2000). Our results from chapter 2 have highlighted the importance 
of IL-18 in promoting Type-1 immune responses. However other studies revealed that IL-18 
can promote Th1 immune responses and resistance to one species of the Leishmania parasite 
(Li et al., 2004), but induce non-protective Th2 responses to another species (Bryson et al., 
2008). Further, one study highlights how IL-18 induces Type-2 responses when IFN-γ is absent 
(Liu et al., 2006), another study implicates IL-18 in suppressing Type-2 cytokine responses to 
T. muris (Helmby and Grencis, 2004). Hence it is possible that in the context of the present 
study, lowered IL-18 level in the absence of NLRP3 may participate in the elevated Type-2 
responses and diminished Type-1 responses against T. muris infection. It is possible that 
NLRP3 suppress immune responses to T. muris infection via inhibiting IL-25, IL-33 and TSLP 
secretion. 
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	5.4 Mechanism by which NLRP3 and NLRP1 regulate early innate immune responses 
following helminth infections. 
 
While our studies have shown that NLRP3 and NLRP1 may play important roles in regulating 
adaptive immune responses to T. muris infections, which develop over weeks, we have also 
evidence that roles for inflammasomes are evident even in the first 1-2 days of infection, which 
would likely involve regulation of innate immune responses. For example, we have 
demonstrated that NLRP3 can also suppress the early innate immune responses against 
hookworm N. brasiliensis infections in the lung, and absence of NLRP3 lead to increased 
resistance to the parasite. Similar to results seen in T. muris infections, this increased anti-
parasitic immunity was associated with increased eosinophilia and Type 2 cytokines such as 
IL-4, however it was the rapid increase in neutrophil recruitment to the lung that was most 
striking. This suggests that NLRP3 may have diverse functions in immunity to different 
helminth pathogens, depending on the type of parasite and the tissue affected. We found that 
NLRP1 is less involved in innate immunity to N. brasiliensis, potentially because it does not 
suppress neutrophil responses into the lung. We could not identify the precise mechanism of 
how NLRP1 is activated and how it suppressed gut-specific immunity to T. muris and N. 
brasiliensis. It would be important in future to conduct a detailed analysis of immune responses 
in the gut of WT and NLRP1-deficient mice via gene expression analysis and flow cytometry 
to determine if there is a specific biological pathway is up or down regulated in NLRP1-
deficient mice, which would provide a clue about how NLRP1 influences anti-parasitic 
immunity.  
While we have shown that neutrophils were present in increased numbers in the lung in the 
absence of NLRP3, and that neutrophils can potently kill N. brasiliensis larvae, there are 
questions that still remain regarding how neutrophils are regulated by NLRP3. For example, 
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neutrophils have a potential role in parasite killing, however they may also participate in 
initiating inflammation and perhaps even being responsible for inflammasome activation and 
function as a feedback loop for lung neutrophil responses (Amulic et al., 2012; Cassatella, 1995; 
Coeshott et al., 1999; Joosten et al., 2009). The mechanism of how neutrophils are recruited 
into the lung remain undefined. It has been revealed that neutrophils are recruited to site of 
infection and arrive following the production of CXCL1, CXCL8 and CXCL2 (Miotla et al., 
2001; Ribeiro et al., 1990). We have demonstrated that one of the key neutrophil 
chemoattractant molecules, CXCL2, is significantly upregulated in the absence of NLRP3, 
implicating this chemokine as likely to mediate elevated neutrophil chemotaxis to the lung. 
How NLRP3 regulates the level of CXCL2 was not determined.  CXCL2 expression is 
dependent on factors such as NF-kappa B, TNF, PAF and IKKα (Burke et al., 2014; da Silva 
et al., 2012; De Plaen et al., 2006; Goktuna et al., 2014), however it is unclear based on the 
current literature how NLRP3 may influence expression of CXCL2 in response to these factors. 
Further, the cell type that expressed CXCL2 and promotes neutrophil recruitment was not 
determined. CXCL2 is expressed by a variety of cell types including epithelial cells, mast cells 
and macrophages (De Filippo et al., 2013; Ohtsuka et al., 2001), hence it is possible that 
following N. brasiliensis infection in the lung, CXCL2 is expressed by epithelial cells and this 
mediates recruitment of neutrophils to the lung tissue, however further work examining cell-
specific expression of CXCL2 is required to demonstrate which cell type is responsible for 
recruiting neutrophils. To further define a causal role for CXCL2 in enhanced neutrophil 
recruitment to the lung in absence of NLRP3, more studies involving such as blocking CXCL2 
receptor could be conducted, to determine whether this prevents neutrophil recruitment. Lastly, 
other factors can influence neutrophil activation and recruitment, including IL-17A which 
promotes neutrophil-mediated immunity by activating microvascular pericytes (Liu et al., 
2016). Similarly, neutrophils can also be recruited into tissues in response to segmented 
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filamentous bacteria, which is dependent on both IL-17A and CXCR2 (Flannigan et al., 
2017). However, I was unable to detect the correlation between IL-17 expression and 
neutrophils recruitment but recent research has highlighted how IL-17A is important for 
neutrophil responses in the lung in N. brasiliensis infections (Sutherland et al., 2014). 
Further work should concentrate on the relative roles for IL-17A in the lung and how this 
may be regulated by parasite-mediated inflammasome activation.  
 
We have reported that neutrophils are immediately recruited to the lung site of infection which 
were consistent with other study who demonstrated that  neutrophils can recruited to the lung 
at day two after primary N. brasiliensis infection (Chen et al., 2012).  Further Chen. et.al have 
demonstrate that macrophages primed during a Type-2 immune response and under the 
influence of neutrophils maintain a long-lived phenotype that facilitates accelerated helminth 
eradication in the absence of T or B cells. (Chen et al., 2014).  These studies suggest that in 
addition to acting alone, neutrophils may also be able to cooperate with other lung-resident 
cells, such as macrophages, to promote anti-parasitic immunity. While we were not able to 
demonstrate a causal role for macrophages in NLRP3-dependent suppression of immunity to 
N. brasiliensis, we did show that depletion of neutrophils only partially suppressed the robust 
protective immunity to N. brasiliensis, hence other cells such as macrophages are likely to play 
a role. The potential synergistic innate immunity afforded by neutrophils and macrophages in 
the lung was supported by a recent study where Chen. et.al demonstrated that N. brasiliensis 
infection triggers the development of an alternatively activated neutrophil (‘N2’) population 
that shows a characteristic global transcriptional profile distinct from LPS-activated neutrophils 
(‘N1’) (Chen et al., 2014). These N2 cells produce Type 2 cytokines that are important for 
promoting alternative-activated macrophage-mediated parasite killing. Hence, it remains 
possible that in the absence of the NLRP3 inflammasomes, neutrophils may exhibit a distinct 
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N2 phenotype that orchestrates the innate Type 2 immune responses, and this could be followed 
up in further studies undertaking detailed gene expression analyses of lung neutrophils sorted 
from WT and NLRP3-deficient mice. 
 
My in vitro culture results suggest that neutrophils alone are highly toxic to N. brasiliensis 
larvae, rendering the larvae straight and immotile. Neutrophils possess an vary of mechanisms 
by which they could kill helminths, including complement-mediated cytotoxicity, production 
of oxygen free radicals or the release of extracellular traps (Bonne-Annee et al., 2013; Galioto 
et al., 2006). Neutrophils are also associated with killing other species of helminth, such as 
larval stages of Strongyloides stercoralis, where neutrophils alone could eradicate the parasite, 
however eosinophils and macrophages were also required for optimal killing (Bonne-Annee et 
al., 2013; Chen et al., 2014; Galioto et al., 2006). However, neutrophils seem to only have a 
partial role during infection with S. mansoni, as their depletion did not influence the severity of 
disease (Herbert et al., 2004). Further, while neutrophils have been shown to be important in 
vitro, there is relatively little evidence that they are important in vivo (Pesce et al., 2008). Hence 
neutrophils seem to be at least partly responsible for increased parasite killing in absence of 
NLRP3, other reasons may also be involved. It would be interesting to conduct a detailed 
analysis such as depletion of other cell including eosinophils, macrophages, ILC2s and 
basophils that are also associated with immune responses to N. brasiliensis may demonstrate 
more information about the range of immune factors that induce innate resistance to the 
helminth. 
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5.5. Potential role for other inflammasomes in regulating immune responses 
following helminth infections. 
My studies have focussed on the roles for the NLRP3 and NLRP1 inflammasomes in regulating 
immunity to helminth infections, however there are different inflammasomes each with 
different functions. Hence it is possible that these other inflammasomes may also be involved 
in regulation the immune responses against helminth infections. For example, NLRP6 is play 
an important role against infectious diseases (Anand et al., 2012; Elinav et al., 2011; Wlodarska 
et al., 2014). Moreover, NLRP12 has also been shown to play an important role against invading 
pathogens (Ataide, 2014; Vladimer et al., 2012). AIM2 is similarly critical for immune 
responses after infection with various viral and bacterial infectious agents, such as vaccinia 
virus, mouse cytomegalovirus (Rathinam et al., 2010), Francisella tularensis (Fernandes-
Alnemri et al., 2010; Rathinam et al., 2010) and Listeria (Kim et al., 2010; Rathinam et al., 
2010). It would be interesting to conduct a detailed analysis of the relative roles for different 
inflammasomes following helminth infections. For example, investigate the activation of 
different inflammasomes in vitro by exposing macrophages or dendritic cells from the various 
inflammasome-deficient mice to different helminth-secreted antigens and seeing which 
inflammasome pathways are activated. Similar studies could be performed in vivo, by 
examining which of the various inflammasome-deficient mouse strains exhibit differences in 
worm-induced inflammasome activation (IL-18, IL-1β secretion) and downstream anti-
parasitic immune responses, using different murine models of helminth infections. 
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5.6. Potential role of the NLRP3 inflammasome as a transcription factor following 
helminth infections. 
Our data have supported the role of NLRP1 and NLRP3 in regulating the innate and adaptive 
immune responses following helminth infections, which we argue is dependent on the 
activation of inflammasome complexes and release of the products of this activation, i.e. IL-18 
and IL-1β. However, it is becoming apparent that some inflammasome proteins have biological 
roles that are independent of their abilities to activate inflammasomes. For example, NLRP3 
can act as a direct transcription factor in promoting Th2 cell differentiation (Bruchard et al., 
2015). Other studies have suggested that NLRC5 is also a transcriptional regulator, 
orchestrating the concerted expression of critical components in the MHC-I pathway (Meissner 
et al., 2010). Further, Class II transactivator (CIITA) has been shown to regulate the 
transcription of genes encoding major MHC but does not act as a classical transcriptional 
factor because it does not bind to DNA (Devaiah and Singer, 2013). Hence, it remains 
possible that NLRP3 and NLRP1 may also play a role as transcription factors or in some other 
biological process, it was impossible for us to distinguish these potential roles in the studies 
described in this thesis. As a first step to address this, further experiments could be conducted 
such as using mice deficient in Caspase-1/11 and testing various inflammasome inhibitory 
molecules (e.g. MCC950). For example, if Caspase 1 deficient mice are treated with MCC950 
and it still has an effect, then NLRP3 may play an inflammasome independent role, such as 
descried in other papers. This could also be done by making double mutant Caspase 1/11-
deficient, NLRP1/3 deficient mice to see if the absence of specific inflammasome proteins has 
a biological effect that is independent of its activity to activate inflammasomes and Caspase 1.  
 
Recent studies have highlighted that inflammasomes are associated with determining the nature 
of the microbiome (Elinav et al., 2018), and also that worm infection can alter the microbiome 
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(Zaiss and Harris, 2016). Further, recent studies have shown that the effects of NLR deficiency 
can vary depending on the research facility (Robertson et al., 2013).  This raises the question 
as to whether the effects of NLRP1 and NLRP3 deficiency on immunity to N. brasiliensis and 
T. muris were direct (via changes in immune function), or indirect i.e. via changes in 
composition of the microbiota. I didn’t directly assess whether there were differences in the 
microbiota of the deficient mice I used in my studies, hence I was not able to determine whether 
the microbiota played a significant role in my findings. However, I did perform studies 
involving targeting the NLRP3 inflammasome acutely with a selective chemical inhibitor 
MCC950, where all mice were on the same genetic background, age and sex matched and thus 
would have had very similar microbiomes. In these studies (described in Chapter 2), acute 
ablation of NLRP3 had a similar effect as genetic NLRP3 deficiency, hence it is unlikely that 
microbiome status alone determined the phenotype we observed. Unfortunately, we could not 
perform similar studies with N. brasiliensis experiments or NLRP1 studies and should be a 
focus of future research. For example, co-housing studies should be performed to determine if 
any of my observed effects could be due to differences in microbiome.  
 
 
5.7. Potential role of inflammasomes in human helminth infections. 
 
We have investigated the molecular mechanisms of how NLRP3 and NLRP1 inflammasome 
are activated by using different model of infections in vivo and in vitro, mostly using an animal 
model of helminth infections. Some of my data from Chapter 2 support the notion that some of 
these mechanisms may operate in human infections with hookworms, but these studies were 
very limited in scope.  It would be important to follow up my human studies in more details to 
see whether helminths activate inflammasomes in humans. Firstly, it would be important to 
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conduct in vitro studies using human monocyte-derived macrophages or dendritic cells exposed 
to antigens from different species of helminth, to see if the results I observed using mouse cells 
translate to humans. This would represent a great opportunity to identify if there are molecules 
from human pathogens that activate or inhibit inflammasomes. Logical follow-up studies could 
involve an analysis of humans naturally infected with helminths, from endemic areas, to 
investigate whether there is evidence of inflammasome activation. This could involve collection 
of blood and serum from these people and an analysis of IL-18 and IL-1β levels as well as 
Caspase-1 cleavage or ASC speck formation. However, there is a significant limitation for these 
studies given that co-infection would be a major confounder, for instance people with 
tuberculosis or malaria co-infections, which are known to activate inflammasomes (Dorhoi et 
al., 2012; Shio et al., 2009). Equally, it would be difficult to know how many times they have 
been exposed to the worm and how many types of worm they have, how long they have been 
exposed to infections. Lastly, there would be no suitable controls for these studies of un-
infected individuals within the same population. More appropriate for these human in vivo 
studies would be the human helminth challenge studies that involve exposure of previously 
helminth naive individuals to safe, low doses of helminth in a controlled clinical setting 
(Giacomin et al., 2016). Collection of blood, serum and even gut biopsy tissue as part of these 
trials would be a unique resource in which to study the impact of helminth infections on 
inflammasome activation. For example, samples could be collected pre- and post-infection and 
cells such as macrophages, neutrophils, dendritic cells and epithelial cells. could be sorted by 
using flow cytometry and analysed for evidence of worm-induced caspase-1 activation and 
cytokine secretion. Together, better understanding of the roles for inflammasomes in human 
helminth infections would identify whether targeting inflammasomes is a viable strategy to 
treat helminth infections of humans. However, people living in helminth endemic regions are 
often exposed to co-infections with infectious pathogens such as tuberculosis, HIV and malaria 
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and previous studies have demonstrated a protective role for NLRP3 in these infection models 
(Dorhoi et al., 2012b; Shio et al., 2009).   
Hence, caution would be warranted to prevent such therapeutic strategies from having 
unwanted effects of reduced ability to fight other infections. Similarly, I have shown that 
blocking NLRP3 results in increased Th2 responses, highlighting a possible risk of therapeutic 
NLRP3 inhibition for people with allergic diseases such as asthma. While it is too early to 
determine whether this is a considerable risk, given that NLRP3 in particular is associated with 
promoting allergic lung inflammation in mice it is possibly unlikely that blocking NLRP3 
would lead to increased allergic disease. However much more research into this possibility 
would be warranted if inflammasome inhibition therapy becomes more widespread in future.  
 
5.8 Conclusion 
The principle aim of my thesis was to provide evidence that different gastrointestinal helminth 
such as T. muris and N. brasiliensis activate NLRP3 and NLRP1 inflammasomes in vitro and 
in vivo and how these influence helminth-induced immunity and inflammation. We have 
identified a novel mechanism by which NLRP3 regulates both innate and adaptive immune 
responses following T. muris infections via regulation of IL-18 expression. In follow up studies, 
we have confirmed that NLRP3, but not NLRP1, can regulate the early anti-parasitic neutrophil 
responses following N. brasiliensis infection. Additionally, we provided evidence that there is 
a dual role for NLRP3 and NLRP1 in suppressing the generation of gut protective immune 
responses against N. brasiliensis and T. muris infections. Together, my studies herein have 
provided significant new information in the understanding of how immune responses against 
helminths are initiated and regulated and have lead to the identification of potential new 
avenues to progress research in this important area in future. Future work should be focus on 
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defining other signals or associated molecules that may facilitate or direct inflammasome 
activation. Also, the roles of other inflammasomes in regulating immunity and inflammation 
following helminth infection are required, which would be important to develop a potential 
treatment against such infections. Understanding these precise mechanisms may allow the 
development of treatments that can specifically target the function of individual inflammasome, 
by inhibiting their suppressive effects on anti-parasitic immunity and potentially reducing the 
burden of helminth infections in humans.  
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